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Chapter 1 
INTRODUCTION 
Chapter 1 
The use of homologous blood products during anesthesia and surgery is not 
without risks. Complications due to homologous blood transfusions include 
transfusion reactions, isosensitization, transmission of infections (including HIV, 
hepatitis, CMV) and immunosuppression (resuiting in increased postoperative 
infections and possibly increased cancer recurrence) [1-3]. Thus, there are 
important reasons to try to avoid the transfusion of homologous blood products 
as much as possible. Several strategies exist which can be employed to 
decrease the amount of homologous blood products used in a patient 
perioperatively, including preoperative autol090U5 blood donation, intraoperative 
cell saving, several hemodilution techniques and acceptance of a lower 
hematocrit perioperatively. 
Preoperative autologous blood donation is only appropriate for elective 
procedures which can be planned several weeks in advance, without a chance of 
postponement, and in which an adequate amount of blood loss is anticipated to 
make the PABO effective. Therefore, this technique can only be used in a limited 
number of cases. Moreover PABO induces a decrease in natural killer cell activity 
[4). 
The different hemodilution techniques can be subdivided according to 
certain characteristics, such as preoperative (acute) or peroperative (more 
gradual), and normovolemic or hypervolemic. Ouring hemodilution the 
hemoglobin level is reduced, resulting in fewer erythrocytes being lost per 
amount of blood loss, but also in a decrease in oxygen carrying capacity. This 
reduction in oxygen carrying capacity can be compensated tor by a number of 
mechanisms. These include an increase in cardiac output, a redistribution of the 
cardiac output, an increase in oxygen extraction ratio and a shift in the oxygen 
dissociation curve to the right [5-8). With respect to hemodilution techniques 
and the amount of blood that can be saved by these techniques, the issue of the 
lower safe limit of the hematocrit perioperatively remains a matter of debate. 
The aim of the work presented in this thesis was to evaluate several 
aspects of different hemodilution techniques, including effe cts on hemodynamics 
and oxygen transport and monitoring during hemodilution, in an experimental 
model as weil as in humans. As experimental model we selected the pig, which 
under several conditions of stress has shown reactions most similar to those of 
humans than any other experimental animal models [9-11). In the pig we 
evaluated the effect of normovolemic hemodilution on blood gas values, oxygen 
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transport, hemodynamics and distribution of cardiac output. Hemodilution could 
be advanced to a much lower hematocrit in this animal model than one would 
dare to try in human subjects. Also the redistribution of cardiac output to many 
organs and tissues could be measured in this anesthetized pig model, with 
special attention to the heart as one of the most vulnerable organs during 
hemodilution. The heart already has a high oxygen extraction ratio under normal 
circumstances. Furthermore the heart is the organ producing one of the main 
compensation mechanisms, that is an augmentation of the cardiac output which 
increases the work load of the heart and thus increases its oxygen demand. 
Since circulating catecholamines have been hypothesized as being one of the 
regulatory factors in the compensation mechanisms during hemodilution [12J 
their levels were also measured during one of the experimental studies. In the 
search for a parameter which could predict the lowest safe margin of 
hemodilution we also evaluated the balance between oxygen delivery and 
oxygen consumption at extreme hemodilution in pigs. The critica I mixed venous 
oxygen pressure (pvo,], the critical mixed vena us oxygen saturation (Svo,], and 
the critical oxygen extraction ratio (ER) were measured in this experimental 
animal model. At present, no ather parameters are available for monitoring of the 
oxygen delivery during hemodilution in hu man studies. 
The studies in hu mans included several investigations on the technique of 
hypervolemic hemodilution, a technique which is much less time consuming than 
acute normovolemic hemodilution but, at least theoretically, carries the risk of 
acute volume averloading. Moderate hypervolemic hemodilution has been used 
in the treatment of acute stroke [13]. The use of hypervolemic hemodilution with 
a large volume laad has not been used as a method for decreasing the amount of 
homologous blood used peroperatively. We studied the safety and efficacy of 
this technique, and its consequences on hemodynamic and oxygenation 
parameters in anesthetized hu mans. At first the methad of hypervolemic 
hemodilution was only used in Jehovah's Witness patients, but after proving its 
safety it has also been used in many other patients. Due to unfortunate 
circumastances, we we re also able to study the effe cts on hemodynamics and 
oxygenation of extreme hemodilution in one patient (a Jehovah's Witness, who 
refused the use of any homologous blood product) who subsequently died. In 
this patient we could calculate several parameters at the critical point of 
hemodilution, as we had previously done in pigs. 
Normovolemic hemodilution (acute preoperative and a more gradual 
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peroperative technique) and its elfects on hemodynamics and oxygenation, use 
of homologous blood products, blood loss and perioperative erythropoiesis were 
also studied, and compared to preoperative autologous blood donation and a 
control group to evaluate its elficacy in humans. 
During hemodilution the systemic oxygen flux is decreased. This implies 
that monitoring of the balance between oxygen flux and oxygen consumption is 
needed. We evaluated the usefulness of some monitoring methods during 
hemodilution. First we studied the accuracy of pulmonary artery catheters able 
to continuously measure mixed venous oxygen saturation (an important 
parameter during acute hemodilution, reflecting the balance between oxygen 
consumption and oxygen delivery) during hypervolemic hemodilution in humans. 
The slope of the oxygen dissociation curve might change during 
hemodilution and thus influence the amount of available oxygen. In an attempt 
to find a parameter which could more accurately predict the critical point of 
hemodilution and thus could be used as the monitoring parameter during 
hemodilution we evaluated the calculated extraction ratio of the available oxygen 
content (ERav) in an animal model and in anesthetized humans. This ERav uses 
the 5 35 (the oxygen saturation at a oxygen pressure in the blood of 35 mmHg) as 
a dynamic parameter also including the position of the oxygen dissociation 
curve, and therefore including changes of the position of the oxygen dissociation 
curve. Normally the P50 is used to describe the position of the oxygen 
dissociation curve. The P50 however can not be used to calculate the amount of 
oxygen available to the tissues. Use of the 535 makes it possible to calculate the 
amount of oxygen available in the arterial blood and thus to calculate the ERav. 
The ERav was evaluated in pigs during extreme hemodilution and in hu mans 
during hemodilution combined with a decrease in body temperature, which shifts 
the oxygen dissociation curve to the left. 
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Chapter 2 
Introduction 
Several risks are associated with transfusion of homologous blood and 
blood products. The risk of alloimmunisation is weil known. Transmission of viral 
infections from homologous blood transfusion (e.g. hepatitis, and especially 
AIDS) draw increasing the altention [1-3). In addition it is suggested that 
transfusion of homologous blood promotes markedly increased tumor growth 
and growth of established metastases, and induces more postoperative 
infections, because blood transfusions exert a long-term (months) 
immunosuppressive action, increasing during the tirst week after transfusion 
[4,5). 
Transfusion with donor blood may be diminished by predeposited 
autologous blood [6), intraoperative autotransfusion with a cell-saver [7) and 
hemodilution techniques. With hemodilution, fewer red cells are lost because of 
the non-linear decrease in packed cell volume during replacement of blood with 
plasma substitutes [8). Hemodilution can be achieved in several ways. First, by 
pre-operative withdrawal of blood or by peroperative blood loss and 
simultaneous infusion of plasma substitutes (normovolemic hemodilution), [9). 
Second, by rapid infusion of fluid without blood withdrawal (hypervolemic 
hemodilution) [10,11). 
In genera I, oxygen flux into the tissue and finally into the cell depends on 
many factors as for example arterial oxygen content (Hb and Hb oxygen 
saturation), systemic hemodynamics (cardiac output), blood flow properties in 
the microcirculation, capillary density in the tissue, hematocrit values in the 
capillaries, Hb affinity for oxygen, release of oxygen from red cells, tissue 
affinity for oxygen, tissue diffusion coefficient and oxygen transport over the cell 
membrane. Regulatory mechanisms by hormones (e.g. catecholamines) or by 
loc al metabolites in relation to receptors in the macro- and microcirculation play 
an important role. Hemodilution might interfere with or change many of these 
factors and regulatory mechanisms. 
Hemodilution and systemic hemodynamics 
It has been postulated that acute isovolemic hemodilution induces a 
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decrease in systemic vascular resistance (SVR) almost parallel to the decrease in 
blood viscosity, whereas cardiac output (CO) increases signilicantly without 
increase in myocardial contractility. Over a wide range ol hematocrit (Het) 
levels, the rise in CO compensates lor the decreased oxygen transport capacity, 
thereby maintaining oxygen transport to tissue (12). The extent ol the ri se in 
CO, however, differs Irom one study to the other, even when studying the same 
proportional change in Het. In anesthetized dogs rises varying between 40% and 
125% are reported [13-181. except in one study where the rise in CO did not 
exceed 10% [19]. In this study, however, lilling pressures (left atrial and end 
diastolic pressure) did not change during so-called normovolemic hemodilution. 
Because of an increased venous return to the heart after a reduction of viscous 
resistance ol blood by hemodilution, a signilicant increase in lilling pressures ol 
the heart during normovolemic hemodilution can be expected. Therelore, 
constant lilling pressures in this study suggest the existence ol hypovolemic 
instead ol normovolemic hemodilution. In conscious dogs, comparing CO values 
ol the different studies in relation to the proportional change in hematocrit, 
reveals that the CO response on hemodilution is less. Related to the degree ol 
normovolemic hemodilution increases ol CO ol 75-120% we re lound [20-221. 
Surprisingly, comparing the studies in conscious dogs with the studies in 
anesthetized dogs, the increase in CO in all anesthetized anima I studies is closely 
related to the increase in stroke volume (SV). while heart rate (HR) remains 
constant while, in contrast, in all conscious dog experiments an increase in CO 
is mainly attributable to an increase in HR. In conscious dogs, plotting the 
change in CO agaÎnst the change in HR by regression analysis a positive 
correlation with r = 0.85 was lound [181. The increase in SV, as observed 
during hemodilution in anesthetized species, has been attributed to several 
mechanisms; 1) increased venous return due to reduced who Ie blood viscosity 
with consequent increased lilling pressures (231; 2) lacilitation ol left ventricular 
emptying by reduced after load because ol reduced viscosity and possible 
vasodilatation [15]; 3) increased myocard ia I contractility due to activation ol 
cardiac sympathetic nerves [20]. 
Because dogs differ Irom humans in anatomy, distribution ol coronary 
arteries and in sympathetic responses [241. we studied cardiovascular 
responses, hemodynamics, oxygen transport to tissue during normoxic acute 
isovolemic hemodilution in sedated and anesthetized pigs [25-271. Ample 
evidence exists to demonstrate that the pig is closely related to the human both 
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anatomically and physiologically with respect to cardiovascular system, regional 
distributîon of cardiac output, metabolism and maximum oxygen consumption 
[24,28,29J. In the sedated pigs we found an increase in CO of 40%, and also 
like conscious dogs, mostly related to an increase in HR, while in the fully 
anesthetized pigs an increase in CO with 100% was observed, as in 
anesthetized dogs, mainly due to an increase in SV. In contrast, others found in 
anesthetized pigs an increase in 30% correlated with an increase in HR while SV 
remained unchanged [301. However, in this study the hemodilution was rather 
hypovolemic, because blood exchange was do ne keeping filling pressures of the 
heart unchanged, ignoring the normally increased filling pressures during 
normovolemic hemodilution. 
Only a few studies report the effe cts of normovolemic hemodilution in 
anesthetized humans, while 00 report exists about acute hemodilution in 
conscious humans. In anesthetized humans, during normovolemic hemodilution 
(range Hct: 40-20%), CO increases with 25-35%, as in anesthetized animais, 
mainly due to increased SV, while HR remains unchanged [23,31-351. Acute 
hypervolemic hemodilution in anesthetized hu mans induces an increase in CO, 
comparable with the increase in CO in normovolemic hemodilution and also 
without any change in HR [10J. 
In conclusion: 1) the increase in cardiac output during hemodilution in 
anesthetized species is mainly due to increased SV, possibly due to reduced 
viscosity; 2) in conscious or sedated animals , reduced viscosity is a less 
important determinant during hemodilution and the increase in cardiac output is 
directly related to an increase in HR; 3) hemodilution can only be called iso- or 
normovolemic when filling pressures of the heart are increased, compared to 
baseline values obtained before hemodilution is induced. 
Hemodilution and systemic oxygenation 
Oxygen flux is the product of CO and arterial oxygen content. During 
hemodilution oxygen flux might remain unchanged or even increased, depending 
on the degree of increase in CO. Further decrease in Hct might be followed by a 
decreased oxygen flux, because the increase in CO as a compensatory factor is 
exhausted. Any further decrease in arterial oxygen content leads to an increased 
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extraction ratio (ER = oxygen uptake divided by oxygen flux) until a certain 
maximum. Further reduction of Hct produces oxygen supply dependeney of 
oxygen uptake (VO,). In sedated pigs a significant drop in oxygen flux eould be 
observed at a Het of 15%, while oxygen supply dependency of the VO, started 
at a Het of 10% [26]. The ER value at this point was 0.57, and the oxygen flux 
350 ml.m·'.min·' (= 15.0 ml.kg-'.min-'). In anesthetized pigs a significant 
inerease in ER eould be observed at a Het of 13%, while at the final step of 
hemodilution (Hct = 9.3%) VO, was weil maintained (ER = 0.61), and the 
oxygen flux was decreased to 7.8 ml.kg-'.min-' [27J. Cain found in anesthetized 
dogs during anemie hypoxia, when oxygen supply dependency of VO, started at 
a Het of 10%, a eritical whole body ER of 0.79, and a critiealO, flux of 10 
ml.kg-'.min-' [13,36]. In another study in anesthetized dogs a critica I systemie 
oxygen flux of 7.9 ml.kg-'.min-' and a eritieal ER = 0.69 were established [37]. 
In a fata I Jehovah Witness case we observed a deerease in oxygen flux 
when Het dropped below 20%. Oxygen supply dependency of VO, started at a 
hemoglobin value of 4.0 g% (Het = 13%). The oxygen flux at this point was 
184 ml.m-'.min-' (= 4.9 ml.kg-'.min-') and the ER 0.46. The patient died at a Het 
value of 8%. Ouring the same stages of hemodilution, the eardiovaseular 
responses of this patient we re similar in comparison to other anesthetized 
humans and this case might therefore be representative for anesthetized 
hu mans. 
Ouring hemodilution the ER might change not only due to changes in 0, 
flux but also beeause of changes in VO,. In some reports inerease in VO, at the 
initial stages of stepwise indueed normovolemie hemodilution are reported 
[13,27,38]. It has been suggested that the extra oxygen use by the heart alone 
with hemodilution could account tor this increase. An increase of tata 1 
eireulating catecholamine level during anemie hypoxia has been diseussed [39J 
whereby the metabolie effect exerted by eatecholamines is to inerease whoIe-
body resting VO, [40]. The eritical point of hemodilution whereby any further 
decrease of Het might induee oxygen supply dependeney of VO, is of course 
also influenced by differences in VO,. Ouring full anesthesia VO, is lowered and 
therefore a lower Het is belter tolerated than during sedation alone or during 
eonsciousness. In sedated pigs we found a eritieal oxygen flux of 15.0 ml.kg-
'.min-', while in fully anesthetized pigs an oxygen flux of 7.5 ml.kg-'.min-' was 
still sufficient to maintain a constant VO,. In patients the induetion of anesthesia 
deereases VO, with 10%, while VO, the first hours after anesthesia is inereased 
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by 20% cam pa red with preanesthetic values [101. Therefore, in clinical practice, 
during surgery and anesthesia a more pronounced hemodilution is acceptable, 
than during the initial postoperative phase. Several factors might influence the 
increased oxygen demand postoperatively as for example shivering during 
recovery from anesthesia and increased catecholamine levels [41 I. 
In conclusion: the critical point of hemodilution with respect to systemic 
oxygenation differs in anesthetized and in conscious or sedated species because 
of differences in va, through: 1) differences in basal metabolism and 2) possible 
differences in catecholamine levels. 
Hemodilution and regiona[ hemodynamics and oxygenation 
In general, in the face of a reduction in a, flux, to meet the different 
metabolic demands of different organs, regional redistribution of blood away 
from lower extracting beds towards more critical tissues might occur. The effect 
of hemodilution on regional flows has been studied in several modeis. Most 
studies used electromagnetic or Doppier flow probes and, in general, showed 
increases in flow to brain and heart 1185-700% increasel, out of proportion 
compared to the increase in CO, and with little or na change in flow to other 
organs [19,21,38,421. Uttle or no change in flow to other organs was especially 
obvious in conscious animal modeis. Another study, using electromagnetic flow 
pro bes, but studying only the splanchnic area, showed that total hepatic blood 
flows and mesenteric arterial blood flow increased, but not compensating totallv 
decreased oxygen content, inducing increased oxygen extractions of liver and 
small intestine (30). However, in th is study onlV a small increase in co is 
observed, because hemodilution was induced, thereby keeping filling pressures 
unchanged. 
The microsphere technique for determining regional flows and oxygen 
flux es has been used in four studies. In sedated rats and anesthetized dogs 
increased flows to heart 1100-130%) and brain 126-140%) are reported, not 
related to increased CO 112-43%), while flow to the spleen decreased and flow 
to other organs measured did not change, or changed on IV slightly 115,16,431. 
In fully anesthetized pigs with hemodilution IDextran 40, 50 g.I·', Isodex®) flows 
increased out of proportion compared to the increased co 1103%) to heart 
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(420%) and brain (170%) while, in contrast to the other microsphere studies, 
flows to all other organs increased proportional to the increased CO, except for 
skin flow (70% increase) and skeletal muscle flow (70% increase) (27). In this 
study myocardial oxygen consumption increased (106%) as hematocrit was 
decreased. However, even at an Het of 9%, left ventricular oxygen ER did not 
increase since the increase in myocardial blood flow produced an increase in 
myocardial oxygen flux sulficient to compensate the decreased arterial oxygen 
content and the increased myocardial oxygen demand. In conscious dogs 
myocardial VO, increased with 108% but was covered by more than seven-fold 
Încrease in coronary flow [38]. 
Redistribution of CO might be explained by changes in circulating 
catecholamines and by enhanced sympathetic activity (20). Carbon monoxide 
hypoxia, used as a model for anemie hypoxia, increases total catecholamine 
levels in anesthetized dogs [391, while infusing drugs with l1-vasodilator activity 
during hypoxic hypoxia can cause a decreased ability to extract 0, [44,45). The 
use of a-adrenergic blockers was reported to lower oxygen extraction rate in the 
hypoxic dog (36). It has been suggested that the main factor of a 
vasoconstrictor response during hypoxia is to ensure oxygen delivery to the 
bra in, and therefore generalized vasoconstriction should be caused everywhere 
except in the brain (13). In our pig study, no increase of catecholamines during 
hemodilution has been found, maybe because of, in these experiments, high-
dose fentanyl anesthesia, known for blocking stress responses and 
catecholamine release. This might explain why in this study, in contrast to the 
other microsphere studies, flow to most organs increased proportional to the 
increased CO (27). 
In-vivo studies of the microcirculation show that in general the Het in the 
capillaries (Hmic) is substantially lower than the systemic Het. This is explained 
by several mechanisms. At first, in the microvesseis red blood cells (RBC) travel 
faster than plasma, because RBC are located more in the center of the vessel 
tube. The result is that blood adjoining to the vessel wall presents a "plasma 
layer". In general, when a solution floats through a tube, that part of the solution 
adjacent to the wall of the tube passes the tube more slowly due to the higher 
resistance. Therefore, plasma me ets a higher resistance in floating through the 
capillaries. Because plasma needs more time to travel through the capillaries than 
RBC, at any moment of time more plasma than RBC will be present in the 
capillary resulting in a lower Het. This phenomenon has been termed "plasma 
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skimming" [46J. However plasma skinning alone is not sulficient to account lor 
the observed reduction in Hmic, which is in the order ol 30-50% Irom systemic 
Hct. Therelore ma ss balance considerations require that the low Hmic seen is 
also compensated by Ilowol blood through high Het shunts. Sueh eapillary 
vessels th at ean lulfill this lunction has been described and are termed 
"thoroughlare channels" [47J. During hemodilution until a systemic Het ol 20 is 
reaehed, different mechanisms, not vet totally elarilied, tend to maintain 
constant RBC inllux and therelore Hmie [48J. Another important laetor to be 
eonsidered during hemodilution is that normally RBC's lose oxygen during their 
travel through the arterioles [481. The loss ol oxygen by the RBC is a lunetion ol 
the transit time. Since hemodilution causes blood flow to inerease in the 
microvaseulature it will decrease the transit time ol RBC and, therelore, blood 
will arrive at the eapillaries with a greater amount ol oxygen [49J. Finally, during 
extreme hemodilution, RBC inllux into the capillary will decrease and the spacing 
between two eells in the eapillary will increase. Until a Hmie ol 20%, blood in 
the capillaries is a continuous and homogenous souree of oxygen to the tissue 
[50J. During extreme hemodilution, ho wever, where spaeing between red eells 
become dominant, RBC act more as point sourees of oxygen to the tissue and 
the tissue beeomes increasingly sensitive to the passage ol eaeh souree [51 I. 
In conelusion: 1) regional distribution ol CO and regional oxygen Ilux might 
be regulated: a) by enhanced sympathetic aetivity and might therelore be more 
pronounced in conscious and sedated animals than in fully anesthetized species 
and b) by vasoaetive metabolites, espeeially during extreme hemodilution and in 
organs with high metabolie rate; 2) until systemie Het ol 20% is reaehed, RBC 
inllux into capillaries remain constant, keeping Hct in capillaries (normally 30-
50% lower than systemic Het) more independent Irom changes in systemie Hct; 
3) during hemodilution RBC reaehing capillaries carry more oxygen. 
Hemodilution and oxyhemoglobin dissociation curve 
A shift to the left ol the oxyhemoglobin dissociation curve (ODC) limits 
oxygen delivery when blood Ilow is limited [521. Acute shift to the right ol 
coronary sinus, venous and arterial blood have been reported during signs ol 
hypoxia ol the hearts in humans [53-551. In two studies, ehronieally redueed Hb 
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concentration is compensated for by improved oxygen unloading, afforded by 
the increased P,o [56,57J. In one study in dogs an acute change in ODC during 
acute hemodilution occurred but not before Het dropped below 10% [12J, while 
in anesthetized pigs at every step of hemodilution the ODC shifts to the right 
[11,58]. A close relationship was found between the shift in ODC and the 
changed, for pH corrected, mixed venous PO, [48J. This relationship is in 
agreement with the mentioned acute changes in P,o during signs of hypoxia of 
the heart. In a fatal Jehovah Witness case we found no change in P,o befare Het 
dropped below 10%. In the pig experiments a further direct significant linear 
relationship was observed between the shift to the right of ODC and the 
increase in 0, ER also during oxygen supply dependency of VO" suggesting that 
the maximum of 0, ER is also influenced by the position of the ODC. This might 
explain differences in the literature about the 0, ER critical value because of 
possible differences during different experiments in the position of the ODC. 
A new concept in monitoring systemic oxygenation that includes the effect 
of changes in ODC has been introduced [58J. Using the S3' [saturation of 
hemoglobin at PO, = 35 mmHg). changing with alterations in ODC, real arterial 
available oxygen content (CavlO,) can be calculated being the maximum amount 
of oxygen that can be extracted from Hb in several organs befare oxygen 
diffusion into tissue becomes compromised and VO, may decrease. The relation 
between VO, and CavlO, expressed by the extraction ratio of the arterial 
available oxygen content (ERav) should give realistic indices of oxygen supply 
and VO" including the effect of changes in ODC. Comparing our pig experiments 
with the fata I Jehovah Witness case revealed differences in critical ER (0.57 vs 
0.46) but not in critical ERav. 
In conclusion: changes in ODC might play a role in oxygen delivery during 
hemodilution and especially, as stated before [59], when oxygen reserves are 
minimal. The position of the ODC is an important determinant for the criticaiO, 
ER value during hemodilution, also when VO, becomes dependent on oxygen 
flux. 
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Chapter 3 
Summary 
The effects ol stepwise isovolemic hemodilution on systemic and regional 
hemodynamics, oxygen flux, and circulating catecholamines ware studied in six 
pigs anesthetized with midazolam and lentanyl. Reduction ol the hematocrit 
Irom 28 to 9% resulted in doubling ol the cardiac output, mainly due to an 
increase in stroke volume. Regional blood flows, measured using the radioactive 
microsphere technique, showed an increase in blood Ilow to all organs ex cept 
liver (hepatic artery fraction) and adrenals, with a redistribution ol cardiac output 
in lavor ol heart and brain (increase in blood Ilow 420 and 170%, respectively). 
Oxygen Iluxes to most organs did not decrease until the hematocrit decreased to 
9%, while total body oxygen consumption was weil maintained. Lelt ventricular 
oxygen consumption increased, but because lelt ventricular blood Ilow also 
increased, left ventricular extraction ratio did not increase. Circulating 
catecholamines did not play any role in these regulatory mechanisms. 
Introduction 
Hemodilution reduces the oxygen-carrying capacity ol the blood. 
Consequently the organs and tissues ol the body have to extract more oxygen 
or augment perlusion to meet their oxygen demand. In anesthetized humans, 
cardiac output increases, but arteriovenous difference in oxygen saturation does 
not change during mild-to-moderate levels ol acute hemodilution, indicating that 
enhancement of perfusion is a primary mechanism for compensation rathef than 
an increased oxygen extract ion [1,21. There are lew studies on the distribution 
ol cardiac output during normoxic isovolemic hemodilution, and most ol them 
employed electromagnetic Ilow probes, which limits the number ol organs that 
can be studied and does not allow assessment ol the distribution ol Ilow within 
an organ. Only three studies used the radioactive microsphere technique to 
determine regional perlusion. Despite experimental shortcomings ol these 
studies, such as only one step ol hemodilution [3,4J and the use ol 
nonsplenectomized dogs [3,51, all three studies indicate that a redistribution ol 
cardiac output and oxygen transport occurs in lavor ol the vitalorgans (heart 
and brain). 
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It has been postulated that inereased levels of eateeholamines play a role in 
hemodynamie responses and the redistribution of eardiae output during 
isovolemie hemodilution [61, but, so far, levels of eateeholamines have not been 
measured during hemodilution. This study was designed to evaluate in 
anesthetized pigs the effe cts of four steps of normoxie isovolemie hemodilution 
on the distribution of eardiae output, oxygen regional fluxes, and eireulating 
eateeholamines. The pig was seleeted for this animal model beeause under 
several conditions of stress the response of pigs, in contrast to dogs, are similar 
to those of humans [7-9). 
Materia) and methods 
GENERAL 
Experimental preparation. After an overnight fast, 12 erossbred landrace x 
Yorkshire pigs (28 ± 1 kg; HVC, Hedel, The Netherlands) we re sedated with 
midazolam (Dormieum, 0.3 mg/kg im) and ketamine (10 mg/kg im). anesthetized 
with thiopental (5 mg/kg iv). intubated, and subsequently eonneeted to a 
respirator (Servo 900b, Siemens, Sweden). Intermittent positive-pressure 
ventilation with a mixture of oxygen and nitrogen (1 :2) and a positive end-
expiratory pressure of -4 Torr was applied to keep arterial blood gasses (ABl3 , 
Radiometer, Copenhagen, Denmark) within the normal range (PO, 120-180 Torr, 
PeO, 35-45 Torr, pH 7.35-7.45). Anesthesia was maintained throughout the 
experiment with midazolam (0.45 mg/kg followed by 0.45 mg.kg·'.h·' iv) and 
fentanyl (12.5 pg/kg followed by 12.5 pg.kg·'.h·' iv). while muscIe relaxation 
was obtained with paneuronium bromide (0.1 mg/kg followed by 0.3 mg.kg-'.h·' 
iv). Body temperature was maintained around 38"C with a heating pad. The 
bladder was eannulated to prevent vagal stimulation assoeiated with distension 
of the bladder. 
Catheters (8F) we re positioned in the superior vena eava for the 
administration of anestheties and dextran solution (to replaee blood) and in the 
aortie areh and pulmonary artery for measurement of blood pressures and 
withdrawal of blood samples for determination of blood gases. Finally, catheters 
(8F) we re plaeed in the descending aorta and the left ventricIe (Millar 
mierotipped catheter) for withdrawal of blood samples and for ealibration of 
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regional blood Ilows assessed with the radioactive microsphere technique and 
measurement ol lelt ventricular blood pressure and its lirst derivate (LvdP/dt), 
respectively. A midsternal thoracotomy was perlormed to expose the heart, and 
an electromagnetic Ilow pro be (Skalar, Delft, The Netherlands) was placed 
around the aseending aorta. The left and right atria we re cannulated lor injection 
ol radioaetive microspheres (ieft atrium) and measurement ol blood pressures. 
The great eardiac vein was cannulated lor withdrawal ol blood samples lor 
determination ol blood gases. 
MEASUREMENTS 
Systemic hemodynalnics. Systemic hemodynamic measurements consisted 
ol heart rate, ascending aortic blood Ilow, and blood pressures in the centra I 
aorta, pulmonary artery, left and right atrium, and left ventricIe. The maximal 
rate ol inerease in left ventricular pressure (LVdP/dtm.,) was obtained by 
electron ic differentation ol the left ventricular pressure. Stroke volume, 
pulmonary vascular resistance (PVR = MPAP -LAP/CO, where MPAP is mean 
pulmonary artery pres su re, LAP is left atrial pressure, and CO is eardiae output), 
and systemic vaseular resistanee (SVR = MAP/CO, where MAP is mean arterial 
pressure) were calculated. 
B/ood gases, hematoerit, and viseosity. Blood samples we re taken Irom the 
central aorta, great cardiac vein, and pulmonary artery for measurement of 
arterial, coronary venous, and mixed venous PO" PCO" pH, and hemoglobin and 
its oxygen saturation, respectively (OSM2 Radiometer). A viseosity meter (Low 
Shear 30, Contraves, Zürich, Switzerland) was used to measure arterial blood 
viscosity at shear rates ranging lrom 0.04 to 34.6/s. 
Regional blood flows. Regional blood Ilows we re measured using the 
radioactive microsphere technique [10J. About 10' mierospheres [15 ± 1 (SD) 
flm diam, New England Nuclear, Dreieeh, FRGJ, labeled with 46SC, l03Ru, 141Ce, 
"Nb, or 113Sn, we re injeeted in random order over a period ol 30-45 s into the 
lelt atrium. For ealculation ol regional blood Ilow values, an arterial referenee 
blood sample was withdrawn (flow rate 10 mi/min) from the descending aorta, 
starting just before and eontinuing until min after the injection ol 
mierospheres. At the end of each experiment, the animal was killed with an 
overdose of pentobarbital sodium and several organs and tissues (heart, brain, 
liver, spleen, lungs, kidneys, adrenals, stomaeh, smal! intestine, skin, and 
skeletal musele samples from different regions) were excised, weighed, and 
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placed in viais. Details of the counting of radioactivity and the processing of data 
have been published previously [111. Blood flow to the various tissue samples 
(0,,) was calculated as 
0" (ml.min·'. 100g") = (VI,) x 0, 
where I" and I, are the radioactivity (cpm) per 100 9 tissue and that of the 
arterial blood sample, respectively, and 0, is the withdrawal rate. CO was 
derived by adding myocardial blood flow (microsphere data) to the ascending 
aorta blood flow (electromagnetic flowmeter). 
Oxygen fluxes and consumption. Systemic (O,flux,y,,) and tissue (O,flux,,) 
oxygen fluxes we re calculated as 
O,flux,y" (mi O,/min) CO x CaO, 
and 
O,flux" (mi O,.min·'.1 OOg") = 0" x CaO, 
where CaO, is the arterial oxygen content (mi O,/ml blood). 
Systemic (total body) oxygen consumption (VO, 'V"~) was calculated as 
VO, "" = CO x C(a-v)O, 
where C(a-v)O, is the difference in oxygen content between the arterial and 
mixed venous blood. Left ventricular myocardial oxygen consumption (VO, LV) 
was calculated as 
VO, LV = 0LV x C(a-cv)O, 
where 0LV is left ventricular blood flow (ml.min·'.100g·') and C(a-cv)O, is the 
difference in oxygen content between arterial and coronary venous blood. 
Extraction ratios of the systemic and coronary circulation we re calculated as 
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and 
respectively. 
Plasma levels of catecholamines. For determination of plasma levels of 
catecholamines (epinephrine, norepinephrine, and dopamine) 10 mi blood we re 
collected from the central aorta into heparinized tubes containing 12 mg of 
glutathione. The plasma was separated immediately by centrifugation (4'C, 15 
min, 3000 g) and stored at -80'C until assayed. Determination was done by 
high-performance liquid chromatography with fluorescence detection after 
extraction and derivation [1 2). 
EXPERIMENT AL PROTOCOL 
Af ter all preparations had been completed, a stabilization period of ;,: 30 
min was allowed. Before the protocol (2-15 min before administration of Dextran 
40), all 12 animals received a 10-ml bolus injection of Dextran 1 (150 g/l in 
0.9% salt solution, Promiten) to prevent possible anaphylactic reactions to 
Dextran 40. Subsequently, baseline systemic hemodynamic data we re collected, 
blood samples we re withdrawn for determination of blood gas va lues and 
catecholamines, and a batch of radioactive microspheres was injected into the 
left atrium. Six animals underwent four steps of isovolemic hemodilution. 
Hemodilution was induced by exchanging blood with isooncotic Dextran 40 (50 
g/l in 0.9% saline, Isodex), which was warmed to 38'C and instilled slowly into 
the superior vena cava. Stepwise isovolemic hemodilution was induced by two 
steps of 10 mI/kg body wt and two steps of 15 mI/kg body wt, producing a total 
volume exchange of 50 mI/kg body wt. Ten minutes after each step of 
isovolemic hemodilution, all measurements we re repeated. Six other animals 
served as controls, in which measurements we re made at corresponding time 
points. 
DATA PRESENT A TlON AND STA TlSTICAL ANAL YSIS 
Unless otherwise stated, all data are presented as arithmetic means ± SE. 
In the control animais, statistica I analysis was performed with the Duncan new 
multiple range test once a parametrie analysis of varianee (randomized block 
design) had revealed that the samples represented different populations. The 
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hemodilution-induced changes we re compared with the solvent group by use of 
an unpaired t test. Statistical significanee was accepted at P < 0.05 (two-
tailed). 
DRUGS 
The drugs used in this study we re midazolam-HCI (Dormicum, Hoffmann-La 
Roche, Mijdrecht, The Netherlands). ketamine-HCI (Nimatik, AUV, Cuyk, The 
Netherlands). fentanyl citrate (Fentanyl-Janssen Pharmaceutical, Tilburg, The 
Netherlands), pancuronium bromide (Pavulon, Organon Teknika, Boxtel, The 
Netherlands). isooncotic Dextran 40 (50 gil in 0.9% saline, Isodex, NPSI, 
Emmer-Compascuum, The Netherlands). and Dextran 1 (150 gil in 0.9% saline, 
Promiten, NPSI, Emmer-Compascuum, The Netherlands) . 
Results 
SYSTEMIC AND PULMONARY HEMODYNAMICS 
Although all anima Is underwent the same anesthetic and surgical 
procedures and we re randomly assigned to the two groups, there was a 
significant difference in baseline heart ra te and LVdP/dtm" between control 
animals and animals that underwent hemodilution (Tabie 1). All systemic 
hemodynamic parameters remained stabie in contral animals throughaut the 
study period. In the hemodilution group, a decrease in the hematocrit was 
accompanied by a doubling of cardiac output, which was primarily due to an 
increase in stroke volume (by up to 55%) as changes in heart ra te we re 
considerably less (26%). The increase in stroke volume appears to result from an 
enhanced left ventricular filling (left ventricular end-diastolic pressure was 
elevated from 4.5 ± 0.7 to 6.8 ± 0.7 mmHg; P < 0.05), since LVdP/dtm • x did 
not change. Furthermare, despite the increase in cardiac output, mean arterial 
blood pressure was weil maintained until the last hemodilution step, when a 
decrease from 108 ± 8 to 90 ± 5 mmHg was observed. These data also imply 
that a decrease in systemic vascular resistance by up ta 60% prevented arterial 
blood pressure from increasing parallel to cardiac output. In comparison, 
pulmonary vascular resistance decreased slightly less (by up to 40%). resulting 
in a mild increase in pulmanary artery pressure (up ta 27%). 
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Table 1. Systemic and pulmonary effects of hemodilution in anesthetized pigs. 
Exchange blood C 0 0 0 0 0 
volume, mi/kg H 0 10 20 35 50 
Het, % C 27.6 ± 0.9 27.2 ± 1.2 26.2 ± 0.9 25.3 ± 0.9 26.2 ± 0.7 
H 27.5 ± 0.7 20.3 ± 0.4" 16.7 ± 0.2'" 12.2 ± 0.5* 9.3 ± 0.3'" 
CO, I/min C 2.83 ± 0.14 2.85 ± 0.11 2.87 ± 0,14 2.98 ± 0.13 2.92 ± 0.12 
H 2.67 ± 0.23 3.75 ± 0.26* 4.26 ± 0.21'" 5.02 ± 0.1T"' 5.42 ± 0.18" 
HR, beats/min C 142 ± 7 146 ± 7 152 ± 10 152 ± 10 153 ± 14 
H 113 ± 7+ 118 ± 7 130 ± 3 134 ± 5 140 ± 4 
SV, mi C 19.9 ± 0.4 19.4 ± 0.7 19.2 ± 1.4 18.8 ± 2.1 19.8 ± 2.0 
H 22.8 ± 2.9 29.9 ± 2.S* 30.5 ± 2.5* 34.3 ± 2.r 34.9 ± 2.2'" 
LVEDP, mmHg C 4.5 ± 0.5 4.4 ± 0.6 4.3 ± 0.5 4.8 ± 0.5 4.8 ± 0.6 
H 4.5 ± 0.7 5.8 ± 0.8* 5.7 ± O.S+ 7.3 ± O.S'" 6.8 ± 0.7* 
LvdP/dtm.,., mmHg/s C 4290 ± 270 4200 ± 200 4420 ± 270 4460 ± 390 4410 ± 570 
H 3370 ± 220 + 3680 ± 290'" 3980 ± 220 4000 ± 310 4050 ± 480 
MAP, mmHg C 108 ± 3 180 ± 3 111 ± 3 114 ± 4 113 ± 7 
H 109 ± 8 110 ± 6 112 ± 7 103 ± 6 90 ± 5* 
SVR, mmHg.I·' .min C 37.9 ± 1.8 36.7 ± 1.3 38.5 ± 1.8 37.1 ± 2.5 38.4 ± 2.5 
H 39.0 ± 4.9 32.5 ± 3.3* 27.7 ± 2.4* 21.7 ± 1.3" 17.6 ± 1.1* 
PAP, mmHg C 18.0 ± 1.6 18.1 ± 1.8 18.7 ± 1.6 19.8 ± 1.3 20.9 ± 1.7 
H 19.5 ± 1.3 21.8 ± 1.9 22.9 ± 1.5 24.2 ± 2.0 24.5 ± 2.0 
PVR, mmHgJ" .min C 5.0 ± 0.8 4.8 ± 0.9 5.0 ± 0.7 5.1 ± 0.6 5.6 ± 0.8 
H 6.8 ± 1.1 5.1 ± 0.7 4.7 ± 0.5 3.9 ± 0.5 3.6 ± 0.4 
Va[ues are means ± SE for 6 control (C) and 6 hemodilution (H) animais. Het, hematocrit; CO, cardiac output; HR, heart rate; SV, stroke volume; 
LVEDP, left ventricular end-diastolic pressure; LVdP/dtm"", maximum rise of left ventricular pressure; MAP, mean arterial blood pressure; SVR, systemic 
vascular resistance; PAP, pu[monary arterial blood pressure; PVR, pulmonary vascular resistance .... Change from baseline significantly different (P < 0.05) 
from change in the control animais. + Significant difference in baseline vaJues, (P < 0.05). 
Table 2. Systemic oxygen tensions and saturations during hemodilution in anesthetized pigs. 
Hct,% c 26.7 ± 0.9 27.2 ± 1.2 26.2 ± 0.9 25.3 ± 0.9 26.2 ± 0.7 
H 27.5 ± 0.7 20.3 ± 0.4" 16.7 ± 0.2* 12.2 ± OS" 9.3 ± 0.3· 
PaOz• Torr C 139 ± 16 138 ± 17 141 ± 15 139 ± 17 135 ± 22 
H 166 ± 6 174 ± 11 164 ± 3 164 ± 9 158 ± 8 
SaO::, % C 97 ± 0.3 97 ± 1.1 97 ± 0.7 96 ± 1.2 96 ± 1.6 
H 97 ± 0.3 97 ± 0.3 96 ± 0.3 95 ± 0.6 94 ± 0.5 
PvOz' Torr C 36 ± 4 35 ± 3 34 ± 4 35 ± 5 35 ± 6 
H 38 ± 3 39 ± 4 38 ± 3 35 ± 3 31 ± 3' 
SvOz' % C 56 ± 7 55 ± 8 53 ± 8 52 ± 1 52 ± 13 
H 57 ± 6 57 ± 7 52 ± 5 47 ± 6'" 37 ± 7" 
VOz .vw mi/min C 141 ± 10 150 ± 11 155 ± 11 163 ± 13 163 ± '6 
H 128 ± 8 + 135 ± 9 144 ± 8 147 ± 8 141 ± 5 
ER.v'l C 0.40 ± 0.03 0.42 ± 0.03 0.45 ± 0.03 0.46 ± 0.04 0.46 ± 0.05 
H 0.41 ± 0.03 0.42 ± 0.03 0.47 ± 0.03 0.54 ± 0.03· 0.61 ± 0.02 
Values are means ± SE for 6 contral (C) and 6 hemodilution (H) animais. PaOz, arterial oxygen tension; 5a02 , arteriaJ axygen saturation; PvOz' 
mixed venous oxygen tension; Sv02, mixed venous oxygen saturation; V02 ayo! ' systemic oxygen consumption; ERsyw systemic extraction ratio .... 
Change from baseline significantly different (P < 0.05) from change in the contro! animais. + Significant diHerence in baseline values, (P < 0.05). 
Table 3. Left ventricular oxygenation during hemodilution in anesthetized pigs. 
Pcv02, Torr C 21 .±; 20 ± 21 ± 20 ± 20 ± 1 
H 24 ± 24 ± 25 ± 28 ± 1 30 ± 2 
Scv02 , % C 23 ± 2 20 ± 23 ± 18 ± 2 21 ± 1 
H 21 ± 2 22 ± 23 ± 26 ± 3 28 ± 2 
V02LV' mLmÎn",100 g.l C 14.9 ± 0.8 12.9 ± 2,5 15,1 ± 0.8 11,2 ± 3.4 15.9 ± 1.7 
H 11,7 ± 0.7 14,4 ± 0,]'*' 17.8 ± 0.7'" 20,3 ± 0,6* 24,1 ± OS" 
ERw C 0,75 ± 0.02 0.78 ± 0.01 0.76 ± 0,01 0.82 ± 0,02 0,77 ± 0.01 
H 0,77 ± 0,02 0.77 ± 0,01 0.75 .±; 0,02 0.72 ± 0.02* 0.70 ± 0,02+ 
Values are means ± SE for 6 control (C) and 6 hemodi!ution (H) animais, Pcv02 , coronary venous oxygen tension; Scv021 coronary venous 
oxygen saturation; VOnvl left ventricular oxygen consumption; ERLv' left ventricular extraction ratio .... Change from baseline significantly different (P 
< 0.05) from change in the control animais. 
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SYSTEM/C OXYGENA TlON 
In both the control and hemodilution groups, arterial oxygen parameters 
remained unchanged during the course of the study (Tabie 2). Hemodilution 
caused mild decreases in mixed venous oxygen tension and saturation. 
Consequently the systemic oxygen extraction ratio increased from 41 ± 3 % at 
baseline to 61 ± 2% after the last volume exchange step, thereby compensating 
for the reduction in systemic oxygen flux. Total body oxygen consumption was 
weil maintained, even at the lowest hematocrit. 
REG/ONAL BLOOD FLOWS AND OXYGEN FLUXES 
In control animais, not only cardiac output but also all regional blood flows 
remained stabie during the course of the study. Hemodilution caused increases 
in blood flow to all organs and tissues except the adrenals and liver (hepatic 
artery fraction only; baseline value 37 ± 5 ml.min·'. 1 00 g", not shown) in which 
flows did not change. In the spleen the increase (46 ± 18%) was significant 
only during the second step. The increase in flow to the heart (420%) was 
considerably larger than th at to the brain (170%), kidneys (100%) and stomach 
(100%) (Figure 1). After the first volume exchange, skin flow (70%) and skeletal 
muscle flow (70%) had increased, but there we re no additional changes when 
hematocrit decreased further. The increase in cerebral blood flow was 
homogeneously distributed over the cerebral hemispheres (160 ± 9%), 
dieneephalon (170 ± 16%), cerebellum (110 ± 13%), and brain stem (150 ± 
13%, not shown). Lung flow (bronchial flow and arteriovenous shunt flow) did 
not change in either the hemodilution or the control group (baseline values 23.9 
± 4.3 and 26.9 ± 3.5 ml.min".100 g", respectively, not shown). 
During the first three volume exchanges (up to 35 mi/kg), the increase in 
blood flow compensated for the reduction in oxygen-carrying capacity of the 
blood, thereby maintaining the oxygen flux to all organs except the skin (Figure 
2). Af ter the last volume exchange (hematocrit 9.3 ± 0.3%), however, oxygen 
flux to kidneys, brain, stomaeh, small intestine, and skin decreased significantly 
and was maintained only in the heart. 
CORONARY C/RCULA T/ON 
The increase in flow to the heart was not homogeneously distributed over 
the four different chambers (Figure 3). Blood flow to right and left atria increased 
by up to 120 ± 20 and 390 ± 70%, respectively, and to the right ventriele by 
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Figure 1. Regional blood flows at 5 steps of hemodilution (baseline Ibl) ~ 0, 1 ~ 10, 2 
~ 20, 3 ~ 35, 4 ~ 50 mi/kg body wt blood volume exchange! in 6 anesthetized pigs 
(hatched columns) and at corresponding time points in contrals {open columns}. Values 
are mean ± SE. '* P < 0.05, mean change vs. contra!; + P < 0.05, contral vs. 
hemodilution. 
Figure 2. Oxygen flux at 5 steps of hemodilution (see figure 1 legend) in 6 anesthetized 
pigs (hatched columns) and at corresponding time points in contrals (open columns). 
Values are mean ± SE. "* P < 0.05, mean change vs. contral; + P < 0.05, contra! vs. 
hemodilution. 
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Figure 3. Myocardial regional blood flows and oxygen fluxes at 5 steps of hemodilution 
(see Hgure 1 legend) in 6 anesthetized pigs (hatched columns) and at corresponding 
time points in controls (open columns). LV, left ventricular; endo, endocardium; epi, 
epicardium. Va/ues are mean ± SE. .. P < O. 05, mean change vs. contra/; + P < 
0.05, contra! vs. hemodilution. 
up to 510 ± 55% af ter a volume exchange of 50 mi/kg (not shown). As a 
result, oxygen fluxes were maintained in both atria but actually increased in the 
right ventricle (110 ± 10%, not shown). The increase in left ventricular 
transmural blood flow (440 ± 60%) was more pronounced in the subepicardial 
layers (460 ± 60%) than in the subendocardial layers (400 ± 70%) so that 
subepicardial-to-subendocardial blood flow ratio decreased from 1.22 ± 0.003 
to 1.06 ± 0.07 (P < 0.05). 
As in the right ventricle, the oxygen flux was also enhanced in the left 
ventricie. Despite the increase in left ventricular oxygen consumption, coronary 
venous oxygen saturation was slightly higher after the last step of hemodilution, 
indicating a decreased left ventricular oxygen extraction (Table 3). 
PLASMA LEVELS OF CA TECHOLAM/NES 
In neither the control nor the hemodilution animals we re plasma levels of 
norepinephrine and epinephrine significantly aftected (Figure 4), although some 
variations occurred between individual animais. Dopamine levels remained 
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unchanged in the control animals but increased in th ree animals during the lirst 
two volume exchanges and resumed prehemodilution values after the third 
volume exchange. 
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Figure 4. Levels of catecholamines at 5 steps of hemodilution (see figure 1 legend) in 6 
anesthetized pigs and at corresponding time points in contrais. 
ARTERIAL BLOOD VISCOSITY 
Arterial blood viscosity was markedly reduced after a total blood volume 
exchange ol 50 mI/kg, which resulted in Newtonian behavior ol the blood in the 
range ol measured shear rates (Figure 5). 
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Figure 5. Whole blood viscosity at different shear rates at baseline (A) and at 50 
mi/kg body wt blood volume exchange (B) in anesthetized pigs (hatched 
columns) and at corresponding time points in controls (open columns). 
Discussion 
The decrease in hemoglobin concentration during acute normovolemic 
hemodilution results in a reduction in the oxygen·carrying capacity of arterial 
blood. To maintain an adequate oxygen supply to tissues, this reduction can be 
compensated by increasing flow rates through augmentation or redistribution of 
cardiac output or by increasing the oxygen extract ion ratio. 
The baseline values of the hematocrit are in good agreement with those 
reported for conscious animals of the same age [13J but rather low compared 
with those reported for humans. Nevertheless, we we re able to reduce 
hematocrit from 27.5 ± 0.7 to 9.3 ± 0.3%, a range we considered to be the 
most interesting for our study. 
In Figure 6 the proportional change in cardiac output and heart rate is 
presented as proportional change in hematocrit (data from literature and th is 
study). In anesthetized dogs the increase in cardiac output during hemodilution is 
mainly due to an increase in stroke volume [3,14,15]. Consistent with these 
studies, we observed in anesthetized pigs only a moderate increase in heart ra te 
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with a more pronounced increase in cardiac output. In contrast to findings in 
anesthetized animais, hemodilution in conscious dogs produces an increase in 
cardiac output that is mainly attributable 10 an increase in heart rate [16,17]. In 
sedated pigs the increase in cardiac output was also mainly due to an increase in 
hearl rate [18,19]. 
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Figure 6. Proportional change in cardiac output and heart rate as proportional 
change in hematocrit in anesthetized dogs [rets. 1, 2, 5, 6, 7, and 14J, 
conscious dogs frets. 9, 19, and 31J, anesthetized humans [rets. 8, 13, and 25J, 
and sedated pigs [rets. 28 and 29J compared with this study. 
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Most studies in anesthetized dogs used pentobarbital-anesthetized dogs 
[3,5,14,15,20]. Pentobarbital, however, increases the accumulation of 
radioactive microspheres in the lungs, probably by opening systemic 
arteriovenous shunts, thereby reducing the nutritional cardiac output [21]. Thus 
an increase in cardiac output in pentobarbital-anesthetized dogs does not 
necessarily correlate with an increase in nutritional flow. In this study no 
increase in arteriovenous shunts was observed and, therefore, using an 
anesthetic regimen as in this study, each increase in cardiac output produces an 
increase in nutritional cardiac output. 
As discussed before, in conscious dogs an increase in heart rate contributes 
more to the increase in cardiac output than elevation of stroke volume [6]. 
Several mechanisms have been proposed as being responsible for this increase in 
cardiac output, including a response to increased levels of circulating 
catecholamines. This hypothesis is based on the observation th at carbon 
monoxide hypoxia, used as a model for anemie hypoxia, increases total 
catecholamine levels in anesthetized dogs [22]. Carbon monoxide hypoxia, 
however 1 not only decreases arterial oxygen content, as in anemie hypoxia, but 
also influences the shape of the oxygen dissociation curve and shifts it to the 
left, whereas in anemie hypoxia the oxygen dissoeiation curve maintains it form 
and, if altered, shifts to the right [23]. Moreover, blood viscosity is not 
influenced by carbon monoxide hypoxia but is decreased in anemie hypoxia. In 
this study plasma catecholamines did not increase during acute hemodilution but 
decreased, probably because of dilution of the blood. Baseline values of 
catecholamine levels in the present study are in good agreement with those 
reported for anesthetized pigs [24] and chronically instrumented conscious pigs 
[25]. Mersmann [241 reported epinephrine levels th at we re three times and 
norepinephrine and dopamine levels th at were two times the highest values 
reported in the present study. Carlson et al. [20] showed that in conscious pigs 
hemorrhagic shock induced the greatest increase in catecholamine plasma levels 
in those animals with the highest baseline levels. These studies indicate th at 
catecholamine release was not maximally stimulated during baseline conditions 
in the present study. It is therefore unlikely th at normovolemic hemodilution 
caused increased catecholamine production. This finding is consistent with the 
observation that cardiac output increases in chronically adrenalectomized 
pentobarbital-anesthetized dogs, as weil as in intact dogs, after severe acute 
exchange anemia [201. Therefore, plasma catecholamines can probably be 
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excluded as one of the contributing factors, at least in anesthetized animais. 
From this study, however, it cannot be concluded that an increase in plasma 
catecholamines does not play a role in conscious or sedated animais. 
The increase in stroke volume, as observed during hemodilution in 
anesthetized animais, has been attributed to several mechanisms: 1) increased 
venous return due to reduced who Ie blood viscosity with consequent increased 
left ventricular end-diastolic pressure [1], 2) facilitation of left ventricular 
emptying by reduced afterload (reduced blood viscosity and possibly 
vasodilatation) [3], and 3) increased myocardial contractility due to activation of 
cardiac sympathetic nerves (6). 
The reduction in hematocrit, as observed in this study, produces a 
reduction in whole blood viscosity. The decrease in whole blood viscosity 
produces a decrease in the systemic vascular resistance and an increase in 
venous return, thereby increasing cardiac output [2). The reduction in whole 
blood viscosity is most pronounced at low shear rates, indicating th at the most 
vigorous effect of hemodilution has to be expected in the postcapillary area. 
Besides producing an increase În flow rate in the microcirculation, hemodilution 
also produces an improvement in flow in the microcirculation [26). To what 
degree changes in blood viscosity measured in vitro affect vascular resistances 
cannot exactly be assessed, because in vivo viscosity is determined not only by 
hematocrit but also by vascular dimensions and flow velocity (shear ratel [3). 
Flow velo city increases with progressive hemodilution, whereas vascular 
dimensions may be changed by either vasodilatation or vasoconstriction. 
Besides the increase in cardiac output, to maintain oxygen supply to tissues 
during hemodilution, an increase in oxygen extraction ratio could compensate 
the decreased arterial oxygen content. In this study, however, because of 
increased flow rates, oxygen flux to most organs did not significantly deerease 
until the last step of hemodilution, and the systemic extract ion ratio did not 
increase either. This is also reflected in mixed venous PO, and oxygen 
saturation, both of which remained constant. 
Finally, besides the increase in tata I cardiac output and change in oxygen 
extract ion ratio, a redistribution of regional flows may accur to meet the 
metabolic demands of different organs. This has already been studied in several 
modeis. Most studies used electromagnetic or Doppier flow probes and, in 
general, showed increases in flow to heart and brain with, in contrast to this 
study, little or no change in flow to other organs [15,17,27,28). The 
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microsphere technique for determining regional flows during hemodilution has, to 
our knowiedge, been used in three studies. In a study on hemodilution in 
conscious rats, increases in flow to heart and brain by 115 and 83%, 
respectively, and little or no change in flow to other organs (kidney, stomaeh, 
intestine, spleen, liver) were observed while cardiac output was not significantly 
increased [4]. In the other two studies using the microsphere technique, regional 
hemodynamics were investigated in pentobarbital-anesthetized dogs, but without 
the use of control animals to exclude the influence of the experimental model on 
hemodynamics and oxygen consumption [3,51. Both groups reported a 
significant increase in flow to heart and brain while, in contrast to this study, 
flow to the spleen decreased and flow to other organs measured did not change 
or changed only slightly. 
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Figure 7. Proportional change in left ventricular blood flow and oxygen 
consumption as proportional change in hematocrit in anesthetized dogs [refs. 5, 
6, and 7}, conscious dogs [ref 20j, anesthetized humans [ref. 8j, compared with 
this study. 
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In this study, blood flow to the heart increased progressively with 
hemodilution. When comparing changes in all organs measured, the change in 
both absolute and relative flow was largest in the heart. Because the heart 
normally has a high oxygen extraction ratio, this can only be increased slightly 
when oxygen supply to the heart is decreased. As arterial oxygen content 
decreases with hemodilution, the main possibility for the heart to meet 
myocardial oxygen demand is by an increase in coronary flow, but myocardial 
oxygen consumption mayalso be influenced by hemodynamic changes during 
hemodilution and, therefore, an even greater increase in coronary flow might be 
needed. 
The proportional change in left ventricular blood flow and left ventricular 
oxygen consumption, as found in the literature, is presented as proportional 
change in hematocrit in Figure 7. Moderate hemodilution in anesthetized humans 
and anesthetized dogs did not produce significant changes in left ventricular 
oxygen consumption [15,29[. In the dog study, however, cardiac output did not 
change significantly either. In conscious dogs hemodilution produced an increase 
in myocardial oxygen consumption which was met by both an increase in 
myocardial flow and an increase in oxygen extraction ratio [16[. However, 
because in conscious animals the increase in cardiac output is mainly due ta an 
increase in heart rate, the effect of hemodilution on myocardial oxygen 
consumption in conscious animals is not comparable to the effect in 
anesthetized animais. In this study, myocardial oxygen consumption increased 
as hematocrit was decreased. However, Ie ft ventricular oxygen extraction ratio 
did not increase, because the increase in myocardial blood flow produced an 
increase in myocardial oxygen flux sufficient to compensate the increased 
myocardial oxygen demand. 
Inasmuch as the subendocardial reg ion of the myocardium is subjected to 
the greatest intramyocardial compressive forces, this region is perfused mainly 
during the diastole. To receive the same amount of blood as the subepicardial 
reg ion, it has ta have a lawer vascular resistance, which causes the vasadilatary 
reserve capacity to become more limited and maximal coronary vasodilatation to 
occur first in the subendocardial region. In the present study, severe 
hemodilution in anesthetized pigs produced a redistribution of coronary flow 
away from the subendocardial muscle with the last step of hemodilution. 
However, as discussed before, oxygen flux to the left ventricle (endo- en 
epicardium) increased, whereas the left ventricular oxygen extraction ratio did 
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not, despite the increase in left ventricular oxygen consumption. 
Another organ sensitive to a decrease in tissue oxygenation is the brain. 
Redistribution of the cardiac output resulted in an increase in absolute flow in 
the brain with every step of hemodilution, whereas relative flow did not increase 
until the last two steps. This caused no significant change in oxygen flux to the 
brain. With the increase in coronary and cerebral flow, one would expect relative 
flow to organs less in need of a constant oxygen supply (skin, muscle, liver, 
spleen, stomach, intestine, adrenals, and kidneys) to decrease. However, relative 
flow to liver (via hepatic artery), stomach, intestine, adrenals and kidneys and 
total liver flow (estimated by summation of flow via hepatic artery and flow in 
intestine, spleen and stomach) remained constant, while relative flow to the 
spleen decreased only at the lower levels of the hematocrit range. 
The observed and discussed redistribution of cardiac output could be 
regulated by the autonomic nervous system, humoral substances, and a variety 
of local factors (4). In the present study, circulating catecholamines have been 
excluded as a regulating factor during hemodilution in anesthetized pigs. The 
redistribution of renal flow from outer to inner cortex, as shown by the increase 
in inner-ta-outer ratio, may suggest an increased renin-angiotensin activity, but 
mayalso resembie an intrarenal flow redistribution produced by enhanced 
sympathetic activity (5). It has been suggested that the main function of this 
vasoconstrictor response is to ensure oxygen delivery to the brain during 
reduced total oxygen transport, and therefore generalized vasoconstriction 
should be caused everywhere except in the brain (30). This vasoconstriction can 
be overcome by local factors through the production of a vasoactive metabolite 
or through a direct effect of the oxygen tension on vascular tissue, especially in 
an active organ with a high metabolic rate, such as the heart (14). These factors 
could help explain the redistribution of cardiac output in favor of the heart and 
brain during hemodilution. 
In conclusion, 1) during acute isovolemic hemodilution in anesthetized pigs, 
cardiac output increased significantly, mainly due to an increase in stroke 
volume; 2) in contrast to other reports, flow increased in all organs with, as 
reported by others, the largest increase in heart and brain; 3) unlike findings in 
dogs, oxygen flux to all organs remained constant, except in spleen and liver (via 
artery fraction); 4) left ventricular oxygen consumption increased, but with no 
increase in myocardial oxygen extract ion ratio; systemic oxygen consumption 
remained constant; and 5) circulating catecholamines we re excluded as a 
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regulatory mechanism of hemodynamics and regional flow patterns, at least in 
th is experimental model. 
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Chapter 3 
Introduction 
Hemodilution causes a drop in hematocrit, thereby lowering the oxygen 
carrying capacity of blood, necessitating an increase in flow or an augmented 
oxygen extraction by the tissues to meet their metabolic demands. Under normal 
conditions the myocardial oxygen extraction is already high and the capacity to 
increase is limited. In the heart the decrease in arterial oxygen content during 
hemodilution is therefore is mainly compensated by an increase in coronary flow. 
This increase in flow can be achieved by both reduction of blood viscosity and 
coronary vasodilatation. The hemodynamic changes during hemodilution may 
increase myocardial oxygen consumption and, therefore, an even greater 
increase in coronary flow might be needed. 
In order to establish whether the subendocardium, the most vulnerable of 
the myocardial layers, is still adequately perfused during isovolemic hemodilution 
we evaluated the effect of stepwise normovolemic hemodilution on regional 
myocardial blood flows and oxygen fluxes, and on myocardial oxygen 
consumption in anesthetized pigs. The pig was selected because the responses 
of pigs under several conditions of stress are similar to those in humans. 
Material and methods 
Twelve pigs (28 ± 1 kg) we re sedated with midazolam (0.3 mg/kg i.m.) 
and ketamine (10 mg/kg i.m.) and subsequently anesthetized with thiopental (5 
mg/kg i.v.). Anesthesia was maintained with fentanyl (12.5 lig/kg bolus followed 
by 12.5 119/kg/h) and midazolam (0.45 mg/kg bolus followed by 0.45 mg/kg/h). 
while muscle relaxation was achieved with pancuronium bromide (0.1 mg/kg 
bolus followed by 0.3 mg/kg/h). 
Catheters we re positioned in the aortic arch, pulmonary artery, descending 
aorta and left ventricie. A midsternal thoracotomy was performed and an 
electromagnetic flow probe placed around the ascending aorta. The left and right 
atria and the great cardiac vein we re cannulated. 
Systemic hemodynamics, blood gasses (OSM2 Radiometer, Copenhagen) 
and hematocrit were measured at baseline and after each step of hemodilution. 
In control animals measurements ware made at corresponding time points. 
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Regional blood Ilows ol the heart we re measured using the radioactive 
microsphere technique [1 J. 
Systemic and myocardial oxygen Iluxes and consumptions we re calculated. 
In six pigs hemodilution was induced by exchanging blood with iso-oncotic 
dextran 40, 50 gil in 0.9% saline (Isodex"). Stepwise hemodilution was induced 
by two steps ol 10 ml/kg lollowed by two steps ol 15 mI/kg. Six other anima Is 
served as controls. 
All data are presented as arithmetic means ± SE ol mean. 
Results 
Hemodilution produced a doubling ol the cardiac output, primarily due to an 
increase in stroke volume with only a moderate increase in heart rate. The mean 
arterial pressure was maintained until the last step ol hemodilution because ol 
systemic vasodilatation (Table 1) [2J. Mixed venous oxygen tension and 
saturation decreased slightly, resulting in an increase in systemic oxygen 
extraction ratio. Total body oxygen consumption was weil maintained (Tabie 2). 
Total myocardial blood flow increased 420%. This increase was not 
homogeneously distributed. Blood Ilow to right and left atria increased by up to 
120 ± 20% and 390 ± 70%, respectively, while oxygen Iluxes in both atria 
were maintained. Blood Ilow to right and left ventricle increased by up to 510 ± 
55% and 440 ± 60%, respectively, resulting in an increase in oxygen Iluxes to 
both ventricles. 
Despite the increase in left ventricular myocardial oxygen consumption, 
coronary venous saturation after the last step ol hemodilution was slightly 
increased, indicating a decreased left ventricular oxygen extraction ratio. 
The increase in left ventricular blood Ilow was more pronounced in 
subepicardiallayers than in subendocardiallayers. Therelore, the subendocardial-
subepicardial blood Ilow ratio decreased Irom 1.22 ± 0.03 to 1.06 ± 0.07 
(P<0.05) (Tabie 3). 
Discussion 
Hemodilution produces a reduction in the oxygen carrying capacity ol the 
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Table 1 . Systemie and pulmonary effeets of hemodilution in anesthetized pigs. 
Exchange 
blood volume 
Het 
co 
HR 
SV 
lVEDP 
lvdP/dtm"" 
MAP 
SVR 
PAP 
PVR 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
o 
o 
27.6 ± 0.9 
27.5 ± 0.7 
2.83 ± 0.14 
2.67 ± 0.23 
142 ± 7 
113 ± 7+ 
19.9 ± 0.4 
22.8 ± 2.9 
4,5 ± 0,5 
4,5 ± 0.7 
4290 ± 270 
3370 ± 220+ 
108 ± 3 
109 ± 8 
37.9 ± 1.8 
39.0 ± 4.9 
18.0 ± 1.6 
19.5 ± 1.3 
5.0 ± 0.8 
6.8 ± 1.1 
o 
10 
27.2 ± 1.2 
20.3 ± 0.4* 
2.85 ± 0.11 
3.75 ± 0.26'" 
146 ± 7 
118 ± 7 
19.4 ± 0.7 
29.9 ± 2.9" 
4.4 ± 0.6 
5.8 ± 0.8* 
4200 ± 200 
3680 ± 290· 
180 ± 3 
110 ± 6 
36.7 ± 1.3 
32.5 ± 3.3" 
18.1 ± 1.8 
21.8 ± 1.9 
4.8 ± 0.9 
5.1 ± 0.7 
o 
20 
26.2 ± 0.9 
16.7 ± 0.2'" 
2.87 ± 0,14 
4.26 ± 0.21 * 
152 ± 10 
130 ± 3 
19.2 ± 1.4 
30.5 ± 2.5" 
4.3 ± 0.5 
5,7 ± 0.8'" 
4420 ± 270 
3980 ± 220 
111 ± 3 
112 ± 7 
38.5 ± '.8 
27.7 ± 2.4'" 
18.7 ± 1.6 
22.9 ± 1.5 
5.0 ± 0.7 
4.7 ± 0.5 
o 
35 
25.3 ± 0,9 
, 2.2 ± 0.5* 
2.98 ± 0.13 
5.02 ± 0.17'*' 
152 ± 10 
134 ± 5 
18.8 ± 2.1 
34,3 ± 2.7* 
4.8 ± 0.5 
7.3 ± 0.8'" 
44$0 ± 390 
4000 ± 310 
114 ± 4 
103 ± 6 
37.1 ± 2,5 
21.7 ± 1.3" 
19.8 ± 1.3 
24.2 ± 2.0 
5.1 ± 0.6 
3.9 ± 0.5 
o 
50 
26,2 ± 0.7 
9.3 ± 0.3+ 
2.92 ± 0,12 
5.42 ± 0.18'*' 
153 ± 14 
140 ± 4 
19.8 ± 2.0 
34.9 ± 2.2'" 
4.8 ± 0.6 
6,8 ± 0.7* 
4410 ± 570 
4050 ± 480 
, 13 ± 7 
90 ± 5* 
38.4 ± 2.5 
17.6 ± 1.,'" 
20.9 ± 1.7 
24.5 ± 2.0 
5.6 ± 0.8 
3.6 ± 0.4 
Blood volume exchange in mi/kg; C "" control (n "" 6); H = isovolemlc hemodilution (n = 6); Het "" hematocrit (%); CO "" cardiac output U/min); HR = heart rate 
(beats/min); SV = stroke volume (mI); lVEDP = left ventricuJar end-diastolic pressure (mmHg); lVdP/dtm,,,, = maximum rise of Jeft ventricular pressure (mmHg/sec); 
MAP = mean arterial blood pressure (mmHg); SVR = systemic vascular resistance (mmHg/I/min); PAP = pulmonary arterial blood pressure (mmHg); PVR 
pulmonary vascular resistance (mmHg/I/min). Data are mean ± SEM; ... change from baseline significantly different (P < 0,05) from change in the control animais. + 
significant difference in baseline values (P < 0.05). From: van Woerkens et al. [121. 
Table 2. Systemic and left ventricl.I/ar oxygenation dudng hemodilution in anesthetized pigs. 
Hct 
pa02 
5a0 2 
pv02 
Sv0 2 
V020Yor 
ER,ySl 
PCV02 
scv02 
VLV0 2 
ERw 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
C 
H 
26.7 ± 0.9 
27.5 ± 0.7 
139 ± 16 
'66 ± 6 
97 ± 0.3 
97 ± 0.3 
36 ± 4 
38 ± 3 
56 ± 7 
57 ± 6 
141 ± 10 
128 ± 8 
0.40 ± 0.03 
0.41 ± 0.03 
21 ± 
24 ± 
23 ± 2 
21 ± 2 
14,8 ± 0,8 
11.7 ± 0.7+ 
0.75 ± 0.02 
0.77 ± 0.02 
27.2 ± 1.2 
20.3 ± 0.4"'" 
138 ± 17 
174 ± " 
97 ± 1.1 
97 ± 0.3 
35 ± 3 
39 ± 4 
55 ± 8 
57 ± 7 
150 ± 11 
135 ± 9 
0.42 ± 0.03 
0.42 ± 0.03 
20 ± 
24 ± 
20 ± 
22 ± 
12.9 ± 2.5 
14.4 ± o.r 
0.78 ± 0.01 
0.77 ± 0.01 
26.2 ± 0.9 
16.7 ± 0.2+ 
141 ± 15 
164 ± 3 
97 ± 0.7 
96 ± 0.3 
34 ± 4 
38 ± 3 
53 ± 8 
52 ± 5 
155 ± , 1 
144 ± 8 
0.45 ± 0.03 
0.47 ± 0.03 
21 ± 
25 ± 
23 ± 
23 ± 
15.1 ± 0.8 
17.8 ± 0.1'" 
0.76 ± 0.01 
0.75 ± 0.02 
25.3 ± 0.9 
12.2 ± 0.5* 
139 ± '7 
164 ± 9 
96 ± 1.2 
95 ± 0.6 
35 ± 5 
35 ± 3 
52 ± 
47 ± 6'" 
163 ± 13 
147 ± 8 
0.46 ± 0.04 
0.54 ± 0.03"" 
20 ± 
28 ± 
18 ± 2 
26 ± 3 
11.2 ± 3.4 
20.3 ± O.S'" 
0.82 ± 0.02 
0.72 ± 0.02" 
26.2 ± 
9.3 ± 
0.7 
0.3' 
135 ± 22 
158 ± 8 
96 ± 1.6 
94 ± 0.5 
35 ± 6 
31 ± 3'" 
52 ± 13 
37 ± r 
'63 ± 16 
141 ± 5 
0.46 ± 0.05 
0.61 ± 0.02 
20 ± 1 
30 ± 2 
21 ± 
28 ± 2 
15.9 ± 1.7 
24,1 ± 0,5'" 
0,77 ± 0.01 
0.70 ± 0.02'" 
C = control {n = 6}; H = isovolemic hemodilution {n = 6}; Hct = hematocrit {%}; PaOl = arterial oxygen tension (mmHg); Sa02 = arterial oxygen saturation {%}; Pv02 
= mixed venous oxygen tension (mmHg); Sv02 = mixed venous oxygen saturation (%); VOl SY$t = systemic oxygen consumption (mI/min); ER.vst = systemic 
extraction ratio; PcvOl = coronary venous oxygen tensÎon (mmHg); Scv02 = coronary venous oxygen saturation {%}; V LV0 2 = left ventricular oxygen consumption 
(mI/min); ERLV = left ventricular extraction ratio. Data are mean ± SEM; ... change from baseline significantly different (P < 0.05) from the change in the control 
animais. + significant difference in baseline values (P < 0.05). From: van Woerkens et al [12]. 
Table 3. Regional myocard/al blood f/ows fml/min/100g) and oxygen fluxes fml/min/100g). 
Regional myocardial blood flows 
RA C 163 ± 25 148 ± 23 153 ± 21 142 ± 29 142 ± 27 
H 157 ± 29 197 ± 34' 234 ± 45' 289 ± 51 ' 330 ± 37' 
LA C 82 ± 6 81 ± 9 105 ± 12 100 ± 19 85 ± 12 
H 75 ± 18 106 ± 19' 154 ± 20' 216 ± 35' 322 ± 34' 
RV C 124 ± 8 119 ± 11 127 ± 11 130 ± 13 132 ± 18 
H 104 ± 6 169 ± 11 ' 271 ± 16' 438 ± 54' 631 ± 74' 
LV C 170 ± 12 171 ± 15 175 ± 14 185 ± 22 180 ± 25 
H 130 ± 5+ 221 ± 11 ' 341 ± 33' 505 ± 57' 690 ± 72' 
LVendo C 192 ± 13 185 ± 19 194 ± 17 201 ± 26 207 ± 29 
H 145 ± 6+ 254 ± 2'- 390 ± 44' 567 ± 79' 717 ± 94' 
LV epi C 154 ± 158 ± 14 160 ± 13 174 ± 20 161 ± 23 
H 119 ± 4+ 201 ± 8' 314 ± 30' 472 ± 49' 670 ± 67' 
Regional myocardial oxygen fluxes 
RA C 1S.S ± 2.3 17.2 ± 2.0 17.6 ± 1.9 15.3 ± 2.8 16.3 ± 2.6 
H 19.3 ± 3.5 1$.1 ± 3.0 17.3 ± 3.0 15.7 ± 2.1 14.0 ± 1.2 
LA C 9.5 ± 0.6 9.5 ± 0.8 12.1 ± 1.2 10.5 ± 1.6 9.8 ± 1.1 
H 9.3 ± 2.2 9.8 ± 1.8 11.4 ± 1.3 11.9 ± 1.6 13.0 ± 1.1 
RV C 14.5 ± 0.7 13.9 ± 0.8 14.S ± 1.1 13.9 ± 1.1 15.1 ± 1.6 
H 12.7 ± 0.8 ,5.5 ± 1.1 ... 20.1 ± 1.0" 24.0 ± 2.0'" 26.6 ± 1.9'" 
LV C 19.5 ± 0.8 20.0 ± 1.3 20.2 ± 1 .1 19.$ ± 1.8 20.7 ± 2.3 
H 15.9 ± 0.6+ 20.2 ± 1. 1 .. 25.3 ± 2.2'" 27.$ ± 2.5'" 29.4 ± 2.6+ 
LVendo C 22.4 ± 1.1 21.7 ± 1.8 22.5 ± 1.6 21.5 ± 2.2 23.8 ± 2.6 
H 17.7 ± 0.7+ 23.2 ± l.S" 2$.9 ± 2.9'" 31.2 ± 3.6* 30.6 ± 3.6' 
LVepi C 17.9 ± 0.8 1S.4 ± 1.1 18.5 ± 1.1 18.6 ± 1.6 18.5 ± 2.0 
H 14.6 ± 0,5+ 18.4 ± O.S' 23.3 ± 1.9'" 26,0 ± 2.0'" 2$,4 ± 2,3* 
endo/epi C 1.25 ± 0.05 1.17 ± 0,06 1,21 ± 0,05 1.15 ± 0.03 1.28 ± 0.02 
H 1.22 ± 0.03 1.25 ± 0.06 1.23 ± 0.03 1.18 ± 0.05 1,06 ± 0.07 
C = control (n=6); H "'" isovolemic hemodilution (n=6); RA =: right atrium; LA =: left atrium; AV = right ventricle; LV =: left ventricIe; LVendo = left ventricular 
endocardial region; LV epi = left ventricular epicardial region; endo/epi = endocardial epicardial flow ratio; Data are mean ± SEM; .. change from baseline 
significantly different (P < 0.05) from change in the contra! animais; + significant difference in baseline values (P < 0.05), From: van Woerkens et al [12], 
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blood. In this study this is compensated for mainly by an increase in cardiac 
output but, at the last step of hemodilution, also by an increased systemic 
oxygen extraction ratio. 
In order to meet the metabolic demands of different organs a redistribution 
of the cardiac output can occur. Hemodilution and its effe cts on myocardial 
blood flow and oxygen delivery has been studied in anesthetized dogs [3-7]. The 
decrease in arterial oxygen content is counteracted by an increase in cardiac 
output mainly due to an increase in stroke volume. In the study by Geha [6] no 
increase in cardiac output was observed during moderate hemodilution. However 
filling pressures did not change either, probably indicating hypovolemia [8], 
Left ventricular oxygen consumption was maintained primarily by an 
increase in left ventricular blood flow, but an additional increase in left 
ventricular oxygen extraction ratio was observed. Due to the increase in 
coronary flow the vasodilatory reserve capacity was significantly reduced. In 
most studies the increased myocardial blood flow was sufficient to maintain 
regional myocardial oxygen supply [4,5,7]' 
Brazier et al. [3] estimated the myocardial oxygen consumption by the 
tension time index, which did not change significantly during moderate and 
severe hemodilution. The myocardial oxygen demand to supply ratio, however, 
feil with moderate hemodilution and decreased further during severe 
hemodilution. The endocardial/epicardial flow ratio decreased as the hemoglobin 
level feil below 5 g% and the augmented cardiac output could not be sustained. 
Reduction of hematocrit to half the baseline value did not change coronary 
sinus oxygen tension in one study [51, while in another study coronary venous 
oxygen saturation even increased during hemodilution, despite the slight 
increase in myocardial oxygen consumption [7]. 
Stepwise hemodilution in anesthetized baboons produced an increase in left 
ventricular flow which was able to maintain both left ventricular oxygen delivery 
and left ventricular oxygen consumption until hematocrit levels of 6%. No 
increase in left ventricular oxygen consumption was observed. At a hematocrit 
of 10% maximal coronary vasodilatation had occurred and a further decrement 
in oxygen supply led to myocardial anaerobic metabolism as shown by left 
ventricular lactate production [9]. 
Moderate decreases in hematocrit levels in anesthetized hu mans 
(hematocrit reduced from 38% to 28%) also produces an increase in myocardial 
blood flow with a slight but not significant increase in myocardial oxygen 
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consumption. Coronary sinus oxygen tension did not change. The increase in 
cardiac output was associated with an increase in external cardiac work solely 
due to an increase in stroke volume. This can be obtained without a substantial 
rise in need of energy [10[. In conscious dogs the elevated cardiac output during 
hemodilution is mainly due to an increase in heart rate [11,12]. Myocardial 
oxygen consumption increases, necessitating an additional increase in 
myocardial blood flow in these studies in conscious dogs. During exercise 
myocardial oxygen consumption increases even further. The increased 
myocardial oxygen consumption was met both by an elevated coronary blood 
flow and an increased oxygen extraction ratio, accompanied by a decrease in 
coronary sinus oxygen saturation. The peak reactive hyperemie flow decreased 
under hemodilution, while at rest dilatory capacity was left even at a hematocrit 
of 10-15%. At moderate levels of exercise the dilatory capacity was exhausted 
at a hematocrit of 20-25% [12). Reduction of hematocrit to 13% produced an 
increase in left ventricular blood flow in conscious dogs which is mainly 
distributed to the epicardium, indicating th at the coronary reserve in 
subendocardium is almost completely exhausted [12). 
In the present study an increase in myocardial blood flow of 420% with a 
doubling of the cardiac output mainly due to an increase in stroke volume was 
observed. In contrast to the studies discussed, in th is study hemodilution 
resulted in a doubling of left ventricular oxygen consumption. However the 
increase in myocardial blood flow produced a rise in left ventricular oxygen flux 
sufficient to meet the elevated left ventricular oxygen consumption. 
The increase in left ventricular blood flow exceeded the increase in cardiac 
output. Since the subendocardial reg ion is subjected to the greatest 
intramyocardial farces of the myocardium, this reg ion is perfused mainly during 
diastole. Therefore, it has to have a lower vascular resistance in order to receive 
the same amount of blood flow as the subepicardial reg ion. The vasodilatatory 
reserve capacity in the subendocardial layers is therefore lower and maximal 
coronary vasodilatation occurs. During severe hemodilution a redistribution of 
the coronary flow away from the subendocardial layers was observed in the 
present study. When maximal vasodilatation and maximal oxygen extraction 
have occurred, a further increase in oxygen demand will lead to myocardial 
ischemia and the heart will not be able to sustain the increased cardiac output. 
This is more likely to happen when myocardial oxygen consumption is increased 
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(e.g. hypertension, valvular heart disease) or when myocardial oxygen delivery is 
further reduced. Myocardial oxygen delivery can be reduced by a reduction of 
the arterial oxygen content (hypoxia), a shortening of the diastolic filling period 
(tachycardia) or a lowered coronary driving pressure. Maximal coronary 
vasodilatation is compromised when coronary artery disease is present. 
In conclusion hemodilution in anesthetized animals produces an increase in 
myocardial blood flow sulficient to meet the myocardial oxygen consumption. 
However, at low levels of hematocrit the endocardial/epicardial flow ratio is 
decreased and the vasodilatory reserve capacity of the coronary arteries is 
exhausted in the subendocardium. This limits the degree of hemodilution which 
can be reached. Additional caution is necessary if factors elevating the 
myocardial oxygen consumption or further reducing the (maximal) myocardial 
oxygen delivery are present. 
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Chapter 4 
Summary 
Mixed venous oxygen saturation of hemoglobin ISvO,) and mixed venous 
oxygen tension (pvO,) may reflect the overall balance between oxygen 
consumption and delivery. Because of the potential value of monitoring SvO, and 
PvO, as indications of the state of tissue oxygenation, the aim of this study was 
ta determine, during normoxic acute isovolemic hemodilution in pigs, the critical 
Pvo" critical SvO" and critical oxygen extraction ratio (ER) at which oxygen 
uptake starts to decline during further induced hemodilution. 
During stepwise induced isovolemic hemodilution, a gradual decline in SvO, 
and PvO, was observed in all animais. The mean ± SD of the critical Pvo, of six 
anima Is was 32.3 ± 3.1 mmHg. The mean ± SD of the critica I SvO, was 44.2 
± 7.9 %. The ER increased gradually. At an ER of 0.57 ± 0.08, oxygen uptake 
started to decline. A significant correlation was found between changes in SvO, 
and changes in ER. The degree of hemodilution we re accompanied by an 
increase in cardiac index, pulmonary wedge pressure, heart rate, and left 
ventricular stroke work index. Only a slight decrease in systemic vascular 
resistance was observed. We conclude that measurements of Pvo, and SvO, 
can be used as indicators of the critica I point of hemodilution and that the SvO, 
during hemodilution reflects the overall balance between oxygen uptake and 
oxygen delivery, confirmed by the strong correlation found between SvO, and 
oxygen extraction ration . 
Introduction 
The mixed venous oxygen saturation of hemoglobin ISvO,) and the mixed 
venous oxygen tension (PV02) refleet, under certain circumstances, the state of 
tissue oxygenation. Changes in cardiac output ICO). arterial oxygen content, and 
oxygen uptake IVO,) influence these parameters [1]. To our knowiedge, there 
are only two reports of PvO, studies during hemodilution. In one, during 
hypovolemia produced in dogs by removal of blood, the critical PvO, at which 
VO, began to deerease was found to be 29.9 mmHg 12). In the other study, the 
critical PvO, in dogs during isovolemic induced anemie hypoxia was 44.B torr 
[31. In both studies, the SvO, at the point at which PvO, had so decreased th at 
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V0 2 started to decrease during hemodilution is not mentioned. In several clinical 
situations hemodilution is benelicial, as it reduces the risks associated with the 
translusion ol homologous blood [4-7]. Because ol the possible value ol 
monitoring Sv02 and Pv0 2 in the evaluation ol tissue oxygenation during 
hemodilution, the aim ol this study was to determine, during normoxic acute 
isovolemic hemodilution in sedated paralyzed pigs, the critical Pv0 2 ' the critical 
Sv0 2 , and the critical oxygen extraction ratio (ER) at which V0 2 starts to decline 
with lurther hemodilution. 
Methods 
This protocol was approved by the Animal Care and Use Committee ol the 
Erasmus University, Rotterdam, The Netherlands. 
Six male Yorkshire pigs (10.2 - 12.0 kg) were used. After giving 0.3 mg/kg 
midazolam intramuscular, a catheter was introduced into one of the ear veins 
and the trachea was intubated. Throughout the experiment procedure sedation 
was maintained with a continuous inlusion ol 0.2 mg.kg·'.h·' midazolam. After 
intubation ol the trachea 0.1 mg/kg pancuronium was given intravenously with 
an additional continuous inlusion ol 0.3 mg.kg".h". The pigs' lungs we re then 
ventilated with air, using tidal volumes adequate to maintain end-tidal CO2 
between 4.5 and 5.0 kPa (33 and 38 mmHg). Catheters we re placed in the left 
lemoral artery , the right lemoral vein, and the right lemoral artery (the latter lor 
arterial blood pressure monitoring). Via the left temoral vein a thermodilution 
catheter (Swan Ganz 93A-095-7F) was introduced into a pulmonary artery. In all 
animals the injectate port was located in the right atrium as proven on 
postmortem examination. The urinary bladder was catheterized. Body 
temperature (blood temperature) was measured with the thermistor electrode ol 
the thermodilution catheter and was kept sta bie throughout the procedure by 
means ol a heating pad. After all preparations we re completed, the sedated 
paralyzed animals we re ventilated until blood gas tensions, pH, and 
hemodynamic parameters we re stabilized (average time 30 min). Pulse rate, 
arterial blood pressures, pulmonary arterial pressures, and the right atrial 
pressure were monitored continuously (Horizon 2000, Mennen Medical, Israel). 
After the stabilization period baseline measurements we re made, including haart 
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rate, mean arterial blood pressure, systolic pulmonary arterial pressure, diastolic 
pulmonary arterial pressure, pulmonary wedge pressure, right atrial pressure, and 
CO. In addition, arterial and mixed venous blood samples were taken for 
measurements of PO, ' pH and rco, (ASl 330, Radiometer, Copenhagen) and 
for the measurement of hemoglobin and oxyhemoglobin content 
(Spectrophotometer OSM3, Radiometer, Copenhagen). Oxygen flux (0 ,flux) was 
calculated as the product of arterial oxygen content and CO. Oxygen uptake by 
the tissue (Va,) was defined as the product of CO and the arteriovenous oxygen 
content difference. The ER was calculated as va, divided by a, flux. 
The first step of isovolemic hemodilution with isooncotic dextran 40, 50 gil 
in 0.9 % salt solution (lsodex, NPSI, The Netherlands) began after baseline 
measurements we re completed. The dextran solution (warmed to 38'C) was 
instilled slowly into the right femoral vein at the same time and at the same rate 
that blood was removed from the left femoral artery. Stepwise isovolemic 
hemodilution was induced by steps of 10 ml/kg until a total exchange of 40 
mL/kg had been reached and afterwards by steps of 5 mL/kg. New sets of data 
we re obtained after each step of isovolemic hemodilution when blood gas 
tension, pH, and hemodynamic parameters we re stabilized again (average time 5 
min). The time between each step of blood exchange was 15 min. 
To establish the mean critical PvO, ± SD, va, was plotted against the 
PvO, in each animal. The critical point of PvO, after which va, gradually 
decreased was analytically chosen from the intersection of the two best-fit 
regression lines, determined by a least sum of squares techniques as described 
by Schumacker et al. (2). The mean ± SD of the PvO, at this critical point was 
defined as the critical PvO, ± SD. The critica I SvO, and critica I ER we re also 
determined by the least sum of squares technique. 
All values are expressed as mean ± SD. In each figure the same animals 
are presented in the same order. The accepted probability for a statistical 
significanee between means was P < 0.05. The statistica I significanee of 
difference was tested by a Wilcoxon signed-rank test. Regression lines we re 
estimated by methods of least squares. For regression analysis, the Spearman 
rank correlation coefficient was used. 
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TabJe 1 Hemodynamic responses after each step of blood exchange 
Blood exchange MAP MPAP PWP HR Cl LVSWI SVR PVR Het 
(mL/kg body wt) (mmHg) (mmHg) (mmHg) (beats/min) (l.min".m'z) (g.cm".m'Z) (dyne.s·'.cm"5) (dyne.s-'.cm-5) (%) 
o (baseline) 96 ±13 17.7±4.5 7.8±6.6 167±20 5.1±1.0 34.0±8.9 3538± 1 1 01 482±163 30.0±3.6 
10 98 ±10 18.5±2.6 8.8±7.0 185±33 5.7±0.7 35.1 ±8.4 3196±987 429±63 23.7±2.2 
20 109 ± 14 22.0±5.2 10.3±8.8 196±27 ... 6.8±1.1 44.9± 12.2 .. 2945±722 424±105 20.1 ±1.8 
30 114 ±9 23.3±5.1 9.0±9.5 213±15 .. 6.8±1.1 46.7±13.3 ... 3141±1037 410±81 18.3±2.2 
40 117 ±9 23.S±3.6 9.7±8.2 ... 216±15 ... 7.2±0.9 47.3±14.4 ... 3037±937 466±223 15.6±1.5 
50 117 ±8 24.2±3.1 ... 10.5±6.9 ... 210±1S'" 7.3±0.8 48.9±16.6 ... 3049±994 490±248 13.2±0.8 
60 116 ±13'" 23.5±3.8 ... 10.2±6.5 ... 208±18 ... 7.1 ±0.6 47.7±14.7 ... 3147±1123 46S±211 12.0±1.1 
65 115±10'" 23.3±3.9 10.7±6.2 ... 206± 19 7.1 ±O.S ... 47.1±15.3" 3087±964 42S±162 10.8±0.8 ... 
70 116 ±1 1 23.3±4.4 1 1.0±6.6 ... 201 ±23 7.1±0.9 49.6± 17.3 ... 31 30± 1 069 427±1S1 9.8±0.6 
75 114 ±11 23.3±4.6 11.0±6.5 ... 204± 16 7.0±1.0 46.1±15.1 ... 3095±963 429±141 9.7±0.8 
80 111 ±12 22.2±4.2 9.8±6.6 ... 202± 17 6.S±0.8 47.3±14.2 ... 3132±107S 445±20S 9.0±1.2 
85 lOS ±12 22.5±3.9 10.5±6.9 .. 201 ±19 6.8±0.8 44.4±17.1 3008±1024 435±175 8.4±0.8 
90 104 ±9 21.5±3.8 9.8±5.4 ... 205±20 6.7±0.7 40.7±15.1 2960±1130 ... 416±191 7.8±0.9 
95 98 ±8 21.0±2.9 10.S±5,9 ... 197±20 6.6±O.7 38.2±10.2 2724±857 389±111 6.9±O.7 
100 91 ±10 20.7±3.9 11.0±5.2 ... 200±18 6.6±0.9 34.4± 13.1 2580±807 364±105 6.6±O.8 ... 
MAP, mean arterial blood pressure; MPAP, mean pulmonary artery pressure; PWP, pulmonary wedge pressure; HR heart rate; Cl, cardiac index; LVSWI, left ventricular 
stroke work index; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance; Het, hematocrit. 
Values are mean ± SD (n = 6) . 
.. P < 0.05 in comparison to baseline. 
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Results 
Hemodynamic Responses 
During hemodilution there was a significant increase in cardiac index (Cl) of 
up to > 40% (Tabie 1). The Cl did not return to baseline values. Even at a blood 
exchange of 100 mLJkg the Cl increased 30% above baseline values; at the 
same time total peripheral vascular resistance (SVR) decreased only slightly (by 
10-15%). left ventricular stroke work index increased 45%, accompanied by an 
increase of 30% in heart rate. A gradual increase in pulmonarv wedge pressure 
up to 40% above baseline values was observed, presumablv due to an increase 
in venous return to the heart. 
In each animal, there was a gradual deeline in PvO, during stepwise 
induced hemodilution. When VO, was plotted against PvO, in each animal, the 
critical PvO, at which VO, starts to decline could be established from the 
intersection of the two best-fit regression lines (Figure 1). The mean of the 
critical PvO, of the six animals was 32.3 ± 3.1 mmHg. The mean critical SvO, 
was 44.2 ± 7.9 (Figure 2). Plotting the VO, against the ER in each animal gives 
a critica I ER value of 0.57 ± 0.08 (Figure 3). During hemodilution a direct 
correlation was found bet ween the SvO, and the critical ER value (Figure 4). 
Hemodilution up to a 100 mLJkg exchange of blood volume did not significantlv 
alter the arterial pH, PO" or PCO,. The baseline pH in the mixed venous blood 
was 7.41 ± 0.02; with 100 mLJkg blood exchange it was 7.35 ± 0.05. levels 
of mixed venous pH, PvO" SvO" O,flux, VO" and the ER after each step of 
induced hemodilution are summarized in Table 2. 
Discussion 
Yorkshire pigs we re chosen for this study because the pig is so elosely 
related to the human, anatomicallv and physiologicallv. The cardiovascular 
svstem and metabolism of pigs and hu mans show similarities with respect to the 
size and distribution of coronarv vessels, blood pressure, heart rate, Cl, regional 
distribution of CO, and maximum oxygen consumption [8-10]. 
Continuous monitoring of SvO, has been used as an indicator of the effe cts 
of various therapeutic maneuvers În criticaUy iII patients, as a predictor in 
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Table 2 Systemic oxygenation and mixed venous blood oxygenation after each step of blood exchange 
Blood exchange Hb Pvc:!. Sv02 pHa pHv °2f1ux va, ER 
(ml/kg body wt) (9%) (mmHg) (%) (mJ.min-1.m':!.) (mL.min'l.m'2) 
o (baseline) 10.0 ±1.2 45.2±4.8 7Q.3±8.1 7.45±O.O3 7.41 ±O.O2 738±202 208± 19 O.30±O,Q8 
10 7.9 ±O.8 44.4±4.1 68.8±7.4 7.45±O.O3 7.41 ±O.O2 649± 123 200± 11 O.32±O.O7 
20 6.7 ±O.7 43.9±3.6 67.5±7.3 7.44±O.O2 7.41 ±O.O2 669± 157 201 ±50 O.33±O.O7 
30 6.1 ±O.8 40.9±3.5 62.5±7.7 7.45±O.O2 7.42±O.O2 593± 1 01 221 ±27 O.38±O.O7 
40 5.2 ±O.5 40.5±4.1 6Q.1 ±6.8 7.44±O.O1 7.41 ±O.O2 539±65 220±21 O.42±O.O4 
50 4.4 ±O.3 37.3±Z.9 54.9±7.0 ... 7.45±O.O2 7.41 ±O.O2 464±47 213± 19 O.46±O.06 ... 
60 4.0 ±O.4 34.2±3.5 47.9±8.4 7.45±O.O3 7.40±O.Q3 405±53 213±Z7 O.53±O.08 ... 
65 3.6 ±O.3 32.9±2.9 43.6±7.8 7.44±O,O3 7.40±O.O3 375±45 213±32 0.56±0.07 ... 
70 3.3 ±O.2 32.0±2.4 42.1 ±7.S 7.44±O.02 7.40±O.02 345±43 201 ±26 O.59±0.08 .. 
75 3.3 ±O.3 31.1 ±2.6 40.1±7A 7.44±O.O3 7.40±O.03 328±43 192±32 0.59±O.07 ... 
80 3.0 ±OA 29.S±2.2 37.4±6.8 7.44±0.O2 7.40±O.O2 304±40 191 ±19 ... 0.63±0.06 ... 
85 2.S ±0.3 29.6±2.6 35.S±S.4 7.43±0.03 7.39±0.O3 2S0±25 1S0±19 ... 065±0.08 .. 
90 2.6 ±0.3 2S.3±2.9 33A±S.1 7A4±O.01 7.3S±O.03 .. 260=.25 173±14 ... O.67±O.07 ... 
95 2.3 ±O.3 2S.3±2.9 32.6±4.0 7.42±O.O3 7.36±O.04 ... 234±41 156±1S ... 0.68±0.OS ... 
100 2.2 ±0.3 27.4±2.1 2S.3±5.2 7.41±O.O4 7.35±O.05 ... 216±34 1 55±23 ... O.72±0.OS .. 
Hb, hemoglobin; PvC:;: , mixed venous oxygen tension; SvO:;: , mixed venous oxygen saturation of hemoglobin; pH a, arterial pH; pH v, mixed venous pH; 0:zflux 
oxygen delivery; VO:;: , oxygen uptake; ER, oxygen extraction ratio. 
VaJues are mean ± SD (n = 6) . 
... P < 0.05 in comparison to baseline. 
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hemodynamically unstable patients, and lor measurement ol oxygen transport 
patterns [11-13]. In a prospective study, SvO, was lound to correlate weil with 
oxygen utilization coefficient; SvO, therelore rellects the overall balance 
between oxygen consumption and delivery in critically ill surgical patients [14J. 
To our knowiedge, no reports are available concerning SvO, during 
isovolemic hemodilution, or concerning the critical SvO, at which VO, starts to 
decline during lurther stepwise isovolemic hemodilution. In this study, the effect 
ol a decrease in oxygen supply on oxygen uptake during normoxic acute 
isovolemic hemodilution started when SvO, was 44.2 ± 7.9%. As in the 
prospective study in critically ill patients [141, we lound a direct correlation 
between the SvO, and the ER during stepwise induced hemodilution. 
Another parameter studied by us is the critical PvO,. In our study, the 
critical PvO, at which VO, became dependent on oxygen Ilux was 32.3 ± 3.1 
torr. To our knowiedge, in only two other studies -one during isovolemic 
hemodilution, the other during hypovolemic hemorrhage- is the critical PvO, 
reported. During hypovolemic hemorrhage in dogs, a critical PvO, ol 29.9 ± 2.3 
was lound [2]. These data, ho wever, cannot be compared to our data because 
ol the differences in experimental procedure (hypovolemia via removal ol blood 
volume with a lixed arterial oxygen content versus isovolemic hemodilution and 
consequent decreased arterial oxygen content). In the other study using dogs, 
Cain reported a critical PvO, ol 44.8 torr during isovolemic induced anemie 
hypoxia, at which point oxygen uptake began to decrease [3]. The large 
difference between the results ol Cain's study and ours may be explained in two 
ways. First, the critical PvO, in Cain's study was identilied in a diflerent manner. 
The percentage change in VO, in comparison to control VO, was plotted against 
the PvO, to obtain the critical PvO,. The single linear regression line obtained in 
this way was intersected with the point ol 100% oxygen uptake, placing more 
weight on the value ol the baseline VO, and less on the observed increase in 
VO, at the initial stage ol hemodilution. 
The other reason lor the observed differences in critical PvO, during 
hemodilution may be the differences in cardiovascular and sympathetic 
responses between dogs and pigs and the differences in the anatomy and 
distribution ol coronary arteries in both animals [8,10]. The differences in 
responses ol Cl and SVR on hemodilution between Cain's report and our study 
support this hypothesis. In our study, a 40% increase in Cl was observed. The 
percentage increase in CO in dogs in comparison to the va lues obtained belore 
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blood gas analysis of mixed venous blood 
isovolemic anemia was induced was more pronounced in Cain's study (130%). 
Cain observed a deerease in SVR of 60% at the initial stage of isovolemic 
induced anemie hypoxia and of 74% at the final stage, whereas in our study in 
pigs the decrease in SVR was not more than 10-15% of the baseline value. Only 
in the fin al stage of anemie hypoxia during isovolemic hemodilution was the 
decrease in SVR enhanced to 25% - probably because at the moment the 
hypoxic induced vasodilation became more dominant than the reported reflex 
vasoconstriction activity during anemia [15). 
The differences in cardiovascular and hemodynamic responses between pig 
and dog mayalso explain the difference in critica I ER in the two species rand in 
the two studies). In dogs, a critical ER value of 0.79 has been reported [16], 
whereas in our study of pigs, the ER level was 0.57 when whole body oxygen 
uptake started to decline. 
Because of the strong correlation found between SvO, and ER, we suggest 
that the monitoring of SvO, may be important as an indicator of the state of 
tissue oxygenation during normovolemic hemodilution. In sedated, paralyzed pigs 
a critical SvO, of 44.2 ± 7.9 and a critical PvO, of 32.3 ± 3.1 mmHg was 
found, at which point oxygen uptake started to decline during further 
hemodilution. 
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EXTRACTION RATIO AND MIXED VENOUS OXYGEN SATURATION: 
A FAlSE RElATIONSHIP 
Percival CJ. 
AnesthAnalg 1991; 72: 713-718. 
To the editor: 
I read with interest the artiele ol Trouwborst et al. 11 J concerning the mixed 
venous blood gas analvsis during normoxic acute isovolemic hemodilution in 
pigs. With ever-increasing numbers ol patients asking th at homologous blood 
translusions be avoided, I think that this inlormation is particular timely. 
Anesthesiologists need to know which indices are predictive ol the limits ol sale 
isovolemic hemodilution, and I think that the authors' results certainly have 
implications in humans. However, when they describe "the strong correlation 
lound between mixed venous oxygen saturation (SvO,J and extraction ratio (ER)" 
and depict this relationship in Figure 4, they have made an error ol the type 
described by Archie 12J as "mathematical coupling". They deline ER as lollows, 
where VO, ~ oxygen consumption, CO ~ cardiac output, CaO, ~ arterial 
oxygen content, Cv02 = mixed venous oxygen content, Sv02 = mixed venous 
oxygen saturation, SaO, ~ arterial oxygen saturation, and O,llux ~ oxygen 
delivery: 
VO, (CO)(CaO,-CvO,) 
ER 
O,llux (CO)(CaO,) 
CvO, SvO, 
1 - 1 - ~ 1 - SvO, 
CaO, SaO, 
(because SaO, approaches 1 J. Therelore, the graph in Figure 4 is basically Y 
1 - X. The authors used percent and lound essentially th at Y ~ 100 - 100X 
where X or, in this case Sv0 2, is greater than zero, but less than one. In 
calculating rather than measuring VO" the graph is predictabie without gathering 
any data at all. I suspect there is a correlation between SvO, and ER, but any 
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attempt to describe it using these data is not meaningful. 
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IN RESPONSE 
Trouwborst A, van Woerkens ECSM. 
Indeed, with oxygenation calculations using the indirect Fick method, a 
souree of error can easily be introduced by mathematical coupling of data. 
Comparing SvO, values with ER, mathematical coupling might exist because in 
calculating the ER, SvO, itself is one of the variables. We therefore agree with 
Dr. Percival that the statement "a strong correlation exists between SvO, and 
ER" deserves further discussion. He suggests th at we used in the calculation of 
the ER the equation 
CvO, SvO, 
1 - 1 -
CaO, SaO, 
which was not the case. In our calculations 
CvO, 
1 -
CaO, 
Hb (mixed venous) x 1.34 x SvO, + PvO, x 0.003 
1 -
Hb (arterial) x 1.34 x SaO, + PaO, x 0.003 
which includes two factors ignored by Dr. Percival: physically dissolved oxygen 
traction and the difference between arterial and mixed venous hemoglobin (Hb) 
content. Furthermore, Dr. Percival makes the assumption that SaO, is al most 
100%. 
Under normal physiologic conditions (e.g., normal Hb content and normal 
SaO,) the amount of dissolved oxygen as part of the total arterial oxygen 
content is minimal (2.0-2.5%) and might therefore be excluded in algorithms. 
However, decreasing Hb content, as in our experiments, at each step of 
hemodilution, the amount of dissolved oxygen as a percentage of total arterial 
oxygen content increases and becomes more and more important as one of the 
varia bles in calculating the ER. 
The difference between arterial Hb content and mixed venous Hb content 
forces one to consider in the algorithm the Hb values. The equation ER = 1 -
Sv0 2 is therefore an oversimplification and a common source of error in several 
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situations (e.g., hemodilution, hypoxemia, hyperoxemia). We do not agree with 
Dr. Percival th at in our presented experiments the relationship between SvO, and 
ER was predictabie without gathering any data at all. Furthermore, it has been 
stated that by keeping the range ol the independent variabie, SvO" as large as 
possible (as in our study), the effe cts ol coupled error are minimized [1 I. 
Nevertheless, we agree that in part the correlation as presented might be 
inlluenced by mathematic coupling because ol calculating VO, rather than 
measuring VO,. Meanwhile, some pilot hemodilution experiments have been 
performed using a totally closed circuit anaesthesia machine developed in our 
department (Physiollex, Weesp, The Netherlands) [21 that measures rather than 
calculates VO,. In these experiments (th ree animais). astrong correlation has 
been lound between ER and SvO" supporting the statement about the 
correlation between ER and SvO,. 
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Abstract 
Background: The use ol homologous blood produets involves several 
important risks. Some methods which can be employed to reduce the amount ol 
homologous blood used perioperatively, including several hemodilution 
techniques and preoperative autologous blood donation (PABO) are investigated. 
Methods: Forty patients (ASA 1 or 2) undergoing radical prostatectomy 
under general anesthesia we re randomly assigned to one ol lour groups (acute 
normovolemic hemodilution (ANH); PABO; normovolemic hemodilution 
peroperative (NHO); and acontrol group). Full sets ol hemodynamic and 
oxygenation parameters we re obtained peroperatively and during 18 hours 
postoperatively. Perioperatively the course ol reticulocytes and hemoglobin level 
was evaluated and the amount ol autologous and homologous blood products 
used was measured. 
Resu/ts: Hemodynamic changes included an increase in cardiac output 
with almost no change in haart rate, and a decrease in systemic vascular 
resistance. Ouring normovolemic hemodilution the pulmonary wedge pres su re 
increased. Oxygen extraction ratio increased and mixed venous oxygen pressure 
decreased. The more critical value ol a Pv02 ol 33 mmHg was reached in 18 ol 
30 hemodilution patients due to decreased oxygen delivery, and in 3 ol 10 
control patients due to a leftward shift in the oxygen dissociation curve (OOC). 
The amount ol homologous blood used was lowest in the PABO group. 
Gonc/usions: Less homologous blood produets we re used with PABO than 
with ANH. Pulmonary wedge pressure increases as hematocrit is reduced. At a 
mean hemoglobin of 4.8 ± 0.2 mmol/I the Pv0 2 decreases below the more 
critical value ol 33 mmHg in some hemodilution patients. 
Introduction 
The use ol homologous blood translusions involves several risks, including 
isosensitization, febriIe reactions, disseminated intravascular coagulopathy, 
immunosuppression (causing an increased risk of postoperative infections and 
possibly of ca neer recurrence) and transmission of several infectious agents 
(hepatitis, cytomegalic virus, syphilis, herpes, malaria, tryptonosomiasis, HIV) [1-
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41. Mismatching of blood can lead to disastrous events. Certain patients, such as 
Jehovah's Witnesses, refuse the use of homologous blood transfusions on 
religious grounds. Finally, the costs of homologous blood continue to increase 
steadily. 
In an attempt to reduce the number of homologous blood transfusions during 
surgery several techniques can be employed, including preoperative autologous 
blood donation and acceptance of a lower hemoglobin level in the perioperative 
period. 
Of particular interest are the hemodilution methods, since it has been 
demonstrated that during anesthesia the body can compensate for the decreased 
arterial oxygen content by increasing the cardiac output. The amount of blood 
which can be saved using acute normovolemic hemodilution remains a matter of 
debate [5,61. Some claim significant savings [7,81, while ot hers report a very 
limited usefulness of acute normovolemic hemodilution as a bloodsaving method 
[9,10). To our kno wied ge, few human studies have been conducted giving a full 
set of physiological hemodynamic and oxygenation parameters [including PvO, 
as an indicator of tissue oxygenation) during hemodilution under general 
anesthesia [Table 1). Most of these studies used only limited hemodilution [11-
141, a small number of patients [3,15,161, or we re performed in children [3,16). 
The aim of this randomized prospective controlled study in anesthetized adult 
humans is to compare three different techniques including acute normovolemic 
hemodilution, preoperative autologous blood donation and normovolemic 
hemodilution used during severe blood loss, to reduce homologous blood 
transfusions peroperatively land 18 hours postoperatively) and to evaluate their 
normal physiological effect on hemodynamics, oxygen transport (including 
effe cts on the oxygen hemoglobin dissociation curve), blood loss, erythropoiesis 
and transfusion needs. In the literature such a randomized prospective controlled 
study in adults addressing a more pronounced level of hemodilution is lacking. In 
the present study, compared to other studies in adults from the literature, 
hemodilution will be more pronounced in order to establish the hemoglobin level 
at a more critical point of mixed venous PvO, [171 during stepwise induced 
normovolemic hemodilution. 
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Table 1. Studies on hemadilutian in anesthetized humans with sets of 
hemadynamie and axygenatian parameters. 
Reference 
number 
3 
11 
12 
Study design n hct/Hb 
R p c 
no yes na 8 het: 9 ± 2.2 
yes yes yes 10 het: 28.2 
yes yes yes 20 het: 31 ± 1.4 
Remarks on studies 
high Fi02 
children 
epidural anesthesia 
cardiovascular medication 
continued 
13 no yes no 20 Hh: 8.8 ± 0.3 g% > 65 yr; no Pv02 
sta bie filling pressures 
14 yes yes yes 60 Hh: 9.9 ± 0.2 g% chronic r.. blocker therapy 
pre CABG 
15 no yes no 4 het: 21.5 ± 0.7 high Fi02 
16 no yes no 6 het: 16 ± 1 children 
Study design: R = randomized; P = prospective; C = controlled; n = number of patients 
studied; hct/Hb = lowest hematoerit or hemoglobin level reached during hemodilution. 
Patients and methods 
PATIENTS 
After obtaining informed consent patients scheduled for radical 
prostatectomy we re included in the study and randomly assigned to ane of four 
groups. Radical prostatectomy was carried out for locally confined (T2) or locally 
extensive (T3) prostate cancer. Patients with cardiovascular instability (untreated 
e!evated blood pressure, cardiac ischemia, recent myocardial infarction, use of 
IS-blockers), severe pulmonary disease, impairment of renal functÎon, increased 
bleeding tendency, recent cerebrovascular accident or anemia (hemoglobin level 
< 7.5 mmol/Il we re excluded from the study. All patients we re informed in 
detail on the protocol and gave written informed consent before start of the 
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procedure. The stud V protocol was approved bV the Medical Ethical Committee 
ol the Universitv Hospital Rotterdam-Dijkzigt. 
DEMOGRAPHICS 
The demographic data are given in Table 2. Mean age ol the patients was 61 
± 1 vears, mean bodvweight 82 ± 2 kg. There we re no relevant differences 
between the lour groups with respect to age, bodvweight or heigth. 
Table 2. Demographic data of the study population. 
group age weight heigth BSA 
(V rs ) (kg) (m) (m2 ) 
1 62 ± 1.4 77 ± 3 1.76 ± 0.02 1.93 ± 0.03 
2 61 ± 1.8 86 ± 4 1.79 ± 0.02 2.07 ± 0.06 
3 63 ± 1.7 86 ± 4 1.79 ± 0.02 2.05 ± 0.06 
4 60 ± 1.9 81 ± 9 1.77 ± 0.02 1.98 ± 0.04 
Group 1 = ANH; group 2 PABO; group 3 = NHD; group 4 = control; BSA 
body surlace area; vrs = vears; kg = kilograms; m = meters; m2 = square 
meters. 
Values presented as mean ± SEM. 
The lour groups we re treated as lollows: 
Group 1: preoperative acute normovolemic hemodilution (ANH). 
After induction ol anesthesia and baseline measurements, autologous blood was 
collected lrom the patient and simultaneouslv replaced with dextran 40, 50 gIL 
in 0.9% salt solution (lsodex®, NPBI, The Netherlands) until the hematocrit 
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reached 0.25-0.30. Blood loss during surgery was replaced with dextran 40 
(lsodex®) until the hematocrit reached 0.20-0.25. Thereafter blood loss was 
initially replaced with the autologous whole blood, starting with the 500 mi ol 
blood collected last (the unit with the lowest hematocrit). 
Group 2: preoperative autologous blood donation (PABO) 
Autologous blood was harvested approximately once a week during a 3-4 week 
period preoperatively and stored at the bloodbank. All patients received oral iron 
supplementation during this period until the dav ol the operation. Hemoglobin 
level and hematocrit we re measured at each blood donation. Blood loss during 
surgery was replaced with dextran 40 (Isodex®) until the hematocrit reached 
0.20-0.25. Thereafter lurther blood loss was initially replaced with autologous 
packed cells and Iresh lrozen plasma (starting with the unit which was eolleeted 
most recently). 
Group 3: peroperative normovolemie hemodilution (NHO). 
Blood loss during surgery was replaeed with dextran 40 (lsodex®) until the 
hematoerit had deereased to the level ol 0.20-0.25, when homologous blood 
transfusion was started. 
Group 4: control group. 
Blood loss during surgery was replaeed with dextran 40 (Isodex®) until total 
blood loss reached 10 mi/kg body weight, lollowed by homologous blood 
translusion (one unit ol 250 mi paeked eells eombined with 250 mi ol colloid for 
every 500 mi of blood loss). 
METHODS 
All patients reeeived 2.5 mg midazolam intramuseularly or 7.5 mg midazolam 
orally preoperatively. After induction of anesthesia with thiopental (4 mg/kg) and 
fentanyl (0.25 mg), and aehievement of muscle relaxation with pancuronium 
bromide (0.1 mg/kg), all patients were intubated and ventilated to maintain 
normocarbia. Anesthesia was maintained with a mixture of oxygen in nitrous 
oxide and a low dose of enllurane (end tidal 0.4-0.8%), supplemented with 
intravenous lentanyl. A 21 gauge catheter was placed into the right or left radial 
artery. A pulmonary artery thermodilution catheter (Swan-Ganz, American 
Edwards Laboratories) was introduced into the pulmonary artery via the internal 
jugular vein. All patients received an urine catheter. 
The lasting period was compensated by administration of 10 mi/kg 
bodyweight ol Ringers' lactate. Ouring surgery the Ringers' lactate infusion was 
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eontinued at a rate ol 8 mi/kg bodywelght per hour to eompensate lor insensible 
losses. Initially blood loss was replaeed by eolloids as described and blood 
translusion was started as soon as the hematoerit level reaehed 0.20-0.25 
(except lor the control group in whom blood translusion was started after blood 
loss ol 10 mi/kg independent ol hematoerit) or the oxygen extraction ratio 
exceeded the aeceptable level ol 0.40. At the end ol surgery the target 
hemoglobin level was 6.0 mmol/!. Postoperatively a blood translusion was given 
il the hemoglobin level was < 6.0 mmol/!. Inlusion ol Iresh Irozen plasma in 
groups 1 (ANH), 3 (NHO), and 4 (control) was started as soon as total blood loss 
exeeeded 70 mi/kg bodyweight, or a coagulation problem was eonsidered on 
clinical grounds. Inlusion ol autologous Iresh Irozen plasma in group 2 (PABO) 
was started simultaneously with the lirst autologous unit ol packed eells. In all 
patients dextran 40 (Isodex"') was used as colloid until the total amount ol 
dextran 40 reached 1.5 g/kg bodyweight. Thereafter gelatin solution 
(Geloplasma"', Roger Bellon, Neuilly-sur-Seine, Franee) was used as colloid. 
MEASUREMENTS 
One dav preoperatively laboratory measurements ol hemoglobin 
coneentration (Hb), hematoerit (ht), number ol erythroeytes, thrombocytes and 
retieuloeytes we re obtained. These measurements we re repeated on the lirst, 
third and seventh dav postoperatively, on the dav the patient was diseharged 
Irom hospita!, and at approximately lour weeks after surgery. In the PABO group 
hemoglobin levels and hematoerit were measured belore each donation. 
After induetion ol anesthesia but prior to surgery all hemodynamic and 
oxygenation parameters were measured. These measurements we re repeated 
after acute normovolemic hemodilution in group 1, and after eaeh 500 mi ol 
blood loss, at the end ol surgery, and at 2, 6, 12 and 18 hours postoperatively 
in all 4 groups. Blood loss was measured by measuring the volume ol collected 
blood and adding the amount as estimated by weighing ol the gauze pads belore 
and after use. 
Hemodynamic measurements consisted of mean arterial pres su re (MAP), 
mean pulmonary pressure (MPAP), pulmonary capillary wedge pressure (PWP), 
cardiac output (CO) and heart rate (HR). Oxygenation measurements were made 
by simultaneously obtaining an arterial and mixed venous blood sample and 
determining oxygen pressure (pO,), carbon dioxide pressure (PCO,) and pH 
(ABl330, Radiometer, Copenhagen) and oxygen saturation (SO,) (OSM3, 
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Radiometer, Copenhagen) in these samples. Hemoglobin level and hematocrit 
we re also measured in these blood samples. 
From these measurements cardiac index (Cl), systemic vascular resistance 
index (SVRI), pulmonary vascular resistance index (pVRI), total oxygen Ilux 
index (00,1), arteriovenous oxygen content dillerence (avO,dill), total oxygen 
consumption index (VO,I) and oxygen extraction ratio (ER) we re calculated. To 
evaluate the position ol the oxygen dissociation curve the Pso (PO, at which 
hemoglobin is 50% saturated with oxygen) was calculated as described 
previously 118). 
STA T/ST/CAL ANAL YSIS 
Data are presented as mean ± SEM. Continuous variables we re compared 
between the lour groups by one-way analysis ol varianee, lor each measurement 
occasion separately. This was lollowed by all pairwise group comparisons, 
corrected lor multiple comparisons by Fisher's Least Significant Dillerence 
method. Comparisons between measurement times within the same group we re 
perlormed using the t-test lor paired observations. The number ol translusions 
was compared between the lour groups using the test ol Kruskal and Wallis, lor 
each measurement occasion separately. II the result ol this test was signilicant, 
all pairwise comparisons between groups ware done using Wilcoxon's two 
sample test. 
The relationship between PWP and hematocrit was studied with a random 
coellicients linear regression model, using the SAS program PROC MIXED [191. 
In this model a linear relationship between PWP (dependent variabie) and 
hematocrit (independent variabie) was assumed on patient level, where the 
intercept and slope was allo wed to diller between patients. The relationship 
between PvO, and hemoglobin was analyzed analogously, but in this case a 
quadratic relationship had to be assumed, the coefficient ol the quadratic term 
being signilicantly negative. 
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Results 
MISSING DATA (see Tables) 
We planned to make measurements at each 500 mi of blood loss. However, 
when blood loss was too rapid it was impossible to make measurements at 
every 500 mi, resulting in missing data in some patients at a few points 
peroperatively. In two cases (one patient in the ANH group and one patient in 
the NHO group) there was no bed available on the intensive care unit resulting in 
some missing data postoperatively. These patients were kept on the recovery 
ward for 6 hours postoperatively, after which period the arterial line and 
pulmonary artery catheter we re removed. Some patients chose to undergo 
postoperative follow-up in a hospital elsewhere, so th at some values on 
reticulocytes, hemoglobin and hematocrit postoperative are also missing. 
BLOOD LOSS AND TRANSFUSION NEEDS 
Data on peroperative and postoperative (lirst 18 hours) blood loss and use of 
autologous and homologous blood produets are given in Table 3. There was no 
significant difference in blood loss between the four groups. Autologous blood 
was only available in groups 1 and 2, by means of acute normovolemic 
hemodilution and by preoperative autologous blood donation, respectively. As 
expected, the use of homologous blood produets was highest in the control 
group. The number of homologous blood produets used in the control group 
peroperatively was significantly higher than used in groups 1 (ANH) and 2 
(PABO). There was no significant difference between the control group and the 
group in which peroperative normovolemic hemodilution (NHO) was employed. 
The lowest use of homologous blood produets was in the group with 
preoperative auto logo us blood donation (PABO); however, this amount did not 
reach statistical significanee compared with the amount used in group 1 (ANH). 
None of the patients in the control group or in the group using only peroperative 
normovolemic hemodilution (NHO) could be managed without homologous blood. 
In the ANH group 3 out ol 10 patients did not receive any homo logo us blood 
peroperatively, while in the PABO group this number was even 7 out ol 10 
patients. However in the lirst 18 hours postoperatively 1 additional patient in the 
ANH group and 3 patients in the PABO group needed homologous blood, 
resulting in a total ol 6 patients (2 in the ANH group and 4 in the PABO group) 
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Table 3. Blood loss and transfusion needs of the four groups. 
group blood loss autologous autologous blood homologous blood 
(mI) blood donated transfused transfused 
(U) (U) (U) 
perop postop perop periop perop periop 
3620 ± 560 620 ± 160 2.9± 0.1 2.8 ± 0.2 2.9±0.2 2.0 ± 0.734 3.5±1.34 
1800-7600 100-1800 2-3.8 2-3.7 2-3.8 0-7 0-14 
2 3870 ±400 350 ± 70 4.0± 0 3.6 ±0.3 3.8±0.3 0.5 ± 0.334 1.3 ±p.43 
1700-6000 120-860 4 1-4 2-4 0-3 0-3 
3 4480 ±460 550 ± 100 4.3 ± 0.512 4.8 ± 0.62 
2100-8000 200-1200 2-7 2-8 
4 3910±430 470 ± 100 5.9 ± 0.8'2 5.9 ±g.8' 
2350-7000 80-1000 3-12 3-12 
Group 1 = ANH; group 2 = PABO; group 3 = NHO; group 4 = control. Perop = perioperative; postop = postoperative 
(first 24 hours). Autologous blood: in group 1 500 mi of whole blood equals 1 unit; in group 2 1 packed cells and 1 fresh 
frozen plasma equals 1 unit. 
Values are presented as mean ± SEM, and as the range. 
'234 = statistical significant difference between groups 1,2,3 or 4, respectively; P < 0.05 (only blood loss and number of 
homo logo us blood product analysed). 
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who did not receive homologous blood perioperatively. 
PERIOPERATIVE ERYTHROPOIESIS (Tabie 4) 
The number of reticulocytes was already increased in group 2 on the dav 
preoperatively, due to the process of donating 3-4 units of blood in the previous 
weeks thus stimulating the erythropoiesis. The increase in postoperative 
hemoglobin level started on the third dav postoperatively in this group and 
remained higher than the hemoglobin level of groups 1 and 3 from th is dav on; 
however this increase is probably not attributable to the number of blood 
transfusions given in this period. During days 2-7 postoperatively a total of three 
units packed cells was given to 2 patients in group 1 (ANH) and to 2 patients in 
group 3 (NHDl, and 2 units to 1 patient in group 2 (PABD) and even 2 units to 1 
patient in group 4 (control). Blood loss could not be measured accurately in this 
period, because drain production consisted of both blood loss, Iymphatic fluid 
and in some instanees of urine (due to leakage) in a varying amount, but it 
seems unlikely that a significant difference would have existed between the 4 
groups. The difference in rise in hemoglobin level between the group with 
predeposited autologous blood and the two other hemodilution groups did not 
reach statistical significanee, perhaps due to the small number of patients. 
HEMODYNAMICS (Tabie 5) 
At the lowest hemoglobin level for each patient the mean increase in cardiac 
index was 37 ± 7%,61 ± 18%, and 49 ± 10% in the hemodilution groups 1, 
2 and 3, respectively, and 18 ± 11 % in the control group in whom only very 
limited hemodilution was used. Heart rate did not change significantly from 
baseline measurements in all groups, indicating that the increase in cardiac 
output was due to an increase in stroke volume. 
During hemodilution, mean arterial blood pressure did not change significantly 
from baseline values to the measurements at the nadir of the hemoglobin level, 
while mean increase in arterial pulmonary blood pressure was 36 ± 13% in 
group 1 (ANH), 87 ± 23% in group 2 and 67 ± 10% in group 3. The control 
group also showed a slight increase in MPAP (33 ± 7%) as hematocrit in this 
group decreased from 39.2 ± 1.2 to 29.6 ± 0.7%. Combined with the 
observed increase in cardiac output this resulted in a decrease in SVRI, with no 
or only small changes in PVRI. 
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Table 3. Blood loss and transfusion needs of the four groups. 
group blood loss autologous autologous blood homologous blood 
(mil blood donated transfused transfused 
(UI (UI (UI 
perop postop perop periop perop periop 
3620 ± 560 620 ± 160 2.9± 0.1 2.8 ±0.2 2.9 ± 0.2 2.0 ± 0.734 3.5 ± 1.34 
1800-7600 100-1800 2-3.8 2-3.7 2-3.8 0-7 0-14 
2 3870 ± 400 350 ± 70 4.0± 0 3.6 ±0.3 3.8 ±0.3 0.5 ± 0.334 1.3 ± 0.434 
1700-6000 120-860 4 1-4 2-4 0-3 0-3 
3 4480 ± 460 550 ± 100 4.3 ± 0.5 '2 4.8 ±0.62 
2100-8000 200-1200 2-7 2-8 
4 3910±430 470 ± 100 5.9 ± 0.812 5.9 ± 0.8 '2 
2350-7000 80-1000 3-12 3-12 
Group 1 = ANH; group 2 = PABO; group 3 = NHO; group 4 = contro!. Perop = perioperative; postop = postoperative 
(first 24 hoursl. Autologous blood: in group 1 500 mi of whole blood equals 1 unit; in group 2 1 packed cells and 1 fresh 
frozen plasma equals 1 unit. 
Values are presented as mean ± SEM, and as the range. 
1234 = statistical significant difference between groups 1,2,3 or 4, respectively; P < 0.05 (only blood loss and number of 
homologous blood product analysedl. 
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Pulmonary wedge pressure increased in all hemodilution groups, but least 
(4.3 ± 0.7 mmHg) in group 1 (ANH). The change in mean PWP was 7.7 ± 1.0 
mmHg and 7.6 ± 1.6 mmHg in groups 2 and 3, respectively at the 
measurement at which the hemoglobin level reached its nadir compared to 
baseline values. In the control group mean PWP increased 3.8 ± 1.2 mmHg 
from baseline to the measurement at 1000 mi blood loss with a concomitant 
decrease in hematocrit from 39.2 ± 1.2 to 30.6 ± 1.0%. PWP in the control 
group showed no essential change after this measurement. Statistical analysis 
showed a linear realtionship between the change in hematocrit and the change in 
PWP (Figure 1). PWP was lower in group 1 (ANH), but showed almost the same 
relationship in the remaining groups. In the hemodilution patients at the end of 
surgery and in the first 2 hours thereafter, the increase in hematocrit due to 
blood transfusions was followed by a decrease in PWP despite the additional 
volume loading caused by the administration of the packed red cells. 
20 
O~~--------~-----------L--------~ 
20 30 40 50 
hematocrit (%) 
-- ANH PABD -- HD -- control 
Figure 1. 
Relationship between hematocrit and PWP for each study group. The relationship 
between PWP and hematocrit was studied with a random coefficients linear 
regression model, using the SAS program PROe MIXED [19}. 
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Table 5. Hemodynamic data on the groups during the study period. 
parameter 
n 
ht 
% 
HR 
beats/min 
MAP 
mmHg 
MPAP 
mmHg 
pwp 
mmHg 
SVRI 
Ds/cm5 
PVRI 
Ds/cm5 
group baseline 
1 10 
2 10 
3 10 
4 10 
1 40.7 ± 0.923 
2 33,5 ± 1.1 134 
3 37.6 ± 0.912 
4 39.2 ± 1.2' 
1 68 ± 4 
2 65 ± 3 
3 66 ± 2 
4 66 ± 3 
1 73 ± 3 24 
2 84 ± 3' 
3 80 ± 3 
4 82 ± 3 1 
14.9 ± 0.9 
2 15.2 ± 1.9 
3 15.1±1.3 
4 16.1 ± 1.2 
1 6.4 ± 0.9 
2 7.4±1.4 
3 8.6 ± 0.9 
4 7.5 ±0.7 
1 1.91 ±0.15 
2 1.92 ± 0.10 
3 1.83 ± 0.09 
4 1.99±0.12 
1 2850 ± 180 
2 3350 ± 210 
3 3210 ± 160 
4 3090±190 
1 378 ± 46 
2 358 ± 77 
3 280 ± 20 
4 357 ± 35 
ANH 
10 
26.9 ± O.5b 
± 
± 
± 
66 ± 3 
77 ± 4 
20.7 ± l.4b 
11.0 ± O.gb 
2.46 ± 0.16" 
170 ± 130b 
3302 ± 50 
1000 
10 
8 
10 
10 
22.6 ± O.6b234 
25.1 ± 1.0b134 
29.2 ± O.7b12 
30.6 ± 1.0b12 
69 ± 54 
67 ± 3 
65 ± 1 
62 ± 2bl 
75 ± 4 2 
90 ± 6' 
88 ± 7 
85 ± 3 
18.0±1.1 b2 
23.1 ± 2.1' 
19.9 ± 1.7b 
20.1 ± 1.2b 
9.8 ± O.Sb 
12.9±0.9 
11.1 ± 1.2b 
11.3 ± 1.3b 
2.38 ± O.13b 
2.27 ± 0.16b 
2.26 ± 0.09b 
2.28±0.12 
2220 ± 100b234 
2740 ± 170b1 
2830 ± 2201 
2700 ± 150bl 
286 ± 22b 
380 ± 52 
312 ± 26 
314 ± 35 
1500 
9 
8 
9 
9 
21.3 ± O.5b234 
23.9 ± O.8b134 
26.4 ± a.9t1ll 
30.7 ± a.sbll 
68 ± 24 
65 ± 3 
67 ± 1 
61 ± 2b1 
73 ± 5 2 
89 ± 6 1 
79 ± 5 
85 ± 4 
19.9 ± 0.8" 
23.0 ± 1,gb 
21.6 ± 1.4b 
20.3 ± 1.8 
10,7 ± o.ab 
13.3±1.3b 
13.1 ± lo1 b 
10.8 ± 1.7 
2.47±0.17" 
2.60 ± 0.21 b 
2.46 ± O.ll b 
2.28±0.11 
2090 ± 150" 
2390 ± 190b 
2220 ± 170b 
2670 ± 1601 
298 ± 29 
298 ± 33 
276 ± 37 
345 ± 45 
2000 
9 
8 
10 
9 
20.0 ± O.6b34 
21.3 ± a.sb4 
23.0 ± o.abl4 
30.2 ± a.sbll3 
73 ± 54 
66 ± 2 
67 ± 2 
60 ± 2b! 
76 ± 54 
84 ± 3 
83 ± 2 
87 ± 4' 
19.9±1.4b2 
24.8 ± 1.6b! 
23.4 ± 1.2b 
22.8 ± 1.3b 
11.2±O.7b2 
14.8 ± 1.5b1 
13.7 ± O.gb 
12.4 ± 1.4b 
2.70 ± 0.21" 
2.67 ± 0. 12b 
2.67 ± 0.13b 
2.31 ± 0.12 
2000 ± 110b4 
2170 ± 130b4 
2250 ± 130b4 
2680 ± 140bl2 , 
274 ± 38b 
306 ± 33 
300 ± 33 
363 ± 36 
n = number of patients at each measurement; group 1 = ANH; group 2 = PABO; group 3 
PNH; group 4 = control; ANH = after acute normovolemic hemodilution (only group 1); 1000, 
2000 = measurement at blood loss of 1000 mi and 2000 mi, respectively; nadir Hb = lowest 
hemoglobin level; end = end of surgery; 2h, 6h, 12h, 18h = 2, 6 , 12, and 18 hours 
postoperatively, respectively; 
Table 5. Continued. 
nadir Hb 
10 
10 
10 
10 
19.7 ± 0.5b4 
20.3 ± 0.81>4 
21.4 ± 0.51>4 
29.6 ± 0.7 b123 
71 ± 5 
68 ± 3 
66 ± 2 
60 ± 2b 
71 ± 4 24 
86 ± 2\ 
80± 3 
85 ± 21 
19.6 ± 1.4b23 
24.9 ± 1.4b1 
24.6 ± 1,8b1 
21.0 ± 1.4b 
10.7 ± 0.6b23 
15.1 ± 1.0b14 
16.2 ± 1.5b14 
11.6± 1.l b23 
2.59 ± 0.20b 
3.14 ± 0.47b 
2.67±0.13b 
2.29±0.17 
1900 ± 70b4 
2070 ± 160b4 
2050 ± 140b4 
2900 ± 460123 
280 ± 35b 
274 ± 36 
268 ± 49 
408 ± 82 
end 
10 
10 
10 
10 
25.7 ± 0.61>4 
25.1 ± 0.81>4 
27.1 ±0.7b4 
31.8 ± 0.9b123 
69 ± 44 
65 ± 3 
69 ± 24 
60 ± 2b13 
78 ± 4 3 
85 ± 3 
88 ±4' 
85 ± 2 
23.2 ± 1.3b 
25.5 ± 1.9b 
27.4± 1.8b 
24.2 ± 1.8b 
12.3±1.1 b 
13.0±1,Ob 
16.1±1.8b 
12.5±1.4b 
2.76±0.18' 
2.69 ± 0.23b 
2.80 ± O.13b 
2.43±0.19 
1970±210' 
2210 ± 140b 
2190±130b 
2770 ± 490 
315 ± 35 
350 ± 47 
330 ± 25 
438 ± 86 
2h 
10 
10 
9 
9 
31.4 ± 1.3b4 
29.9 ± 0.5b4 
31.8 ± 0.5 b4 
35.6 ± 0.8b123 
99 ± 7b 
88 ± 5b 
85 ± 3b 
88 ± 4b 
93 ± 8b 
97 ± 5b 
93 ± 3b 
89 ± 1 
16.8 ± 1.2 
21.3 ± 2.2 
18.4 ± 1.4 
17.5 ± 1.6 
6.0 ± 1.02 
10.3±1.914 
9.7±1.54 
5.8 ± 0.923 
4.44 ± 0.37b 
4.60 ± 0.37' 
3,90 ± 0.18b 
3.77 ± 0.33b 
1670 ± 190b 
1640 ± 200b 
1800 ± 110' 
1900 ± 200b 
201 ± 14b 
201 ± 24 
180 ± 24b4 
257 ± 24b3 
6h 
10 
10 
10 
10 
31.4±1.3b4 
30.3 ± 0.5b34 
33.0 ± 0.5b2 
34.9 ± 0.9b12 
87 ± 6b 
82 ± 4 b 
82 ± 3b 
82 ± 6b 
88 ± 4b 
98 ± 3b 
91 ± 4 
96 ± 5b 
17.0± 1.2 
18.7±1.5 
18.0 ± 1.3 
18.8 ± 2.0 
6.8 ± 1.1 
9.8 ± 1.2 
7.1 ± 1.4 
8.0 ± 1.4 
4.00 ± 0.37b 
3.61 ± 0.27b 
3.25 ± 0.13b 
3.47 ± 0.35' 
1810 ± 180b 
2130±230b 
2140±160b 
2110 ± 270' 
221 ± 31 b 
214 ± 35b 
269 ± 30 
262 ± 28 
18h 
10 
10 
9 
10 
30.1 ± 0.8b4 
29.8 ± 0.9b4 
31.1 ±0.7b4 
33.4 ± 0.7 b123 
86 ± 4b 
84 ± 5b 
81 ± 3b 
80 ± 5b 
88 ± 3b 
97 ± 4 
92 ± 4 
92 ± 3 
18.8 ± 1.7 
19.2±1.1 b 
18.1 ± 1.7 
16.9 ± 1.7 
7.3±1.1 
9.0 ± 1.0 
6.8 ± 1.4 
6.4 ± 1.2 
3.94 ± 0.18' 
3.68 ± 0.27b 
3.48 ± 0.10b 
3.71 ±0.10b 
1690 ± 140' 
1970±130b 
1980 ± 80b 
1930 ± 110b 
237 ± 33b 
237 ± 29 
264 ± 24 
225 ± 15b 
Hb = hemoglobin; HR = heart rate; MAP = mean arterial blood pressure; MPAP = 
mean pulmonary artery blood pressure; PWP = pulmonary wedge pressure; Cl = 
cardiac index; PVRI = pulmonary vascular resistance index; SVRI = systemic 
vascular resistance index. All values are presented as mean ± SEM. 
1234 = statistica! significant difference between groups 1,2,3 or 4, respectively.; b = 
statistical significant difference from baseline within group; P < 0.05. 
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OXYGENATION AND OXYGEN CALCULATIONS (Tables 6 and 7) 
There we re no significant changes in arterial blood gas values peroperatively 
in any group, except for an increase in arterial oxygen pressure and saturation in 
the control group which may be due to the lower baseline values in th is group 
(Tabie 6). Arterial pH showed the same slight decrease in all four groups. 
During the procedure mixed venous blood gases showed a decrease in both 
mixed venous oxygen pressure and mixed venous oxygen saturation. As the 
hemoglobin level decreased, despite the simultaneous increase in cardiac output, 
oxygen delivery decreased. This resulted in an increase in oxygen extraction 
ratio, as al ready indicated by the deerease in mixed venous oxygen pressure and 
saturation. Systemic oxygen consumption was maintained throughout the entire 
operative period. 
Peroperatively the slope of the oxygen dissoeiation curve became slightly 
shifted to the left as indicated by the decrease in P50 (PO, at which hemoglobin 
is 50% saturated with oxygen, corrected to body temperature of 37°C and pH 
= 7.40). This change is seen in all four groups and started during the 
transfusion of homologous blood. The baseline value of the P50 was higher in 
group 2 (PABO), indicating a rightward shift in the oxygen dissoeiation curve 
originating fram the donation of four units of autologous blood. 
PvO, AND HEMOGLOBIN 
In each patient individually we evaluated whether the mixed venous oxygen 
pressure at one point peroperatively decreased below the critical point of 33 
mmHg. If a patient did reach this PvO, for the first time the corresponding 
hemoglobin level was noted. In the three hemodilution graups combined (groups 
1, 2, and 3) in 18 patients this value of PvO, of 33 mmHg was reached for the 
first time at a mean hemoglobin level of 4.8 ± 0.2 mmol/!. Also in three patients 
in the contral group (group 4) the PvO, decreased below 33 mmHg at some 
point peroperatively. In these patients the decrease in PvO, was directly related 
to a more pronounced deerease in P,o related to the transfusion of homologous 
blood. 
Statistical analysis of the relationship between hemoglobin level and PvO, 
showed a curvilinear relationship between these two parameters, as shown in 
Figure 2. There were no significant differences in the form of th is curvilinear 
relationship, but there we re minor differences in the vertical position of each 
individu al curve. 
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Figure 2. 
Relatianship between hemagiobin level and Pv02 far eaGh study group. The 
relatianship between Pv02 and hemagiobin level was studied with a random 
GaeffiGients linear regression model, using the SAS program PROe MIXED [191. 
ADVERSE EVENTS 
Group 1 (ANH): postoperatively one patient complained of angina pectoris 
and dyspnoea due to a combination of lung embolisms and a pneumonia. He 
was treated with antibiotics and anticoagulants and recovered completely. 
Group 2 (PABO): one patient underwent a relaparotomy on the eighth dav 
postoperatively due to dehiscence of the cysto-urethral anastomosis. Another 
patient received anticoagulants because of a thrombophlebitis. 
Group 3 (NHD): one patient developed thrombosis two weeks postoperatively 
and received anticoagulants. 
Group 4 (control): one patient complained postoperatively of loss of 
shortterm memory; peroperalively this patient had a low PvO, value of 30.6 
mmHg and at the same moment a P50 of 23.4 mmHg. One patient unexpectedly 
died trom a myocardial infarction a few weeks after the operation and after 
discharge from the hospita!. One palient underwent a relaparotomy because of 
wound dehiscence. 
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Table 6. Blood gas analyses data during the study period. 
parameter 
n 
Paûz 
mmHg 
PaCOz 
mmHg 
pHa 
Pv0 2 
mmHg 
group baseline ANH 
1 10 10 
2 10 
3 10 
4 10 
133±11 142±7 
2 133 ± 7 
3139±11 
4 117±9 
1 37±1 37±1 
2 36 ± 1 
3 37 ± 1 
4 36± 1 
1 7.43 ± 0.02 7.40±0.01' 
2 7.44 ± 0.01 
3 7.43 ± 0.02 
4 7.42 ± 0.01 
1 99 ± 0.3 99±0.2 
2 99 ± 0.34 
3 99±O.24 
4 98 ± 0.523 
1 38±1 38±1 
2 38 ± 1 
3 37 ± 1 
4 37 ± 1 
1 72±2 72±2 
2 70±2 
3 72 ± 1 
4 72 ± 1 
1000 
10 
8 
10 
10 
143±8 
134±3 
149±7 
147±6b 
36±1 
37±1 
38±1 
37±1 
7.42±0.01 
7.40±0.01' 
7.40±O.02b 
7.40±O.Ol b 
99±0.2 
99±0.2 
99±0.1 
99±O.2b 
34±1 b4 
37±1 
37±1 
38±1 \ 
65 ± l b4 
65 ±2b4 
69±2 
71 ± 112 
1500 
9 
8 
9 
9 
142±6 
139±5 
146±7 
147±7b 
36±1 
37±1 
37±1 
37±1 
7.40±0.01 
7.41 ±O.Ol b 
7.40±O.02b 
7.37±0.03 
99±0.2 
100±O.24 
99±0.2 
99±O.32 
34±l b 
36±1 
36±1 
38±1 
65±l b 
66±2b 
69±l b 
71 ± 1 
2000 
9 
8 
10 
9 
145±7 
138±5 
152±7 
148±6b 
36±1 
38±1 
38±1 
37± 1 
7.41 ±0.01' 
7.39±0.01' 
7.40±O.02b 
7.39±O.Ol b 
99±0.1 
99±0.3 
99±0.2 
99±O.2b 
33±l b4 
35±l b 
35±1 
37±1 1 
65±2b4 
63±2b4 
67±2b4 
72±1 123 
n = number of patients at each measurement; group 1 = ANH; group 2 = PABO; 
group 3 = PNH; group 4 = contral; ANH = after acute normovalemie hemodilution 
(only group 1); lOOD, 2000 = measurement at blood loss of 1000 mi and 2000 mi, 
respective[y; nadir Hb = lowest hemoglobin level; end = end of surgery; 2h, 6h, 12h, 
18h = 2, 6 , 12, and 18 hours postoperatively, respectively; 
Table 6. Continued. 
nadir Hb 
10 
10 
10 
10 
143±9 
134±5 
151 ±7 
145±7b 
36±1 
38±l b 
38± 1 
36±1 
7.41±0.01 
7.40±O.Ol b 
7.40±O.02b 
7.39±0.01' 
99±0.3 
99±0.3 
99±0.2 
99±O.2b 
32±1 b4 
33±l b4 
33±1 b4 
37±1 123 
62±1 b4 
63±2b4 
65±2b4 
71±1 123 
end 
10 
10 
10 
10 
132±6 
130±7 
147±9 
143± 7b 
38±1 
37±1 
39±l b 
36±1 
7.40±0.01' 
7.41 ±O.Ol b3 
7.37±O.01 b12 
7.38±0.01' 
99±O.23 
99±0.3 
99±O.2 1 
99±0.2 
35±1 
33±1 b4 
34±2 
36±1 2 
70±2 
65±2b4 
68±2 
71 ± 12 
2h 
9 
9 
10 
9 
107± 12 
88±5b 
92±6b 
91±7 
41 ±1 
41 ± l b 
40±l b 
40±l b 
7.38±0.02 
7.38±O.Ol b 
7.37±0.01' 
7.36±O.Ol b 
97±0.7 
97±1.2 
97±0.5b 
96±O.8 
36±2 
37± 1 
34±1 
37±1 
72±2 
73±1 
70±1 
73±1 
6h 
10 
10 
10 
9 
109±10 
103±5b 
105±5b 
101 ±5 
41 ±2 
40±l b 
39±1 
39±l b 
7.38±0.02 
7.40±O.Ol b 
7.39±0.Ol b 
7 .38±O.01 b 
97±0.7 
98±0.5 
98±O.3b 
98±0.4 
36±2 
36±1 
34±l b 
36±1 
71±3 
71 ±2 
71 ±1 
74±1 
18h 
7 
10 
9 
10 
89±6 
84±5b 
81 ±4b 
78±4b 
40±1 3 
37±1 
36± 114 
39±l b3 
7.41 ±O.01 2 
7.44±O.01 14 
7.42±0.01 
7.40±O.01 2 
97±O.5b 
97±0.6b4 
97±O.5b 
96±O.6b2 
34±1 
35±2 
33±l b 
33±1 
71±1 
70±2 
69±1 
68±3 
Pa02 = arterial oxygen pressure; PaC0 2 = arterial carbon dioxide ten sion; pHa 
= arteria1 pH: Sa02 = arterial oxygen saturation of hemog1obin: Pv0 2 
mixed venous oxygen ten sion; Sv0 2 = mixed venous oxygen saturation of 
hemog10bin. 
All values are presented as mean ± SEM. 
1234 statistica1 significant difference between groups 1,2,3 or 4, 
respectively. b = statistical significant difference trom baseline within group; P 
< 0.05. 
Table 7. Oxygen data during the study period. 
parameter group 
n 1 
2 
3 
4 
Hb 1 
mmolil 2 
0021 
3 
4 
ml.min· l m·2 2 
3 
-4 
V0 21 1 
ml.min·1 .m·2 2 
3 
4 
ER 
AUT 
U 
AUT 
number of 
patients 
HOM 
1 
2 
3 
4 
1 
2 
3 
4 
2 
1 
2 
U 2 
3 
4 
HOM 1 
number of 2 
patients 3 
4 
baseline 
10 
10 
10 
10 
8.3±0.223 
6.8±0.2134 
7.7±0.213 
8.2 ±0.2 2 
343±25 
289± 194 
309±15 
346± 19 2 
92±3 
87±3 
88±5 
93±4 
ANH 
10 
5.6±O.P 
304± 18b 
86±4 
O.275±0.016 0.290±0.015 
0.308±0.015 
0,281 ±0.010 
0,273±0.012 
26.5±0.42 
27.7±0.2 134 
26.3±0.22 
26.3±0.42 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
26.4±0.5 
o 
o 
o 
o 
1000 
9 
8 
9 
9 
4.7±0.pm 
5.2±0.2b134 
6.1±0.l b12 
6.5±O.2b12 
241±19bH 
264± 204 
302± 15 14 
323± 1 0 12 
87±3 
93±3 
92±5 
95±4 
0,355± 0.01364 
0.362±0.021 b4 
0.319±0.015b 
0.294± 0.013 12 
26.1 ±0.3bl 
27.5±0.2134 
26.4±0.22 
26.0±0.32 
0.08±O.06 
o 
2 
o 
0' 
0' 
0' 
O.37±O.08 12 
o 
o 
o 
7 
1500 
9 
8 
9 
9 
4.4±0.p34 
5.0±O.2b4 
5.3±0.2b14 
6.5±0.2b12l 
242± 15° 
293±31 
296±15 
324± 15 
86±2 
99±5b 
96±6 
95±4 
0.364±0,014° 
0.351 ±0.022b 
0.325± 0.015b 
0,295±0.01l 
26.2±0.32 
27.3±0.2134 
26.1 ±0.32 
25.7±0.52 
OAO±0.152 
0' 
5 
o 
0' 
0' 
0' 
1.23±O.15 12 
o 
o 
o 
9 
2000 
9 
8 
10 
9 
4.2±0.l b34 
4.4±0.l b4 
4.8±0.2b14 
6.3±0.l b123 
254±1964 
262±16b4 
283± 17 
315± 16 12 
91 ±4 
99±5b 
96±3 
91±4 
0.368±O.0176Ji 
0.384±0.019b4 
0.344±0.016b4 
0.292±0.009123 
26.0±0.4°4 
26.9±0.334 
25.8±O.3 b2 
24.9±0.4bI2 
1.00±0.102 
0.50±0.171 
9 
5 
0' 
0' 
0' 
2.31 ±O.07 12 
o 
o 
o 
9 
Graup 1 ANH; group 2 = PABO; group 3 PNH; group 4 = contral; ANH after acute 
normovolemic hemodilution (only group 1); 
1000, 2000 = measurement at blood loss of 1000 mi and 2000 mi, respectively; nadir Hb = 
lowest hemagiobin level; end = end of surgery; 2h, 6h, 12h, 18h = 2, 6 , 12, and 18 hours 
postoperatively, respectively; n = number of patients at each measurement; ht = hematocrit; 
0021 = oxygen delivery index; VOll = oxygen consumption Îndex; ER = oxygen extraction 
ratio; P50corr = Pso (Pal at which hemoglobin is 50% saturatedl corrected to body temperature 
of 3rC and pH ~ 7.40; 
Table 7. Continued. 
nadir Hb end 2h 6h 18h 
10 10 9 10 7 
10 10 9 10 10 
10 10 10 10 9 
10 10 9 9 10 
4.1 ±O.P 5.5±O.264 6.5±O.364 6.6±O.364 6.4±O.1 64 
4.2 ±O.2b 5.3±O.1 b4 6.2±O.1 34 6.4±O.1 34 6.2±O.2b4 
4.4±O.l b 5.7±O.1 1A 6.6±O.12b4 6.9 ± O. 1 b24 6.6±O.2 b4 
6.2±O.l b 6.7±O.2bU3 7.5±O.l b123 7.5±O.l b123 7.1±O.l b123 
226±1664 337±26 610±436 557±426 532±26h 
280±39 317±26 589±43b 502±42b 469±43b 
265± 15b 352± 17 b 550±26b 485±21 b 482± 19b 
311 ±221 356±30 600±57 b 554±55b 549± lab 
89±42 100±46 157±lP 153±76 148±562 
104±6b1 111±4b 146±10b 139±10b 130±6b1 
96±4 114±6b 151±4b 137±6b 140±6b 
90±6 103±8 147±13b 141±12b 142±6b 
Q.386±O.011 64 O.309±O.019b2 O.272±O.O17 O.277±O.O24 O.280±O.O12 
O.383±O.022b4 O.359±O.017b14 O.249±Q,Q05b O.283±O.O18 O.288±O.O15 
O.368±O.017 b4 O.329±O.Olab 0.281 ±O.O13 O.285±O.O10 O.292±O.O11 
O.288±O.OlO123 O.292±O.OO92 O.248±O.O10 O.270±O.O15 O.260±O.O12 
26.2±O.54 25.1 ±OAb 24.3±O.3° 24.0±O.3b1 24.4±O.3bl 
26.3±O.4b-4 25.4±O.4b3 24.6±O.2bH 25.3±O.3b134 26.1 ± O.6b134 
25.3±O.3b 24.1 ±O.4b2 23.5±O.3b2 23.6±O.2 b2 24.6±O.5 b2 
25.0±OAb12 25.0±O.5b 23.7±O.3b2 23.9±OAb2 24.3±O.5b2 
1.21 ±O.32 2.80±O.17 2 2.90±O.15 2 2.90±O.15 2 2.90±O.15 2 
1.20±O.29 3.60±O.31 1 3.63±O.301 3.80±O.201 3.80±O.201 
7 10 10 10 10 
8 10 10 10 10 
O.10±O.104 2.00±O.7034 2.10±O.6934 2.60± 1 .06 34 3.40±1.3534 
0< O.56±O.3434 O.90±O.35 34 1.1O±O.41 34 lAO±OA334 
O.55±O.284 4.10±OA812 4.50±O.6212 4.60±O.6012 4.50±O.6012 
2.35±OA2 123 5.85±O.8412 5.90±O.82'2 5.90±O.8212 5.90±O.8212 
7 7 7 8 
0 3 5 5 6 
3 10 10 10 10 
9 10 10 10 10 
AUT U = number of units of autologous blood transfused; AUT number of 
patients = number of patients who received an autologous blood transfusion up 
to th at point; HOM U = number of units of homologous blood transfused; HOM 
number of patients = number of patients who received a homologous blood 
transfusion up to that point. 
All values are presented as mean ± SEM. 
1234 = statistical significant difference bet ween groups 1,2,3 or 4, respectively. b 
= statistical significant difference from baseline within group; P < 0.05. 
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Discussion 
Ouring this study seven staff members and five residents in training at the 
Oepartment of Urology, all at different levels of experience, we re involved. The 
study was carried out during a period that can be considered part of a "Iearning 
curve" for many. This is reflected in large volumes of blood loss which have 
drastically decreased in recent years. 
In an a!tempt to reduce the amount of homologous blood products used 
peroperatively a number of methods can be employed including preoperative 
autologous blood donatÎon, acute normovolemic hemodilution and peroperative 
normovolemic hemodilution. Ouring oncologic procedures the use of the cell 
saver is still considered to be contraindicated, but this point remains 
controversial. We chose not to use the cell saver due to the risk of inducing 
metastasis. Induced hypotension is not without risks and its efficiency has been 
questioned 20• It should not be employed at the same time as hemodilution 
techniques, because induced hypotension wiU interfere with the compensation 
mechanisms occurring during hemodilution. The use of erythropoietin 
preoperatively has been employed to increase the efficiency of predepositing 
autologous blood (21,221, as an adjunct to acute normovolemic hemodilution 
(23) or to accelerate the recovery from anemia postoperatively (24). 
Erythropoietin treatment has been associated with an increased risk of 
thrombosis and hypertension (25) and the costs of erythropoietin therapy are 
high. A meticulous surgical technique also helps to diminish the amount of 
homologous blood required. 
Preoperative autologous blood donation is known to be an effective method 
to decrease the amount of homologous blood used perioperatively during major 
surgical blood loss (26,27) and is confirmed by the results of the present study. 
The amount of homologous blood used in the PABO group was least in all four 
groups, and many patients (4 out of 10) could be managed without any 
homologous blood perioperatively. PABO could probably be made more effective 
by beginning erythropoietin treatment before the start of the donations (21,22). 
Iron supplementation should always be given during PABO. There are, however, 
several disadvantages associated with PABO. These include the risk of adverse 
events (mainly cardiovascular accidents) due to the donation and wastage of 
autologous blood due to postponement of surgery or due to less blood loss 
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during the operation than 
predeposited blood has been 
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expected. Average wastage ol 
reported to be 30-50% [28,29], 
autologous 
which also 
increases the costs. The procedure is time consuming lor both the patient and 
blood bank personnel. There is also a risk ol administrative error, introducing the 
possibility of transfusion reactions and transmission of infectious diseases. 
Furthermore, a decrease in natural killer cell activity has been reported with 
preoperative blood donation [30). Finally, PABO can only be employed lor 
procedures which can be planned several weeks ahead. 
The technique ol acute normovolemic hemodilution offers several advantages 
over preoperative autologous blood donation. This technique does not require 
planning ol the surgical procedure several weeks belorehand. The blood th at is 
withdrawn during ANH is usually kept in the operation room thus minimising the 
risk ol giving a wrong unit to the wrong patient. Because the blood is whole 
blood containing Iresh erythrocytes, lunctioning thrombocytes and labile clotting 
lactors this should have a benelicial effect on clotting parameters which may 
diminish postoperative blood loss and reduce the amount ol homologous blood 
used. The procedure is relatively inexpensive. Oisadvantages include extra 
workload lor the anesthesia personnel and the lact that ANH is less efficient in 
avoiding blood translusions than PABO, as is also shown in the present study. 
The technique ol hemodilution as a method lor limiting the amount ol 
homologous blood needed perioperatively has been addressed extensively in 
both animal and human studies. The degree ol efficacy has been one ol the 
questions [5,6,10,31). Mathematical models evaluating the efficiacy ol 
normovolemic hemodilution have resulted in contradicting conclusions. It has 
been concluded that savings attributable to normovolemic hemodilution are less 
than previously expected [5,10,31). However a mathematical analysis ol ANH 
showed that this method can diminish or (in some circumstances) even eliminate 
the need lor allogenic translusion [6). Clinical studies employing acute 
normovolemic hemodilution have also shown conflicting results with respect to 
the decrease in the use ol homologous blood [7,9,28). The amount ol 
homologous blood saved by using ANH depends on several lactors, including the 
initial and the target hematocrit, and circulating blood volume. In the present 
study a signilicant difference was lound between the amount ol homologous 
blood used in the control group and in the group with ANH but with no 
signilicant difference in blood loss. This might have been improved by lowering 
the target hematocrit below the 25% as employed in this study, thereby 
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increasing the amount of blood withdrawn above 1450 ± 80 mi and making the 
procedure of ANH even more effective. The minimal acceptable hematocrit, 
however, has not vet been proven. 
We investigated whether any evaluation could be made regarding the critica I 
value of the hemoglobin level during hemodilution and whether a conclusion 
could be drawn concerning a possible transfusion trigger. In order to do this we 
evaluated the hemoglobin level at which in each individual patient the PvO, 
started to decrease below the more critical level of 33 mmHg [17]. Indeed, in the 
present study 60% of the hemodilution patients did reach such level of PvO,; 
the mean corresponding hemoglobin level in these patients at that point was 4.8 
± 0.2 mmol/!. Therefore, at a hemoglobin level lower than 4.8 mmol/I in some 
patients the chance of reaching the more critical level of tissue oxygenation 
during hemodilution starts ta increase. However f in 3 patients in the contral 
group the PvO, also decreased below 33 mmHg at some points during the study. 
Further analysis showed that in these 3 patients the P50 showed the greatest 
decrease of all patients at this measurement. Mean change in P50 (trom baseline 
to the measurement at which PvO, for the first time decreased below 33 mmHg) 
in these 3 contral patients was -2.75 ± 0.47 versus -0.03 ± 0.31 in the 18 
hemodilution patients. Therefore, in these control patients a more pronounced 
leftward shift of the oxygen dissociation curve [ODe) was observed than in the 
patients in the hemodilution groups. Thus, the change in PvO, in the patients in 
the control graup was caused by a mechanism fleftward shift of the oxygen 
dissociation curve) other than the change in the other groups (decrease in 
oxygen flux). The leftward shift of the oxygen dissociation curve can probably 
be explained by the administration of homologous blood with low 2,3-DPG level, 
since the different transfusion practice was the major difference between the 
contral group and the hemodilution groups. 
Such a leftward shift of the ODe with transfusion of donor blood might 
impair the tissue oxygenation as reflected by the decrease in PvO" while a shift 
to the right of the ODe as found in the patients who donated their own blood 
(PABO graup) in this study might be beneficia!. Our observation of a rightward 
shift of the ODe with donation of blood is in accordance with earlier 
observations [32]. In pigs we observed at every step of hemodilution an acute 
shift of the ODe to the right [17, 18J while in one study in dogs an acute shift to 
the right during acute anemia occurred, but not before hematocrit drapped below 
10% [33J. In our studies in pigs a close relationship was found between the shift 
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in Doe and the changes in the lor pH corrected PvO, (18]. In the present study 
in anesthetized patients we did not observe such an acute change in the position 
ol the Doe during hemodilution. However, it has been suggested that changes 
in Doe might play a role in oxygen delivery, especially when oxygen reserves 
are minima I (34]. 
The value of the pulmonary wedge pressure as an indicator of normovolemia 
during hemodilutîon is unclear. Several studies used centra I venous pressure or 
pulmonary wedge pressure as an indicator to keep their subjects normovolemic 
during the induction ol hemodilution (13,35). Others, however, lound an 
increase in central venous pressure or pulmonary wedge pres su re as the 
hematocrit decreased [3,15). In the present study we lound a linear relationship 
between the hemoglobin level and the measured pulmonary wedge pressure 
(Figure 1). The recorded values in group1 [ANH) we re lower than all three other 
groups and can probably be explained by the procedure lollowed in this group. 
Acute normovolemic hemodilution was induced immediately after induction ol 
anesthesia. This was lollowed by a period with only limited blood loss 
Ilymphnode dissection), which lasted approximately 1-2 hours. During this period 
the gelatin solution used as colloid could have already been partly excreted; this 
would have induced a slightly hypovolemic situation. The relationships between 
the other three groups are very similar lalthough the control group has no 
measurements at low hematocrit values), and no increase over time was 
observed in the control group once the lowest hematocrit was reached in this 
group. This indicates that the observed increase in PWP can not be explained by 
any lactor other than the hemodilution itself. Therelore we speculate th at the 
normal PWP value during normovolemia is dependent on the hematocrit and that 
during hemodilution higher PWP values should be pursued. Increased PWP 
values in the hemodilution groups can also be explained by the lact th at the 
change in plasma volume caused by the inlused plasma substitutes might have 
exceeded the volume ol blood loss; this, however, is unlikely. In another study 
in humans the inlusion ol one liter ol dextran 40 Iisodex®) increased plasma 
volume in vivo by only 640 mi, while one liter ol the gelatin solution 
IGeloplasma®) increased plasma volume by only 470 mi (36]. It is therelore more 
likely that, in the present study, the volume ol blood loss was not totally 
replaced by the inlused amount ol plasma substitutes. Furthermore, in the 
control group inlusion ol 250 mi ol packed red cells together with 250 mi ol 
colloid lor every 500 mi ol blood loss and keeping the hematocrit constant, did 
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not cause an increase in PWP, while in the hemodilution patients at the end of 
surgery and in the first 2 hours postoperatively the increase in hematocrit 
associated with the transfusion of blood decreased the PWP despite the volume 
loading. In studies keeping central venous pressure or pulmonary wedge 
pressure at baseline values during hemodilution the increase in cardiac output is 
much less, while heart rate may increase [37,38). During hemodilution blood 
viscosity is decreased resulting in an acceleration of blood flow, especially in low 
flow vessels such as the venous circulation. Increased flow at the venous site 
might have increased venous return and therefore the filling pressures of the 
heart. 
Hemodilution causes a decrease in oxygen carrying capacity t which is 
compensated by an increase in cardiac output, mainly due to an increase in 
stroke volume combined with an increase in oxygen extraction ratio. Some 
hemodilution studies in humans showed a decrease in heart rate during moderate 
hemodilution [11,13,39). In several studies applying moderate normovolemic or 
hypervolemic hemodilution in hu mans it was shown th at oxygen delivery and 
tissue oxygenation are weil maintained with no change in arteriovenous oxygen 
difference [15,40,41). However, in contrast, several other studies applying 
normovolemic hemodilution in humans have shown an increase in cardiac output 
accompanied by an increase in oxygen extraction ratio [2,3,11,13,15,16,39,42). 
It has also been shown in dogs that hemodilution can alter the slope of the 
oxygen dissocation curve, improving oxygen unloading (43). In the present study 
we observed in all three hemodilution groups, as weil as in the control group in 
which very limited hemodilution was induced, an increase in cardiac index with 
no significant change in heart rate but with an increase in oxygen extraction 
ratio. The hemodynamic changes observed we re comparable to these observed 
in other studies on hemodilution during general anesthesia (Figure 3). One of the 
obvious differences in hemodynamic changes during hemodilution that was 
observed between the three hemodilution groups was the increase in pulmonary 
wedge pressure, which was less pronounced in the group with acute 
normovolemic hemodilution (as discussed above). This might have caused slight 
hypovolemia which is also suggested by the fact that the initial increase in 
cardiac index is somewhat less pronounced in this group thus resulting in the 
largest decrease in oxygen flux. The calculated decrease in oxygen flux in the 
ANH group was 33 ± 4% with a simultaneous decrease in hemoglobin level of 
51 ± 1 %, while this deerease in oxygen flux was 5 ± 8% and 13 ± 6% in 
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Comparison of changes in several hemodynamic and oxygenation parameters in 
other studies in anesthetized humans [3,11,12,13,14,15,161 and the present 
study, 
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groups 2 (PABD) and 3 (NHD), respectively with a concomitant decrease in 
hemoglobin of 38 ± 3% and 44 ± 1 %, respectively. This stresses the 
importance of maintaining normovolemia during hemodilutîon in order to maintain 
the compensation mechanisms at the optima I level. This probably means that 
keeping central venous pressure or pulmonary wedge pressure constant during 
induction of hemodilution results in a more or less hypovolemic state and thus 
restricts the compensation mechanisms during the decline in hemoglobin level. 
The conclusions drawn from the present study are: 
1. PABD is more effective in reducing the amount of homologous blood needed 
peroperatively than ANH (or NHD). 
2. During normovolemic hemodilution the pulmonary wedge pres su re increases 
as hematocrit decreases. 
3. In 60% of the hemodilution patients PvO, started to decline below 33 mmHg 
at a maan hemoglobin level of 4.8 ± 0.2 mmol/l. 
4. In some patÎents receiving homologous blood the Pv02 reached critical values 
due to a leftward shift of the oxygen dissociation curve. 
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Summary 
16 patients underwent acute hypervolaemic haemodilution with dextran 40 
and Ringers lactate, to see whether th is procedure could avoid perioperative 
blood translusion. Packed cell volume (PCV) and oxygen extraction decreased, 
and cardiac index and pulmonary wedge pressure increased, although end-
systolic area was unchanged. PCV was not signilicantly different between 
patients who lost less than or greater than 20% ol their initial blood volume. 
This preoperative manoeuvre, which reduces loss ol red blood cells, allowed 
major surgery to be completed salely without blood translusion . 
Introduction 
The risk of alloimmunisation and transmission of viral infection trom 
homologous blood translusion is weil known. In addition, it is suggested that 
translusion may promote tumor growth [1]. Some patients may reluse blood 
translusions on religious grounds [2]. Translusion with donor blood may be 
diminished by predeposited autologous blood [31, intraoperative autotranslusion 
with a cell-saver [41, and haemodilution techniques. With haemodilution, lewer 
red cells are lost because ol the non-linear decrease in packed cell volume after 
the procedure [5].Preoperative acute haemodilution can be achieved in two 
ways. First, by withdrawal ol blood and simultaneous inlusion ol plasma 
substitutes (normovolaemic haemodilution) [6]. Second, by rapid inlusion ol Iluid 
without blood withdrawal (hypervolaemic haemodilution). We have evaluated the 
effe cts ol hypervolaemic haemodilution on haemodynamics, lelt ventricular size, 
systemic oxygenation, and packed cell volume to establish whether this 
technique avoids blood translusions peroperatively. 
Patients and methods 
16 consecutive Jehovah's Witness patients (3 males, 13 lemales; mean 
age [SOl, 51 [14J years) were admitted lor major surgery and relused both 
homologous blood products and autologous translusion. All patients gave 
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informed consent to the study protocol, which was approved by an ethical 
committee at the Erasmus University Hospital, Rotterdam. 
On the dav of surgery two intravenous cannulae we re inserted. The radial 
artery was cannulated and a thermodilution catheter ('Swan Ganz', AEL, USA) 
introduced into a pulmonary artery via the internal jugular vein. 2.5 mg 
intravenous midazolam was given before catheter placement. Heart rate, arterial 
blood pressure, pulmonary artery pressures, and right atrial pressure were 
monitored continuously ('Horizon 2000', Mennen Medical, Israel). After 30 min 
stabilisation, baseline values of mean arterial pressure (MAP), mean pulmonary 
artery pressure (PAP), pulmonary wedge pressure (PWP) and cardiac output (CO) 
we re obtained. In addition, arterial and mixed venous blood samples we re taken 
for measurements of haemoglobin (Hb), Hb oxygen saturation 
('Spectrophotometer OSM3', Radiometer, Copenhagen), packed cell volume 
(PCV), and PO" PCO" and pH ('ABL 330', Radiometer, Copenhagen). Systemic 
vascular resistance, pulmonary vascular resistance, oxygen flux, and oxygen 
uptake were calculated from these data. Oxygen flux is the product of arterial 
oxygen content and cardiac output. Oxygen uptake is the product of cardiac 
output and the arteriovenous oxygen content difference. The oxygen extraction 
ratio is calculated by dividing oxygen uptake by oxygen flux. 
Anaesthesia was induced with fentanyl 5 f/g/kg, thiopentone 5 mg/kg, and 
pancuronium 0.1 mg/kg. After tracheal intubation, the lung we re ventilated with 
70% nitrous oxide in oxygen, and tidal volume was adjusted to achieve 
normocapnia. Anaesthesia was maintained with fentanyl and enflurane (end-tidal 
0.4 vol %) and muscle relaxation was achieved with pancuronium. The bladder 
was catheterised. 
A transoesophageal ultrasound transducer (5 MHz 'Toshiba', connected to 
a Toshiba 'SSH 160' machine) was placed for continuous real-time visualisation 
of the heart. The transducer was positioned to obtain a two-dimensional short-
axis view of the left ventricIe at the level of the papillary muscie. After the 
optimum view had been obtained, the steering mechanisms of the transducer 
we re locked to maintain the identical cross-sectional view throughout the period 
of volume loading. Simultaneously with the haemodynamic recordings, the 
images were recorded on 'VHS' videotape for subsequent analysis. The end-
diastolic and end-systolic enclosed areas of the left ventricIe we re measured 
after tracing the endocardial borders. Three consecutive beats were averaged. 
After 15 min stabilisation, haemodynamic and echocardiographic 
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measurements together with an analysis ol blood gases we re made. We 
undertook hypervolaemic haemodilution in th ree equal steps. 500 mi dextran 40 
and 500 mi Ringers lactate we re inlused over 10 min. All measurement we re 
repeated after each step. After surgery began, the same variables, except lor the 
echocardiographic va lues, we re recorded after the 500 mi blood loss. 
Peroperatively, Ringers lactate was inlused in a volume equal to the urine output 
plus 8 mi/kg per h (to compensate lor fluid loss lrom the wound). Blood loss 
was replaced by an equal volume ol gelatin solution . 
Immediately belore surgery was completed, the lorced inlusion was 
stopped. Measurements we re repeated at the end ol surgery, and at 20 min, 2 
h, and 4 h thereafter. 
The reported baseline blood volumes are calculated values [7]. The 
accepted probability lor a statistica I difference between means was p < 0.05. 
Statistical analysis ol results was by Students's (-test and the Wilcoxon signed-
rank test. 
Results 
11 patients underwent a laparotomy and 1 a nephrectomy; 3 patients had a 
hip replacement; and 1 patient received a lacial bone reconstruction. 
Haemodynamic and echocardigraphic results are summarized in Table 1. 
Stepwise acute hypervolaemic haemodilution, with a change in PCV Irom 36.9 
(3.1) to 26.3 (2.4), resulted in a 29.3% decrease in the mean systemic vascular 
resistance index. The increase in the mean cardiac index ol 27.5% (2.45 [0.65J 
vs 3.10 [0.68]) correlated with a 27.6% increase in the mean end-diastolic area 
ol the left ventricie. Increases in the mean PWP and PAP Irom 5.3 mmHg (3.2) 
to 20.8 mmHg (4.2) and lrom 12.3 mmHg (3.9) to 31.0 mmHg (5.2) 
respectively, we re recorded. Other haemodynamic variables did not change, 
except lor a slight increase in MAP and a slight decrease in heart rate. 2 hours 
postoperatively all haemodynamic varia bles had returned to pre-anaesthetic 
values except for the systemic vascular resistance index. The increase in cardiac 
output was associated with an increase in end-diastolic area. With further 
volume loading, end-diastolic area no langer increased, and the rise in cardiac 
output was associated with a decrease in end-systolic area. In no patient did an 
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increase in end-diastolic area lead to a significant decrease in cardiac output. 
The results of systemic oxygenation are shown in Table 2. Stepwise 
hypervolaemic haemodilution did not lead to changes in arterial or mixed venous 
blood gases. Oxygen flux was constant over the study period because cardiac 
output compensated for the decreased oxygen transport capacity th at took pi ace 
with haemodilution and blood loss. The constant oxygen flux and decreased 
consumption resulted in a decreased extraction ratio. 
The changes in PCV in patients with a blood loss < 20% of their calculated 
initial blood volume (14.2 [4.1]%; n = 8) and in patients with a blood loss > 
20% of the baseline blood volume (42.4 [17.7]%; n=8) are shown in the figure. 
2 h postoperatively the difference in PCV was not statistically significant (32.2 
[2.7] vs 30.8 [4.1]). Only at the end of surgery was a significant difference in 
PCV seen between the two groups (27.8 [1.6) vs 24.8 [3.9]). Blood loss in all 
patients was 28.2 [18.3)% of the calculated initial blood volume. 
Hematocrit 
-- < 20% bi ----- >20% bi 
43 
Ht (%) 
38 
33 * 
-1----1 ---
28 //'1 
" 
23 
"'1' 
18 
pre post H1 H2 H3 ES 20min 2h 4h 
Fig 1. Change in PCV pre and post anesthetic induction. 
---, < 20% blood loss; ......... , > 20% blood loss . • P < 0.05. 
Table 1 Systemic haemodynamic measurements before and af ter induction of anaesthesia 
HR MAP PAP PWP Cl 
(bpm) (mmHg) (mmHg) (mmHg) (!/min/m2) 
Pre-induction 85 (1 SJ 104 128) 14.3 13.1 ) 4.9 12.9) 3.06 10.85) 
Post-induction 95 +(16j 81 + 115) 12.3 + 13.9) 5.3 13.2) 2.43 + (0.65) 
Hl 84'" (1S) 87 + 1151 , 9.4 + ... (4.3) 10.8 +... (4.4) 2.94' 10.78) 
H2 83'" (14) 87 + 1151 24.9 + .. (3.B) 16.6 + ... (4.1) 3.07" (0.741 
H3 85'" (15) 91 + .. (15) 31.0 + ... (5.2) 20.8 +.. (4.2) 3.10 ... (D.BBl 
ES 89 120) 83 + (15) 19.8 +* O.S} '1.4 +.. (B.B) 3.19 ... (0.89) 
20 min post-OP 89 (11) 92 • (15) 17.0 +* (4.0) 6.5 (4.6) 3.53 (1.19) 
2 h post-op 87" (13) 86 + 116) 14.9 13.11 4.3 12.81 3.43 (1.24) 
4 h post-op 88"(15) 84 + 1151 15.0 13.2) 4.4 (3.3) 3.51 10.911 
H1, HZ, and H3 show data for each step of hypervolaemic haemodi1ution up to the end of surgery (ES). 
HR =: heart rate; Cl = cardiac index; ESA ::= end systolic area . 
... p<0.05 compared with post~induction va lues. + p<0.05 compared with pre~anaesthetic values. 
Table 2 Systemic oxygenation before and af ter induction of anaesthesia 
PaO:: PaC02 Pvo, PvC02 °2flux 
(mmHg) (mmHg) (mmHg) (mmHg) (l/min/m::) 
Pre~induction 87 115) 36 131 41 14) 40 131 505 (144) 
Post~induction 168 + 1291 32 131 44 + (4) 37 • 141 418 +(127) 
Hl 166 + 1331 33 13) 46 + (4) 36 • 13) 431 + (122) 
H2 167 + 1291 33 13) 46 + (4) 36 • 13) 404 +(103) 
H3 170 + 127) 32 14) 47 + (4) 35 • 131 378 + (97) 
E5 135 + 138) 36 • 141 45 + (6) 39 141 399 + (123) 
20 min post~op 88 • 1191 42 + ... (4) 43 16) 45 + ... (4) 477 (151 ) 
2 h post~op 102 ... 1241 39 151 42 161 44 + .. (6) 492 (164) 
4 h post~op 96 • (24) 39 • 14) 42 161 43 • 14) 500 11381 
. 
... p < 0.05 compared with post-induction values. + p < 0.05 compared with pre-anaesthetic values. 
EDA 
{cm:>'} 
12.3 13.7) 
14.4'" (3.9l 
15.7' 13.5) 
15.7'" (3.9) 
VO, 
(I/min/m2) 
102 1211 
91 + 1211 
84 + 117) 
80 + ... (1S) 
73 + .. (15) 
82 + ... (21) 
112 .. 135) 
119 + ... (33) 
123 ... 1301 
ESA PCV 
(cm2) (%) 
38.3 12.8) 
6.0 12.7) 36.9 13.21 
6.6 12.9) 32.1 +' 12.81 
6.2 12.5) 28.8 +* 12.9) 
5.8 12.3) 26.3 +'" (2.4) 
26.6 + 13.2) 
30.6 +* 13.41 
31.6 + .. 13.6) 
31.6 + ... 13.8) 
ER Fi02 
(%) 
0.21 10.041 0.21 
0.23 +(0.05) 0.32 
0.20'" (0.04) 0.32 
0.21 ... (O.05) 0.32 
0.20 • 10.061 0.32 
0.22 10.07) 0.32 
0.24 +(0.05) 0.21 
0.26 +(O.07) 0.21 
0.25 10.061 0.21 
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Discussion 
Hypervolaemic haemodilution improves cerebral circulation [8) and may be 
a useful treatment for haemorrhagic disorders in pre-eclampsia [9). In these 
reports, haemodilution was induced slowly over 24 h or more. Apart from one 
case-report of an anaemic Jehovah's Witness [10), the effect of rapid volume 
loading have not been documented in man. 
We found significant increases in PWP and PAP. This result may be 
because of an increased venous return to the heart after a reduction of viscous 
resistance of blood by haemodilution [11). Excessive volume loading is also likely 
to have contributed to an increased PWP, but in no patient was there any clinical 
evidence of pulmonary oedema. Intermittent positive pressure ventilation may 
have avoided such a complication. Extubation of the patients' lungs was 
possible directly after surgery because, when the forced infusion was stopped, 
PWP and PAP returned quickly to normal. 
Although the end-diastolic diameter of the left ventricIe increased, there 
was no reduction in left ventricular performance because end-systolic diameter 
remained the same. 
A small but significant reduction of oxygen consumption and extract ion 
ratio was observed. Postoperatively the extraction ratio increased to a value 
above th at seen before induction of anaesthesia and was due to an increase in 
oxygen consumption that confirms the findings of others [12). 
Acute preoperative isovolaemic haemodilution gives a supply of the 
patients' blood and results in fewer red cells being lost in an episode of 
haemorrhage. This technique is time consuming and needs special arrangements 
- eg, collection and storage of patients' blood. This technique of hypervolaemic 
haemodilution allowed major surgery without blood transfusion and was 
tolerated safely by all patients. However, this study applies only to surgical 
patients with no associated medical iIIness and cannot be recommended in 
patients with a compromised cardiovascular system. Furthermore, it is uncertain 
whether hypervolaemic haemodilution can influence the total amount of blood 
loss during surgery. 
This work was supported by the Foundation for Fundamenta! Medica! Research (SFMO), the Netherlands. 
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Chapter 6 
Summary 
Preoperative acute hypervolemic hemodilution is used in anesthesia to 
reduce the loss ol blood cells during intraoperative bioodioss. Indications lor use 
ol the technique might be broadened il it can be shown to be sale in older as 
weil as younger patients. Few data are available describing heart lunetion in 
hu mans subjected to hypervolemic hemodilution. 
Methods: Nineteen anesthetized Jehovah's Witnesses (ages 22-70 yrl 
without evidence ol heart disease had hypervolemic hemodilution belore surgery 
in three stages, each consisting ol an inlusion ol 500 mi dextran 40 (50 g/l) and 
500 mi Ringer's lactate over a 10-min period. After each stage, the size and 
lunetion ol the left ventriele we re recorded by transesophageal cross-sectional 
echocardiography in the short-axis view. Simultaneously heart rate, arterial blood 
pressure, pulmonary arterial and wedge pressures and cardiac output we re 
recorded, to compare the echocardiographic and hemodynamic data. 
Results: No complications occurred. Hypervolemic hemodilution resulted in 
an increased cardiac output by increasing the stroke volume Irom 48 mi in basal 
conditions to 67, 71, and 72 mi over the three stages, whereas heart rate did 
not increase. There was an initial increase in end-diastolic volume ol the left 
ventricIe, as assessed lrom the cross-sectional end diastolic area lrom 12.9 to 
15.5, 16.6, and 16.9 cm' lollowed by a deerease in the in cross-sectional end-
systolic area Irom 6.3 to 6.8, 6.0, and 5.7 cm'. The increase in wedge 
pressures (Irom 5.9 to 12.4,17.9, and 22.6 mmHgl did not lead to progressive 
cardiac dilatation. There was a curvilinear relation between wedge pressure and 
cross-sectional end-diastolic area. Stroke volume did not decrease, nor did cross-
sectional end-systolic area increase; instead, a decrease in end-systolic area was 
a common observation. 
Conclusions: The described regimen ol acute hypervolemic hemodilution is 
weil tolerated during anesthesia by patients without heart disease and does not 
lead to cardiac lailure. It leads to an increase in stroke volume that is generated 
initially Irom an increase in end-diastolic volume, lollowed in many patients by a 
decrease in end-systolic volume, the mechanism of which is as vet unclear. 
Key words: Blood: translusion. Measurement techniques: transesophageal 
echocardiography. Translusion, hemodilution: hypervolemic. 
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Introduction 
Preoperative acute hypervolemic hemodHution is used to reduce the loss of 
blood cells during intraoperative bleeding and thus avoid the need for blood 
transfusion. After surgery the hematocrit is partially resto red by administering 
diuretics to re move the ex ce ss of intravascular fluid. To date, hypervolemic 
hemodilution usually has been used in patients who need major surgery but 
refuse (often for religious reasons) all blood transfusion, including autologous. 
The indications, however, could be expanded to include any major surgery if the 
potential risks (especially the risks of acute cardiac faHure and pulmonary 
congestion) can be proven to be low. Dur initial experience showed that the 
procedure is clinically safe 11,2]. In this study we describe in greater detail the 
effects of acute hypervolemic hemodilution on cardiac size and function and the 
relation of th is echocardiographic information to hemodynamic information 
obtained through pulmonary artery catheterization and systemic pres su re 
monitoring. 
Material and methods 
Nineteen patients (3 men and 16 women) undergoing preoperative acute 
hypervolemic hemodilution we re studied. Their ages we re 22-70 yr (mean 48 yr) 
and their weights 48-99 kg (mean 70 kg). All patients were Jehovah's 
Witnesses who refused any blood transfusion. All had to undergo procedures 
with an expected significant blood loss. Four were scheduled for orthopedic 
surgery, the remainder for oncologic surgery. All we re informed in detail on the 
procedure and gave written informed consent before surgery. The study protocol 
was approved by the Medical Ethical Gommittee of the University Hospital 
Rotterdam-Dijkzigt. 
Any evidence of heart disease was an exclusion criterion for hypervolemic 
hemodilution. Eligible patients we re referred to our hospital after screening for 
heart disease. None of the referred patients was subsequently excluded. One 
patient had a history of mild hypertension, and one had a history of hypertension 
and chest discomfort without documented ischemia. The others had no evidence 
of cardiovascular disease in the history or physical examination or on the 
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preoperative electrocardiogram or chest x-ray. 
After receiving 2.5 mg midazolam intravenouslyy, two venous cannulae, an 
arterial cannula (radial artery), and a pulmonary artery thermodilution catheter 
(Swan-Ganz, American Edwards Laboratories) we re inserted and calibrated to 
room air for the zero-level of the pressure. Heart rate, arterial blood pressure, 
right atrial pressure and pulmonary artery pressure we re recorded continuously 
(Horizon, Mennen Medica!). The pulmonary capillary wedge pressure (PCWP) 
was measured intermittently, as a mean pulmonary occlusion pressure at end-
expiration. Cardiac output was determined by thermodilution as a mean of three 
consecutive measurements. A five-Iead electrocardiogram (leads X, Y, Z, V2, 
and V5) was monitored continuously in combination with automated ST-segment 
analysis. Standard 12-lead electrocardiograms we re obtained in all patients 1 dav 
preoperatively, 1 dav postoperatively, and 5-8 days postoperatively. 
Anesthesia was induced with lentanyl 5 tig/kg, thiopental 5 mg/kg, and 
pancuronium 0.1 mg/kg. After tracheal intubation the lungs we re ventilated with 
70% nitrous oxide in oxygen, and tidal volume was adjusted to achieve 
normocapnia. Anesthesia was maintained with enllurane (end-tidal 0.4 vol%). 
No additional fentanyl was administered during the hypervolemic hemodilution. 
After induction ol anesthesia a transesophageal ultrasound pro be (5-MHZ 
transducer connected to a Toshiba SSH 160 ultrasound machine) was 
introduced for continuous and real-time imaging of the heart. The transducer 
was positioned in the stomach to obtain a two-dimensional short-axis view of 
the left ventriele at the level of the papillary muscles. A fter the optimum view 
had been obtained, the steering mechanisms of the probe we re locked and the 
probe was carefully secured to maintain the identical cross-sectional view 
throughout the preoperative hypervolemic hemodilution. Af ter a stabilization 
period ol 15 min after induction of anesthesia, baseline hemodynamic data were 
recorded; blood gas samples we re drawn from the arterial and pulmonary arterial 
catheters; and for 1 min the echocardiographic short-axis view of the left 
ventriele was recorded on videotape tor subsequent analysis. 
Hypervolemic hemodilution was then undertaken in three equal stages. 
Each stage consisted of the infusion of 500 mi dextran 40 (50 g/l) and 500 mi 
Ringer's lactate over alO-min period. After each stage, all measurements and a 
recording of the echocardiogram we re repeated. The whole procedure took 45-
50 min in all patients. Surgery did not start until the hype rvo Ie mie hemodilution 
and all the measurements had been completed. 
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The echocardiographic two-dimensional images we re analyzed oft-line Irom 
the videotape recordings. Adequate echocardiographic recordings we re available 
lor 17 ol 19 patients; lor 1, the images we re lost after a technical error, and lor 
another the image quality was inadequate lor analysis. Ol three consecutive 
cardiac cycles, the end-diastolic and the end-systolic echoirames were selected. 
The end-systolic Ira me was delined as the one with the smalle st enclosed area 
ol the left ventricular cavity. (In case ol doubt, several we re measured to lind 
the smallest.) The end-diastolic Irame was delined as the one with the largest 
enclosed area, and this always happened to be the lirst Irame on which the ORS 
complex was visible on the synchronously recorded electrocardiogram. The 
endocardial borders ol the left ventricle we re traeed with a hand-held input 
device (a "mouse") and a digitizing tablet connected to a microcomputer-based 
analysis system, used to calculate the enclosed area ol the lelt ventricular 
cavity. Data ol three cardiac cyeles were averaged, and il two measurements 
diftered by more than 10% the data we re rejected and the tracing was repeated 
using three other cardiac cyeles. 
Analysis ol variance with subsequent tests we re used lor all 
hemodynamic and echocardiographic variables to identily any signilicant 
changes during hypervolemic hemodilution and to determine the stages between 
which the changes we re signilicant. level ol signilicance was delined as P < 
0.05. 
Results 
Preoperative acute hypervolemic hemodilution was completed in all patients 
according to the protocol without complications, and all patients subsequently 
underwent uneventful surgery without blood translusions. The mean values lor 
the whole group are summarized in Table 1. 
Hypervolemie hemodilution resulted in an increase in cardiac output by 
36%, solely the result of an increase in stroke volume because heart rate, after 
an initial decrease, was unchanged. This was a consistent finding in all 
individuals (Figures 1 and 2). 
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Figure 1. Heart rate of individual patients during hypervolemic hemodilution. 
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Figure 2. Stroke volume of individual patients during hypervolemic hemodilution. 
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The cross-sectional end-diastolic area (EDA) initially increased in all 
patients. However, in most patients the EDA reached a maximum at some point 
in time during the volume loading, bevond which there was na lurther increase 
in EDA despite a lurther increase in PCWP. The relation between EDA and PCWP 
was curvilinear lor the mean values (Tabie 1) as weil as lor most individual 
patients (Figure 3). There was a wide range in the volume ol Iluid inlused belore 
the maximum EDA was reached; in 5 ol 17 patients the EDA did not increase 
after the lirst liter, in 5 ol 17 the maximal EDA was reached after 2 liters 
inlusion and in 7 patients the largest EDA was present after inlusion ol 3 liters. 
In these 7 patients, however, increases trom the previous recarding ware 
minimal. The maximal EDA was usually reached at PCWPs between 15 and 18 
mmHg. 
The change in cross-sectional end-systolic area (ESA) was variabie. In 12 ol 
17 patients a decrease in ESA was observed, which had commenced at the 
stage wh en EDA had reached its maximum in 10 ol these 12, whereas in two 
patients the ESA had started to decrease one stage earlier. In 5 patients no 
decrease in ESA was observed, and 4 ol these were patients in whom the EDA 
was still increasing at the linal stage ol the study. Because there was 
considerable variation among patients in the amount ol Iluid inlused belore a 
decrease in ESA, the mean changes in ESA (Tabie 1) are somewhat blunted with 
a signilicant decrease only between the second and third stages ol hemodilution. 
Hypervolemic hemodilution was associated with a steep increase in PCWP 
(Tabie 1 and Figure 3). Although the PCWP correlated closely with the amount 
ollluid inlused in the individual patient, the amount ol Iluid required to reach a 
certain level ol PCWP varied widely among patients, depending also on the 
PCWP at baseline. In 4 ol 19 patients PCWP had exceeded 15 mmHg already 
alter inlusion ol 1,000 mi, in 10 ol 19 patients atter the inlusion ol 2,000 mi, in 
3 patients after 3,000 mi, whereas in 2 patients PCWP was still Ie ss than 15 
mmHg after the inlusion ol 3,000 mi fluid. 
In lour ol the live patients with the greatest increase in PCWP (ending at 
25, 28, 26, 26, and 30 mmHg) EDA had reached its maximum after inlusion ol 
1,000 mi (at PCWPs ol 14, 16, 14, and 16 mmHg) and had not increased 
thereafter. 
In one patient in this series, there was a decrease in cardiac output betore 
the completion ol hemodilution (Irom 5.9 to 5.1 I/min during the linal stage) 
associated with an increase in ESA (Irom 6.2 to 7.0 cm'), suggesting that 
cardiac function was depressed. However, these changes we re associated with 
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Figure 3. Changes in echocardiographic end-diastolic area (EDA) during 
hypervolemic hemodilution in individual patients versus simultaneously measured 
pulmonary wedge pressure (PCWP). 
14.00 
10.50 
1125 1650 
SVR 
/ 
2175 2700 
Figure 4. Changes in echocardiographic end-systolic area af ter the maximal end-
diastolic area had been reached versus systemic vascular resistance. 
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Table 1 Hemadynamie data_ 
volume Het CO HR sP.v., SPd'''''' BPmoM PCWP SV LVSW SVR EDA ESA SF aES 
load % L/min beats/min mmHg mmHg mmHg mmHg mi g/min dyne.s.cm 5 cm' cm' % 
(mi) 
baseline 37±3 4.4±1.1 93±14 105±21 66±10 al±14 5.9±2.6 48±11 49±14 1,498±626 12.9±3.5 6.3±2.6 6.7±6.5 14B±58 
',000 32±3" S.S±' .3+ 83±1S" 114±20" 67±lQ S7± 14+ 1 2.4±3.0'" 66±lS+ 67±19+ 1,197±46'''' 1S.5±3.3" 6.S±2.6 6.8±6.4 162±61 
2,000 29±3* 5.S±1.S+ 82±14 117±23 SB±11 88±15 17.9±3.S* 71±17* 68±24 1,063±39'" 16.6±3.4" 6.D±2.3" 7.l±7.7 163±55 
3,000 26±3* 6.0±1.5 83±14 121 ±21 70±11 92±14 22.6±4.2" 72±18 68±23 1,O12±307 16.9±3.7 5.7±2.1 8.0±8.6 162±47 
Values are mean ± SD. 
Het = hematocrit; CO = cardiac output; HR = heart rate; BPsyst = systolic arterial blood pressure; BPdi~st = diastolic arteriaJ 
blood pressure; BP mooo = mean arterial blood pressure; PCWP = pulmonary capillary wedge pressure; SV = stroke volume; 
LVSW = left ventricular stroke work; SVR = systemic vascular resistance; EDA = end-diastolic cross-sectional area of the 
left ventricular cavity; ESA = end-systolic area; SF = pulmonary shunt fraction; (lES = end-systolic wall stress_ 
* P < 0.05 versus the previous measurement. 
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Table 2 Distribution of Sex, Age, and Weight of the 19 patients 
patient sex age weight 
no (Vr) (kg) 
1 F 43 48 
2 F 50 74 
3 F 44 61 
4 F 42 55 
5 F 48 68 
6 F 59 64 
7 M 22 65 
8 F 68 64 
9 M 70 70 
10 F 49 88 
11 M 44 99 
12 F 49 90 
13 F 41 57 
14 F 50 69 
15 F 49 70 
16 F 54 88 
17 F 46 86 
18 F 51 55 
19 F 38 66 
a signilicant increase in svstemic vascular resistance (SVR) and mean arterial 
blood pressure (Irom 79 to 101 mmHg) and not by any sign ol ischemia. In all 
other patients, the cardiac output was either increasing or sta bie throughout 
hypervolemic hemodilution. 
No regional wall motion abnormalities ol the left ventricle, indicating 
myocardial ischemia, [3J were encountered. In one patient, aged 70 Vr, ST-
segment changes ol just less than 0.1 mV developed after induction ol 
anesthesia, resolved during the initial stages ol hemodilution, and than returned 
at maximal inlusion. There we re no other patients with intraoperative ST-
segment changes, nor we re the postoperative electrocardiograms different Irom 
the preoperative electrocardiogram in any patient. 
No pulmonary or ventilatory problems we re encountered despite the high 
PCWPs. No positive end-expiratory pressure ventilation was used in any patient. 
At an unchanged inspired oxygen Iraction ol 30% and with tidal volumes 
adjusted to maintain nommocapnia, the systemic arterial and mixed venous 
oxygen tensions remained unchanged, in accordance with our previously 
reported experience [2J. Pulmonary shunt Iractions we re stabie lor each 
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individual patient and at group level (Tabie 1), despite considerable variation 
among patients. 
Discussion 
Hypervolemic hemodilution caused an increase in cardiac output resulting 
entirely from an increase in stroke volume; heart ra te and arterial blood pressure 
remained unchanged. This observation is in agreement with other studies in 
which acute hypervolemic hemodilution was used in humans [4·7]. 
Initially the increase in stroke volume was generated from an increase in the 
end-diastolic volume of the left ventricle, suggesting a Frank-Starling effect, up 
to a maximum, which was reached at PCWP of approximately 15-18 mmHg. 
With further filling there was only an insignificant increase in the end-diastolic 
volume, even when PCWPs of as much as 28 or 30 mmHg were achieved. This 
is in agreement with previous animal experiments [8]. It is weil known that 
healthy myocardium has an extremely low distensibility when sarcomere length 
exceeds 2.2 jJm, and it is almost impossible to stretch a strip of cardiac muscIe 
to sarcomere lengths greater than 2.4 jJm. This has been explained by the 
presence of a collagen skeleton that surrounds the cardiac muscle fibers and that 
constitutes an effective protection against acute dilatation. Also the pericardium 
has a rale in limiting acute cardiac dilatation. More insight into the relative 
importance of these mechanisms might be obtained from simultaneous 
measurements of intrapericardial pressure. No clinical experienee is available on 
hypervolemic hemodilution in patients who have had a previous pericardiectomy. 
Some animal studies suggest that the left ventriele does not need the 
pericardium as a protective mechanism against acute dilatation, in contrast to 
the right ventriele [9]. Few data are available in humans. Mangano et al. [101 
showed that the muscle of the left ventriele itself, and not the pericardium is the 
major determinant of diastolic compliance when filling pressures and volumes are 
moderately increased. However, others do attribute a role to the pericardium in 
protecting the left ventricle trom progressive dilatation in acute increases in 
volume load in the range our patients received [11]. The clinical implication is 
that it might be dangerous to apply hypervolemic hemodilution in patients who 
have undergone a previous pericardiectomy. 
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The end-systolic volume of the left ventricIe decreased with further 
hypervolemic hemodilution. This change could be due to a decrease in afterioad, 
a Frank-Starling effect, an increase in myocardial inotropic state, or some 
combination of these effects. Studies in animals undergoing normovolemic 
hemodilution have shown that a decrease in hematocrit leads to an increased 
stroke volume th at is generated from both a (slight) increase in end-diastolic 
volume (despite normovolemia in these experiments) and a decrease in end-
systolic volume [12J. This decrease in end-systolic volume was then attributed 
to a decrease in afterload due to the lowered blood viscosity. The identical 
decrease in end-systolic volume was seen when animals we re prevented trom 
increasing their inotropic state by p-adrenergic blockade. In our patients, 
however, na decrease in arterial pressure was encountered because the decrease 
in SVR was compensated by the larger stroke volume, resulting in minor 
changes in systemic arterial pressures. A simplified estimate of end-systolic wall 
stress, as an index of afterioad, remained unchanged (Tabie 1 ).# 
A possible explanation is that after maximal EDA is achieved, a state of 
stabie optimal performance exists in which ESA is dependent mainly on SVR. 
When we review the correlation between ESA and SVR in our patients after 
maxima I EDA was achieved, the limited number of data do suggest such a direct 
correlation (Figure 4). 
Dur results are different from those of a study in hu mans by Mangano et 
al., [13J who reported an increase in end-systolic volume and a decrease in 
ejection fraction when increasing the preload. There are, however, several 
differences in study design that may explain these opposite findings. First, they 
infused 1,500 mi who Ie blood rather than plasma-expanders. Their decrease in 
SVR was small compared to ours, and arterial blood pressure increased 
considerably. Second, they studied patients immediately after coronary bypass 
surgery, and 13 of 15 patients had one or more previous myocardial infarctions. 
# 
The end systolic walls tress (tabIe 1) was ca1culated using a simplif1calion of laplace's law: 
slressa '" Px~ 
2h' 
where P = pressure; r = radius; and h == wal! th!ckness. r was calculated from Ihe area, making the assumption 
that the shor1-axis of Ihe left venlric!e is a drele. Wa!! Ihickness was not cans!dered because changes in end-
systaHc wa!! thickness Ihroughout hemodilution ware with!n Ihe margin of error al M-mode echocardiographic 
measurements. 
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Hearts damaged by ischemie heart disease might respond differently to volume 
loading. Third, because PCWP in their study increased Irom 2 to 7 mmHg, their 
patients shifted lrom hypovolemia to normovolemia. The tendency to decrease 
end-systolic volume in our patients was observed only during hypervolemia. 
Indeed in our patients as weil, the initial change in ESA often was an increase, 
especially in those who had a PCWP < 7 mmHg at baseline. 
The decrease in SVR in this series cannot be explained by rheologic 
changes alone. Because ol the nonlinear relation bet ween hematocrit and blood 
viscosity", the decrease in hematocrit lrom 37% to 25% would result in 
decrease in viscosity by 19%, presuming that the inlused Iluid has the same 
viscosity as plasma. Based on the viscosity ol dextran 40 and Ringer's, this 
assumption is valid within areasonabie margin of error. Others have measured 
viscosity during hemodilution with combined Dextran 40 and crystalloid and 
could not demonstrate a change in plasma viscosity. But even il dilution had 
been perlormed with water, the predicted decrease in blood viscosity would be 
less than 30%. Because SVR decreased by 33% and because viscosity has a 
linear relation with SVR (Hagen-Poiseuille law), a net vasodilation must have 
occurred during hemodilution. This may be the result ol the sum ol the 
autoregulatory organ redistributions of circulating volume that oecur in 
hemodilution (14,15)). Vasodilation mayalso have been caused by atrial 
natriuretic factor, the concentration of which rises steeply wÎth acute 
hypervolemic hemodilution (16]. Other mechanisms that might in theory have 
decreased arteriolar tone include loeal tissue hypoxia, laetie acidosis or 
vasodilating metabolites sueh as adenosine. Unfortunately no measurements of 
atrial natriuretic factor, catecholamines or other neurohumoral factors we re 
included in the study protocol. Another explanation might be the activation ol 
vagal or nonmedullated receptors in the lelt ventricIe, responding to ventricular 
distension and causing reflex arteriolar vasodilation [17J. This might also explain 
why the decrease in ESA started usually only after a maximal EDA had been 
reached, rather than running parallel with hemodilution. 
This study did not include patients with a history ol ischemie heart disease, 
and it is unknown whether hypervolemic hemodilution can be perlormed salely 
* * Predicled change in blood viscosity (see discussion) are based on Ihe emperical van equation 
v:=: vp(1 + O.025H + 0.000735 H2), where v::= blood viscosity; Vp ::= viscosity of plasma; and H = hemalocril (percentage). 
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in such patients. In animal experiments, coronary blood flow increased out of 
proportion to the increased cardiac output during hemodilution, and th is was due 
not only to rheologic changes but also to autoregulatory coronary vasodilation 
[14,18,19]. It is not known to what extent vasodilation occurs in atherosclerotic 
coronary arteries. A lower viscosÎty may improve flow across a stenosis, but in 
addition steal effects may occur after coronary vasodilation. 
As an alternative to hypervolemic hemodilution, isovolemic hemodilution 
has been used in patients who accept the rein fusion of their own blood during or 
after surgery. It is not known, from the current literature, wh ether the apparently 
more physiologic condition of normovolemia is beneficial to the hemodiluted 
patient. Withdrawal of blood results in a decrease in maximum oxygen transport 
capacity, which is unaffected in hypervolemic hemodilution. When hypervolemic 
hemodilutian was compared ta narmovalemic hemodilutian, the former was 
shown to result in a higher oxygen transport, peripheral oxygen delivery and 
aerobic exercise capacity [20,21]. In an animal study, Messmer et al. [22J 
demonstrated that acute hemodilution to a hematocrit of 0.07 was survived by 
all animals if they were kept normovolemic, but by none that was hypovolemic, 
thus stressing the importance of volume status for the compensatory 
mechanisms for acute hemodilution. 
In conclusion, preoperative acute hypervolemic hemodilution was weil 
tolerated in patients without evidence of heart disease. No adverse cardiac 
events we re encountered. At unchanged heart rates, the stroke volume 
increased significantly. This increase was the result of both an increase in end· 
diastolic volume, as was to be expected on the basis of the Frank-Starling 
mechanism, and of a decrease in end-systolic volume. The mechanism of these 
changes is partially explained by the Frank-Starling effect and the decreased 
blood viscosity, but additional factors cannot be excluded. Further studies are 
required on the neurohumoral changes, the rheologic and arteriolar changes, the 
consequences of coronary artery stenosis and the effects of inotropic and, p-
blocker drugs in hypervolemic hemodilution. 
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Introduction 
The risks of homologous blood transfusions are weil known, and some 
patients may refuse blood transfusions on religious grounds. Transfusion 
requirements may be diminished by hemodilution techniques. The critical level of 
hemodilution in hu mans, defined as the critical point at which oxygen 
consumption (VO,) starts to decrease because of insufficient oxygen delivery 
(DO,). is not known. With the permission of the family, the case history of a 
Jehovah' s Witness patient with a critical level of hemodilution and DO,-
dependent VO" due to excessive blood loss during surgery, is presented. 
Case report 
An otherwise healthy 84-yr·old, 60-kg, male Jehovah's Witness had 
bleeding from the stomaeh. At admission, the bleeding stopped spontaneously 
with a hemoglobin concentration of 7.7 g/dL. Examination revealed a malignant 
tumour of the stomaeh. Five weeks after admission, the hemoglobin 
concentration was 10.1 g/dL (hematocrit 33%). Because of the danger of 
massive and lethal bleeding from the ulcerative tumour, it was decided to 
perform a total gastrectomy. The patient refused homologous blood products 
and any form of autologous blood transfusion. Fully informed consent was 
obtained for invasive monitoring and for the use of the technique of acute 
hypervolemic hemodilution [1,21. Because of the adhesions between the 
stomach and spleen, the spleen ruptured during surgery and mobilization of the 
stomach and massive bleeding followed. At the end of surgery, blood loss was 
4500 mlo Twelve hours postoperatively, the patient died. In accordance with 
medico ethical law in The Netherlands, it was forbidden in this case to 
administer any blood transfusion. 
We now describe the methods and results of our investigations during this 
case. On the dav of surgery, two intravenous cannulas were inserted. The radial 
artery was cannulated and a thermodilution catheter introduced into a pulmonary 
artery via the internal jugular vein. Midazolam (2.5 mg IV) was administered 
before catheter insertion. Heart rate, mean arterial blood pressure, pulmonary 
artery pres su re, and right atrial pressure we re monitored continuously. After 30 
min of stabie cardiovascular status, baseline cardiovascular values we re 
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obtained. In addition, arterial and mixed venous blood samples we re obtained for 
measurements of hemoglobin, hemoglobin oxygen saturation, hematocrit, and 
analysis of blood gases. Systemic vascular resistance, pulmonary vascular 
resistance, DO" va" and P,o (PO, at which hemoglobin is 50% saturated with 
oxygen) we re calculated from these acquired data. The oxygen extract ion ratio 
was calculated by dividing va, by DO,. P50, corrected to 37'C and pH = 7.40, 
was calculated (and not measured by an in vitro biotonometric technique) from a 
single measurement of venous pH, PO" and oxygen saturation of hemoglobin 
(3). Anesthesia was induced with fentanyl (5 Jlg/kg IV), thiopental (5 mg/kg IV), 
and pancuronium (0.1 mg/kg IV). Af ter tracheal intubation, the lungs we re 
ventilated with 70% nitrous oxide in oxygen, and tidal volume was adjusted to 
achieve normocapnia. Anesthesia was maintained with fentanyl and enflurane 
(end-tidal 0.4 vol% throughout the who Ie surgical procedure) and muscIe 
relaxation maintained with pancuronium (2 mg/h). The bladder was catheterized. 
Before surgery began, hypervolemic hemodilution was undertaken in three equal 
steps. Per step, 500 mL dextran 40 (50 g/dL) and 500 mL of lactated Ringer's 
solution we re infused over 10 min. All measurements we re repeated after each 
step. The same variables were recorded after 1500- and 3500-mL blood loss. 
Peroperatively, lactated Ringer's solution was infused in a volume equal to urine 
output plus 8 mL.kg".h" (to compensate for !luid loss from the wound). Blood 
loss was replaced by an equal volume of gelatin solution. Measurements we re 
repeated at the end of surgery (blood loss 4500 mL) and at 1, 2, 4 and 8 h 
thereafter. 
Postoperatively, anesthesia was maintained with continuously intravenous 
midazolam (0.1 mg.kg".h"), and muscle relaxation was achieved with 
pancuronium (2 mg.h"). The lungs we re ventilated with 40% oxygen in air, and 
body temperature was kept normal. Postoperatively, lactated Ringer's solution 
was infused at 110 ml/h. 
The critical level of hemodilution was determined from a plot of va, against 
DO,. The critical point was defined as the point at which va, became dependent 
on DO, with further hemodilution. To avoid the investigator bias of selecting th is 
point by eye, the critical point was analytically chosen from the intersection of 
the two best-fit regression lines determined by a least sum of squares technique, 
as described previously by Schumacker et al. 
The resultant hemodynamic data are summarized in Table 1. Stepwise 
acute hypervolemic hemodilution, with a change in hematocrit from 31 % to 
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20%, resulted in a deerease in systemie vaseular resistanee of 53% and an 
inerease in eardiae output of 54%. At a hematoerit of 8%, eardiae output was 
slightly deereased but still maintained eompared with the postinduetion of 
anesthesia value before hemodilution was indueed. Mean arterial pressure 
deereased at hematoerit values of < 10% because of slightly decreased cardiae 
output and further decreased systemie vaseular resistanee. During extreme 
hemodilution, heart rate increased only slightly. 
The results of systemic oxygenation are shown in Table 2. The critical 
point of DO, af ter which VO, gradually decreased was analytieally chosen from 
the intersection of the two best-fit regression lines (Figure 1). The DO, at th is 
critical point was 184 ml.m·'.min·' (4.9 ml.kg·'.min·'). The hemoglobin content at 
this critical point was 4.0 g/dL (Figure 2), with Ihe oxygen extraction ratio 0.44, 
the mixed venous PO, 34 mmHg, and the mixed venous oxygen hemoglobin 
saturation 56%. The position of the oxy-hemoglobin dissociation curve (ODC), 
corrected for changes in pH and PCO" shifted to Ihe right, but not before 
hematocrit was 8%. At a hematoerit of 8%, the mixed venous pH decreased, 
but the arterial pH did not. Twelve hours postoperatively, the patient died at a 
hemoglobin concentration of 1.6 g/dL. 
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Fig 1. Relationship between oxygen delivery (DO,) and oxygen consumption 
(VO,) during increasing hemodilution. 
134 
Profound hemodilution: what is the critical level? 
10 
8 
6 
4--------------
.' • I 
2 
°0~------~10=0~----~2~0~0-------3~0-0-------"400 
002 (ml.m-2.min-1) 
Fig 2. Relationship between oxygen delivery (D02) and hemaglabin (Hb) 
cancentratian with critical point af 002' 
Discussion 
In the present case, values of several variables at the critical point of 
hemodilution at which DO,-dependent VO, starts could be recorded. There are 
no reports in the literature on the systemic oxygenation in humans at such a 
critical point of hemodilution. The point at which VO, becomes dependent on 
DO, during hemodilution is not established in humans. In our anesthetized 
patient, VO, started to decline at a DO, af 184 mL.m·'.min·' (4.9 mL.kg·'.min·'). 
There are only a few reports concerning critical DO, in anesthetized cardiac 
patients in whom DO, was limited, not because of decreased arterial oxygen 
content but because of decreased cardiac output [5,61. In one study, VO, 
decreased at DO, < 330 mL.m·'.min·' and in the other study at DO, < 300 
mL.m-'.min·'. The difference in critical DO, between our patient and those of the 
other reports can be easily explained. A decrease in DO, by decreased cardiac 
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output of blood with a normal hemoglobin content is often accompanied by an 
even more decreased blood flow through the micro circulation, whereas during 
hemodilution, flows in the micro circulation are accelerated, owing to improved 
rheologic properties of blood [71. In animal studies, Cain and Chaplet [8,91 found 
a critical DO, of 10 ml.kg·' .min·' in anesthetized dogs during anemic hypoxia and 
when oxygen-supply dependency of VO, started at a hematocrit of 10%. In 
another study in anesthetized dogs, a critical DO, of 7.9 mL.kg·'.min·' was 
established [101. However, in anesthetized pigs, which are more closely related 
to humans anatomically and physiologically [11 I, during hemodilution at a DO, of 
7.8 mL.kg·'.min·' (the final step of hemodilution in the study protocol), we found 
that VO, was still weil maintained [12]. In another pig study, in which the critical 
DO, was not discussed, a critical hemoglobin content (where oxygen-supply 
dependent VO, started) of 3.9 ± 0.7 g/dL, similar to the present case was 
found [131. In other pig studies we also found a critical hemoglobin 
concentration of 4.0 g/dL [141. In our patient, as in another study using the 
same anesthesia technique [1], VO, and DO, decreased with the induction of 
anesthesia. Therefore, the values of DO, and VO, before induction of anesthesia 
we re not used in Figure 1 to establish the critical point of hemodilution. It is 
possible that if the patient had been conscious, a different critical level of 
hemodilution would have been found. 
The position of the ODC, corrected for changes in pH and PCO" shifted to 
the right, but not before the hematocrit was 8%. There are no reports 
concerning the position of the ODC in humans during acute hemodilution, except 
reports of the ODC during chronic anemia. In two studies in humans, chronically 
reduced hemoglobin concentration is compensated by improved oxygen 
unloading, afforded by the shift to the right of the ODC [15,16]. In one study in 
dogs, an acute change in ODC during acute hemodilution occurred but not 
before the hematocrit decreased below 10% [171, whereas in sedated pigs at 
every step of hemodilution, the ODC shifted to the right [11,181. In these pig 
studies, a close relationship was found between the shift in ODC and the 
decreased mixed venous PO, for corrected pH 7.4. Therefore, just as in our 
case, changes in ODC may play a role in oxygen delivery during acute 
hemodilution and especially, as stated previously [18,191, when oxygen reserves 
are minimal. 
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Table 1. Systemic hemodynamic measurements before and after induction of anesthesia in en 84-year-old male patient. 
HR MAP PAP PWP CO SVR Hot Hb 
(beats/min) (mmHg) (mmHgl (mmHgl (Urn'ln) (dyne.s.cm·5) (%) (g/dL) 
Preinduction 85 103 23 12 4.4 1818 31 10,1 
Postinduction 81 66 14 12 3.5 1440 30 9.6 
H1 77 71 21 15 5.0 1040 24 7.5 
H2 81 76 28 15 5.2 969 21 6.7 
H3 84 73 32 16 5.4 844 20 6.1 
1500-ml blood loss 103 82 35 17 5.3 1072 16 5.0 
3500-ml blood loss 95 70 31 17 5.5 887 10 3.4 
ES 92 56 24 15 5.8 648 9 2.6 
1 h pestop 117 89 22 5 5.7 1179 12 2.7 
2 h pOStop 104 80 25 10 5.0 1120 12 3.0 
4 h postop 92 58 26 13 4.5 800 9 2.6 
8 h postop 105 47 25 15 3.8 653 8 1.8 
HR, heart rate; MAP, mean arteriaJ pressure; PAP, mean pulmonary artery pressure; PWP, puJmonary wedge pressure; CO, cardiac output; SVR, 
systemic vascular resistance; Het, hematocrit: Hb, hemoglobin; H', H2, H3, data for each step of hypervolemic hemodilution: ES, end of surgery; 
postop, postoperatively. 
Table 2. Systemic oxygenation before and after induction of anesthesia. 
PaO, PaC02 Pv02 PvC02 pH pH D02 VOl ER P50<lCt P,oc 
(mmHg) (mmHg) (mmHg) (rnmHg) ,~ voo (L.m·2.min") lL.m·<.rnin"') (%) (mmHg) (mmHg) 
Preinduction 75 37 31 40 7.46 7.44 339 126 37 26.2 27.3 
Postinduction 250 36 37 39 7.45 7.43 275 97 35 27.9 29.0 
H1 220 35 42 39 7.45 7.42 326 93 30 28.1 29.2 
H2 225 36 41 38 7.44 7.41 304 91 30 27.9 28.8 
H3 215 36 42 38 7.43 7.40 285 88 31 28.3 29.0 
1 500"ml blood 1055 92 34 33 36 7.40 7.38 218 95 44 28.6 29.1 
3500"ml blood 1055 170 36 30 39 7.37 7.34 163 86 53 29.3 28.5 
ES 226 37 32 39 7.37 7.33 146 75 51 28.7 27.7 
1 h postop 230 44 33 46 7.37 7.34 190 90 48 28.7 27.7 
2 h postop 262 34 33 40 7.46 7.38 142 68 48 27.5 27.3 
4 h postop 293 30 26 38 7.48 7.40 116 73 63 27.5 27.6 
8 h postop 345 30 31 38 7.39 7.26 78 53 68 34.6 30,1 
Art, arterial; ven, venous; D02' oxygen delivery; V02, oxygen consumption; ER, oxygen extraction ratio; Psoact, P02 at oxyhemoglobin saturation of 
50% measured in mixed venous blood; Psoc, Pso of mixed venous blood corrected at pH = 7.40 and PC02 = 40 mmHg; H1, H2, H3, data for each 
step of hypervolemic hemodiJution; ES, end of surgery; postop, pos!operatively. 
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One might argue that lrom a single case no meaninglul conclusions can be 
made. However, during the same stages ol hemodilution (at the same hematocrit 
level), the cardiovascular responses to hemodilution ol this patient we re similar 
to those in another report on anesthetized hu mans 111, and this case might 
therelore be representative lor anesthetized humans. Furthermore, the advanced 
age ol the patient could have inlluenced the critical point ol hemodilution. 
However, in a clinical study there we re no dillerences lound between young and 
elderly patient in hemodynamic compensatory mechanisms during hemodilution 
120]. Finally, it has been suggested that by calculating VO,' rather than 
measuring VO,' and using the same variabie (e.g., cardiac output) lor calculating 
VO, and DO" the relationship between DO, and VO, might be based on 
mathematic coupling. However, it has been stated th at by keeping the range ol 
independent variables as large as possible (as in our patient), the effect ol 
coupled error are excluded 121J. 
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SEVERE ACUTE NORMOVOLEMIC HEMODILUTION AND SURVIVAL 
Chaney MA, Aasen MK. 
Anesth Analg 1993; 76: 369-378. 
T 0 the editor: 
We re ad with great interest the case report by van Woerkens et al. 111 and 
the accompanying editorial by Leone and Spahn [2], because we recently treated 
a patient who survived an episode of severe acute normovolemic hemodilution. 
Our patient was otherwise healthy 22-yr-old, 50-kg, female who underwent 
bilateral maxillectomies, bilateral ethmoidectomies, sphenoidectomy, and re sec ti-
on of a midline skull-based chondroblastoma. During the preoperative interview 
the patient rejected the use of homologous blood produets and any from of 
autologous transfusion because she was a Jehovah's Witness. The preoperative 
hemoglobin level was 12.7 g/dL and the first postoperative hemoglobin level was 
2.3 g/dL. Unfortunately, we did not have the benefit of central venous access. 
To minimize oxygen consumption and maximize oxygen delivery in the postope-
rative period, we continued paralysis and sedation, actively cooled the patient to 
30'C, and maintained the FiO, at 1.0. Erythropoietin and iron supplementation 
we re also initiated. By the 14th postoperative dav the hemoglobin level was 4.8 
g/dL and on the 28th postoperative dav it had increased to 9.1 g/dL. At this 
point, after 28 days, the patient was actively rewarmed, and the paralysis and 
sedation were discontinued. She quickly regained consciousness and was wea-
ned promptly from mechanical ventilation. No neurologie deficits we re identified 
and no obvious organ damage occurred. Our patient is living proof that acute 
normovolemic hemodilution to extremely low hemoglobin levels can be weil 
tolerated in selected patients for extended periods of time. 
We are curious as to why van Woerkens et al. chose not to utilize moderate 
hypothermia and an FiO, of 1.0 in the treatment of their patient. Certainly, their 
use of muscIe paralysis [3J and sedation [4J decreased oxygen consumption. The 
utilization of moderate hypothermia to 30'C will not only decrease oxygen con-
sumption 48% below basal levels [5], but will also increase the amount of 
dissolved oxygen in the blood by 10% [6], therefore increasing oxygen delivery. 
At extremely low hemoglobin va lues, dissolved oxygen in the blood plays an 
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integral role in oxygen delivery. Indeed, lichtenstein et al. [7) discuss a case 
involving a Jehovah's Witness who experienced severe acute normovolemic 
hemodilution for 4 h before a Massachusetts Superior Court-ordered blood 
transfusion. At a hematocrit of 4%, an FiO, of 1.0, and a body temperature of 
30"C, they calculated via invasive hemodynamic monitoring that 51 % of the 
patients oxygen delivery was accounted for by dissolved oxygen in the blood 
and th at this dissolved oxygen provided for 90% of the patient's oxygen con-
sumption. This situation differs markedly from the ordinary scenario of breathing 
room air, at normal body temperature with a normal hematocrit, where only 2% 
of the oxygen delivery is accounted for by dissolved oxygen, thus providing for 
only 5% of the oxygen consumption. 
We believe that utilization of moderate hypothermia to 30"C and maintenan-
ce of an Fi0 2 of 1.0 are vital to successful management of severe acute norm-
ovolemic hemodilution. Oxygen consumption is decreased and the increased 
amount of dissolved oxygen may provide important additional oxygen delivery to 
these patients who are surviving almost exclusively on dissolved oxygen in the 
blood. 
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IN RESPONSE 
Trouwborst A, van Woerkens EGSM, van Lanschot JJB. 
We appreciate the interest that Drs. Ghaney and Aasen have shown in our 
case report and that they have raised fundamental questions about utilization of 
moderate hypothermia to 30'G and maintenance of an FiO, of 1.0 during severe 
normovolemic hemodilution. 
We also considered the use of moderate hypothermia because of the decre-
ase in oxygen consumption, the increase in the amount of dissolved oxygen in 
plasma, and the increase in the affinity of tissue for oxygen during hypothermia. 
However, hypothermia also has negative effects on tissue oxygenation. During 
hypothermia the oxyhemoglobin dissociation curve (OOG) is shifted to the left, 
increasing hemoglobin affinity for oxygen and thereby decreasing the release of 
oxygen from the hemoglobin molecule. Decreasing body temperature from 37'C 
to 30'G decreases the P50 value (PO, at which hemoglobin is 50% saturated 
with oxygen) from 26.9 to about 18.7 mmHg [lJ. 
It is concluded that, in several clinical situations, the leftward shift of the 
OOG during hypothermia may be detrimental to oxygen delivery to tissue [1,21, 
especially when oxygen reserves are minimal, such as during hemodilution [2-4J. 
Therefore, more research is needed to determine whether the positive effe cts of 
hypothermia during severe anemia (e.g" decreased oxygen demand, increased 
amount of dissolved oxygen, and increased tissue affinity for oxygen) play a 
more important role on tissue oxygenation than the negative effect (leftward 
shift of OOG) of hypothermia. 
Furthermore Drs. Ghaney and Aasen, presenting their case, discuss the 
issue of an FiO, of 1.0 during a long periad, thereby increasing the amount of 
dissolved oxygen in plasma. However, inspired oxygen in concentrations of 
50%-100% during long periods carries the risk of lung damage [5J. Increased 
ratias of daad space to tidal volume and increased arteriovenous shunting have 
been reported in patients (with irreversible brain damage) after ventilation with 
an FiO, of 1.0 for 40 h [6J. Using a bronchoalveolar lavage technique in volun-
teers exposed to more than 95% oxygen for 17 h, a significant alveolar-capillary 
leak expressed by the presence of increased plasma albumin and transferrin in 
lavage fluid was detected [7J. Another study in healthy human subjects indicates 
increased lung epithelial permeability, in a dose-dependent manner, with increa-
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sing FiO, [8J. Furthermore, it is suggested that increased FiO, during a long 
period induces ongoing Iree radical lormation in the lung with consequent lung 
tissue damage [5). 
Another argument against use ol an FiO, ol 1.0 during a critical level ol 
hemodilution is our observation in pigs (unpublished data) that FiO, acutely 
increased to 1.0 at this critical point ol hemodilution induced, despite a recovery 
ol hemodynamics, an acute decrease in brain tissue PO" probably because ol 
the vasoconstrictive action ol high arterial PO, on the cerebrovasculature. 
Nevertheless comparison ol the case ol Drs. Chaney and Aasen with our 
case suggests that hypothermia and hyperoxia may decrease mortality during 
severe normovolemic hemodilution. However, we have to note that our patient 
died, but not belare the hemoglobin level dropped to less than 1.6 g/dL, where-
as the lowest hemoglobin level measured in their patient was 2.3 g/dL. 
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Summary 
Objective: To determine the accuracy of in vivo mixed venous hemoglobin 
saturation (SvO,) measurements with a fiberoptie thermodilution catheter during 
acute changes in hematocrit. 
Design: Comparison of fiberoptic in vivo Sv0 2 values with in vitro Sv0 2 values 
obtained with a multi wavelength spectrophotometer. 
Setting: Operating room in an university hospita!. 
Patients: Six consecutive patients who are Jehovah's Witnesses. 
Measurements and main resu/ts: Before and after each step of hypervolemic 
hemodilution and after 500 mL of blood loss, blood gases we re analysed and 
hemodynamic, hemoglobin, hematocrit, and in vitro and in vivo Sv02 
measurements we re made. Hematocrit values we re measured in the range of 
40% to 18%. Plotting all in vivo SvO, values (n ~ 74) against the in vitro SvO, 
measurements obtained during the entire study period gives r' ~ .86. The 
accuracy of in vivo Sv0 2 measurements was not affected by changes in 
hematocrit or cardiac output. The SvO, catheter value at the beg inning of the 
study differed from the in vitro SvO, value by -0.86 ± 2.56 % and at the end of 
the study period of 8 to 10 hours by 0.71 ± 3.04%. 
Gonc/us/ons: The accuracy of the studied fiberoptic continuo us measuring SvO, 
system was not affected by changes in hematocrit or cardiac output. No 
significant drift in the in vitro Sv02 measurements was observed. 
Introduction 
The mixed venous oxygen saturation of hemoglobin (SvO,) reflects, under 
certain circumstances, the state of tissue oxygenation. Changes in cardiac 
output, arterial oxygen content, and oxygen uptake influence these variables 
[1,2]. Therefore, continuous monitoring of SvO, has been developed and is used 
as an indicator of the effe cts of various therapeutic manoeuvres in critically ill 
patients, and for measurement of oxygen transport patterns [3-51. However, due 
to scattering of the erythrocyte wall itself, sudden changes in hematocrit might 
influence the reliability of SvO, values, measured by such fiber optic systems 
[6]. Situations leading to sudden changes in hematocrit are not uncommon 
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during surgery and intensive care due to, for example, hemorrhage, infusion 
regimes, and blood transfusions. 
A two-wavelength, fiber optic, balloon-tip thermodilution catheter 
(Spectracath®, Viggo-Spectramed, Oxnard, CA) has been developed, with a third 
fiber (the far fiber) ending two fiber diameters from the source fiber, which also 
receives backscattered light. The manufacturer claims that with this system, the 
reliability of SvO, measurement is not aftected bV sudden changes in hematocrit 
and that any change in hematocrit wil! not entail the need to update or 
recalibrate the device. To our knowiedge, no reports exist concerning the 
reliability of in vivo measurements with this svstem during sudden changes in 
hematocrit. Therefore, this study was designed in which, during acutely induced 
hypervolemic hemodilution followed bV surgical blood loss (with no recalibration 
of the svstem during the study period), we compared the in vivo SvO, values 
measured with the fiber optic device 
multiwavelenght spectrophotometer 
Denmark). 
with in vitro SvO, values obtained by 
(OSM3, Radiometer, Copenhagen, 
Materials and methods 
The catheter type studied has three fibers ending in the plane of the tip of 
the balloon-tip 7.5-Fr thermodilution catheter. A light-emitting fiber directs 
infrared light (805 nm) and red light (660 nm) into the blood. A second fiber (the 
near fiber) ends adjacent to the emitting fiber and receives backscattered light 
from RBC' s. A third fiber (the far fiber) is terminated two fiber diameters (500 fl) 
from the source fiber and also receives backscattered light. The ratio of the 
infrared (IR) and red (R) light signals from the near fiber is designed as x = IR 
near/R near. The variabie "x" was found by the manufacturer to be highly 
dependent on saturation, but also dependent on hematocrit. However, they 
found the ratio R = IR near fiber/iR far fiber directly related to hematocrit but 
independent of saturation because 805 nm is an isosbestic wavelength. The 
manufacturer of the fiber optic device claims th at algorithms, which are 
incorporated in the SvO, measuring device and based on these observations, 
give reliable SvO, values in the range of 20% to 50%, independent of 
hematocrit changes. 
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The study compromised 74 measurements in six consecutive patients who 
we re Jehovah's Witnesses and we re scheduled lor major surgery. All patients 
we re American Society ol Anesthesiologist class 1 or 2, with an age range ol 38 
to 84 years (mean 51 ± 10 [SD]). No patient was excluded during the study 
period. In accordance with rules and regulations observed and enlorced by the 
Medical Ethical Committee ol our institution, all patients we re lully lamiliarized 
with the objectives ol the study and signed an inlormed consent. On the dav ol 
surgery, two iv cannulas we re inserted and the radial artery was cannulated. 
Using the Seldinger technique, an introducer sheath was placed in the internal 
jugular vein. Alter in vitro calibration according to the manulacturers's 
specilications, the SvO, catheter with three optical libers was inserted. 
Catheters we re positioned in the pulmonary artery by observing the 
characteristic pressure waveforms. 
Belore cannulation ol the internal jugular vein, 2.5 mg midazolam iv was 
given. The lasting period was compensated with 500 mL of lactated Ringer' s 
solution. Heart rate, arterial BP measurements, pulmonary artery pressures, and 
right atrium pressure we re monitored continuously (Horizon 2000, Mennen 
Medical, Israel). After a stabilization period of 30 mins, baseline values we re 
obtained tor mean arterial pressure, mean pulmonary artery pressure, pulmonary 
artery occlusion pressure (PAOP), and cardiac output. 
In addition, arterial and mixed venous blood samples we re taken for 
measurements of hemoglobin, hemoglobin oxygen saturation (spectrophotometer 
OSM3, Radiometer), hematocrit, PO" and PCO, and pH (ABL330, Radiometer). 
All arterial and mixed venous samples were collected anaerobically into 
heparinized syringes and analyzed immediately. Just belore blood collection, the 
in vivo SvO, value was obtained. Anesthesia was then induced with lentanyl 5 
tig/kg, thiopental sodium 5 mg/kg, and pancuronium 0.1 mg/kg. After tracheal 
intubation, the lungs we re ventilated with 70% nitrous oxide in oxygen and tidal 
volume was adjusted to maintain normocapnia. Anesthesia was maintained with 
fentanyl and enllurane (end tidal 0.4 vol%), while muscIe relaxation was 
obtained with pancuronium. The bladder was catheterized. After a 15-min 
stabilization period, blood gases were analyzed and hemodynamic, hemoglobin, 
hematocrit, and in vitro and in vivo Sv02 measurements ware made. 
Hypervolemic hemodilution was induced in three equal steps. 
At each step, the patients received 500 mL ol dextran-40 (50 gil) with 
500 mi ol lactated Ringer's solution over 10 mins. The same measurements that 
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we re taken belore and after induction ol anesthesia we re repeated after each 
step. Surgery was perlormed and the same variables we re again recorded alter 
every 500 mL ol blood loss. During surgery, lactated Ringer's solution was 
inlused in a volume equal to the urine output plus 8 mL.kg".hr" to compensate 
lor loss ol Iluid lrom the open wound. Blood loss was replaced by an equal 
volume ol gelatin solution (Geloplasma®, Roger Bellon, Neuilly-sur-Seine, France). 
Just belore the end ol surgery, the lorced inlusion was stopped. Directly after 
surgery, the patient's trachea was extubated. Measurements were repeated at 
the end ol surgery, and at 20 mins, 2 hrs, and 4 hrs after surgery. Throughout 
the study period, the in vivo SvO, system was not recalibrated or updated lor 
hematocrit changes. The baseline blood volume values are calculated values [7]. 
All values are reported as mean ± SD. Statistical analysis was performed by the 
paired Student's [-test and the Wilcoxon signed-rank test. Furthermore, the 
correlation value, coefficient ol determination, and regression line were 
determined [8J. These relations were also tested by means ol Fisher's Z 
translormation (correlation coefficient) and by means ol the test ol the 
regression slope [9J. The accepted probability lor a statistica I difference between 
means was p < 0.05. 
Results 
All patients underwent a laparotomy. Each patient study varied between 8 
to 10 hours, depending on the duration ol the surgical procedure. The in vitro 
calibration ol the SvO, catheter at the beginning ol the study approximated the 
spectrophotometer SvO, ' differing by -0.9 ± 2.6%. At the end of the study 
period the catheter SvO, value differed lrom the spectrophotometer SvO, value 
by 0.7 ± 3.0% (Tabie 1). Throughout the study period no signilicant drift in the 
in vivo SvO, measurements was observed because the difference between the 
SvO, catheter value and the spectrophotometer SvO, value at the beginning ol 
the study period was not signilicantly different Irom the dillerence in SvO, 
va lues at the end ol the experimental procedure. 
Hypervolemic hemodilution changed the hematocrit Irom 36 ± 2% to 26 ± 
2%. During the study period, hematocrit values in the range ol 40% to 18% 
we re measured. Plotting the hematocrit against the difference between in vivo 
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Figure 1. Scatterplot of the difference between in vivo mixed venous hemoglobl"n saturation 
($vo2) and in vitro reference $vo2 (Svo2 diff.) against the decerase in hematocrit {top} and 
cardiac output (bottam). Testing bath the Gaffe/ation and regression coefficient hypotheses (H) 
(Ho: r = 0, 13 = 0 vs. alternate hypotheses Hf: r > 0, /3 > 0 fa = 0.025J) demonstrated that 
we Gould not rejeel the nul! hypotheses, proving that the catheter was not dependent on 
changes in hematocrit or in cardiac output in the measured range r? = .057, Y = -O.04x - 0.51 
Itopl;r' = .036, Y = 0.02x +0.15 Ibottomll. 
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Figure 2. Scatterp/ot of al! fiberoptie mixed venous hemog/obin saturation (Svo,) 
data (Svo, cat) against the in vitro reference spectrophotometer va/ues (Svo, 
OSM3). The dotted line represents the line of identity Ix = y) and the solid line 
represents the linear regression fine (y = 0.89x + 9.32). The coefficient of 
determination is? = .87. Testing both the corre/ation and regression coefficient 
hypotheses (H) (Ho: r = 1,!3 = 1 vs. a/tema te hypotheses H,: r < 1,!3 < 1 [a 
= 0.025J) demonstrated that we cou/d not reject the nul! hypotheses. 
SvO, and in vitro SvO, (catheter SvO, minus spectrophotometer SvO, values) 
showed th at the catheter gave reliable SvO, va lues independent ol changes in 
hematocrit (Figure 1, top). Similarly, changes in cardiac output did not inlluence 
the accuracy ol the liber system (Figure 1, bottom). Plotting in vivo 
determination ol SvO, by the liber optie system against the in vitra relerenee 
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Table 1 Selected data on systemic hemodynamics and oxygenation before and after induction of anesthesia" after each step of hypervolemic 
hemodilution (H1" H2" H3)" at the end of surgery (ES)" and 20 mins, 2 hrs" and 4 hrs postoperatively (postop) (mean ± SD). 
SvOz SvOz 5vO, ICath)-
Hgb Het C) PAOP SaOz PaOz 105M3) ICath) 5vO,105M3) 
Ig/dL) (%) (l/min/mz) (mmHg) (%) (torr) (%) (%) (%l 
Before induction 11.6 ± 0.8 36 ±2 3.0 ±0.5 6 ±2 97 ±1 95 ±14 76 ±3 75 ±4 -0.86 ±2.56 
After induction 11.5 ± 1. 1 35 ±3 2.4 ± OS 6 ±2 99 ±1 a 183 ±28° 79 ±3 78 ±2 -0.71 ±0.95 
H1 9.7 ± 0.7 3 •tJ 29 ± 3o,b 3.4 ±0.8b 16 ±23 ,b 99 ±1'" 188 ±32' 84 ± 3""b 83 ± 2O,b -0.57 ±1.10 
H2 9.2 ± 0.6 3 ,tJ 27 ± 2o,b 3.6 ±0.8' 22 ± 33 ,b 99 ±1' 188 ±20' 85 ± 53 ,b 84 ±4O,b -0.57 ±0.67 
H3 8.7 ± 0.4O,b 26 ± 2o,b 3.5 ±0.8' 26 ±2O,b 99 ±P 188 ±25' 84 ±43 84 ± 5o,b -0.57 ±0.96 
E5 8.3 ± 1.23,b 24 ± 33 ,b 3.5 ±0.8b 18 ±6o,b 99 ±1 146 ±35'" 81 ±5° 82 ±5° 0.71 ±2.38 
20 mins postop 9.8 ± a.8O,b 29 ±33 •b 3.9 ±0.6""b 8 ±3 97 ±2b 101 ±21 b 66 ± 9J ,b 67 ±8tJ 0.14±2.57 
2 hrs postop 9.9 ± 0.9' 29 ±3""b 3.4 ±0.43 ,b 5 ±2 97 ±2b 111 ±32b 73 ±5b 74 ±4 0.43 ±2.98 
4 hrs postop 9.5 ± 1.0a.b 29 ± 33 ,b 3.6 ±0.4o,b 4 ±1 97 ±2' 109 ±29 72 ±4b 72 ±4b 0.71 ±3.04 
Hgb, hemoglobin; Hct, hematocrit; Cl, cardiac index; PAOP, pulmonary arterial occlusion pressure; Sa0 2, arteria! hemoglobin saturation; Sv02 , mixed 
venous hemoglobin saturation; OSM3, spectrophotometer; Cath, catheter. 
° p < .05 compared with preanesthetic values. 
b p < .05 compared with postinduction values. 
SI conversion factor tor hemoglobin (g/dl to gIL) is 10.0, and for Pa02 (torr to kPa) is 0.133. 
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spectrophotometer value ol all data points obtained during the entire study 
period gives r' = .87 (y = 0.89x + 9.32) (Figure 2). All values (n = 74) ol 
SvO, catheter minus spectrophotometer SvO, (SvO, dill) have a mean ol 0.5 ± 
2.6% with median ol 0%, minimum value ol -8%, and maximum value ol 7%. 
Between -5% and + 5% are 69 (93%) ol all measured pairs during the whole 
study period measured pairs. 
During surgery, there was a blood loss ol 30.6 ± 19.2% ol the calculated 
initial blood volume. No patient required a blood translusion. Other relevant data 
selected during the study are presented in Table 1. 
Discussion 
The value ol continuous determination ol SvO, depends on how accurately 
in vivo Sv02 approximates the I reference spectrophotometric-measured 
saturations under different physiologic conditions. Specilic obstacles might be 
vessel wall artilact and conlounding effe cts ol varying hematoerit. In vivo 
measurements ol blood oxygen saturation using optical libers is based on 
differences in light rellection between oxygenated and reduced hemoglobin. 
However, saturation measurement is influenced by secondary effect including 
blood Ilow, erythrocyte shape, and hematocrit [10]. The hematocrit ol the blood 
Iloating along the tip ol the catheter might be inlluenced by Ilow properties 
(linear Ilow vs. turbulent Ilow), and by the systemic hematocrit value. A balloon-
tip thermodilution catheter with three optical libers lor measurement ol SvO, is 
available (Spectracath®, Viggo·Spectramed). Inlrared light and red light are 
delivered to the blood through a sou ree liber. Backscattered light Irom 
erythrocytes is received by two libers: one is adjacent to the souree liber; the 
other is two liber diameters away (far liber). The manulacturer claims that the 
ratio between the intensity ol in Ira red light lrom the near liber to the intensity ol 
the lar liber varies as a lunetion ol hematocrit and, therelore, can be used to 
validate in vivo oxygen saturation measurements, independent of hematocrit 
changes. However, to our knowiedge, there are no reports about the accuracy ol 
SvO, measurements with this device during in vivo sudden changes in 
hematocrit. 
Because many situations during surgery and intensive care lead to sudden 
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changes in hematocrit, such a device must produce reliable continuo us in vivo 
SvO, measurements, independent ol changes in hematocrit. Furthermore, SvO, 
itsell is an indicator ol the critical point ol hemodilution; continuous registration 
of in vivo Sv02 ' if accurate, might be used as an extra variabie to asses oxygen 
transport capacity ol the blood. In a previous study [11 in pigs during stepwise-
induced isovolemic hemodilution, a gradual deerease in SvO, was observed while 
the oxygen extraction ratio increased. A direct and strong correlation was lound 
between SvO, and oxygen extraction ratio, conlirming th at SvO, during 
hemodilution rellects the overall balance between oxygen uptake and oxygen 
delivery. Furthermore, a critical SvO, value was lound at which oxygen uptake 
started to decrease during lurther hemodilution [11. In this study in humans, the 
reliability ol the test catheter (Spectracath"') continuous SvO, device was tested 
during sudden changes in hematocrit, cardiac output , and PAOP. Acute 
hypervolemic hemodilution was induced in patients who are Jehovah's 
Witnesses belore major surgery because hypervolemic hemodilution results in 
lewer RBC's being lost per volume ol blood loss [11·13]. 
The results ol this study demonstrate th at the liberoptie device can be 
calibrated in vitro belore insertion. Furthermore, the reliability ol the device was 
not aftected by changes in hematocrit, cardiac output, or PAOP, even though no 
recalibration was perlormed after in vitro calibration belore insertion. The 
fiberoptie device was able to accurately track measured SvO, over the time 
course of this study. The system did not drift; thus, no more statistically 
significant deviations we re lound lrom the relerence·measured SvO, at the 
conclusion ol the study period compared with the deviations at the beg inning of 
the experimental procedure. We cannot conclude that the system is more 
accurate than other continuous SvO,-measuring devices because of the 
difterence in study protocol between our study and studies of other devices (e.g. 
three-wavelength catheter with two fibers) [3]. To answer this question, a 
randomized-designed study is needed to measure SvO, values concurrently with 
changes in the same physiologic variables. However it is concluded that the test 
device accurately reflects measured Sv0 2 over a wide range of time, and also 
during abrupt changes in hematocrit, cardiac output, and PAOP. Therefore the 
continuously displayed in vivo SvO, value derived with this system can also be 
used during acute hemorrhage as an extra variabie to asses the oxygen transport 
capacity of the blood. 
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Introduction 
The mixed venous saturation of hemoglobin (SvO,) reflects, under many 
circumstances, the state of tissue oxygenation. Changes in cardiac output (CO), 
arterial oxygen content, and oxygen uptake by the tissue influence this 
parameter [1,2]. Therefore continuous fiber optie monitoring of SvO, has been 
developed. Due to scattering of the erythrocyte wall itself, ho wever, sudden 
changes in hematocrit (het) might influence the reliability of SvO, values, 
measured by such fiber optie systems [3). Two manufacturers claim that their 
system overcome this problem, one because of using th ree wavelengths 
(Opticath"') and the other using two wavelengths via one fiber but receiving 
backscattered light by two other fibers (Spectracath®). The manufacturers claim 
that with their systems the reliability of SvO, measurements are not aftected by 
sudden changes in Het and that any change in Het will not entail the need to 
update or recalibrate the device. In this study, during acutely induced 
hypervolemic hemodilution [4) followed by surgical blood loss and with no 
recalibration of the systems during the study period, the in vivo SvO, values 
measured with the fiber optie devices we re compared with the in vitro SvO, 
values obtained with a multiwave length spectrophotometer. 
Patient and methods 
One of the studied catheters (Spectracath®, Viggo-Spectramed, Oxnard, 
USA) has three fibers terminated in the plane of the tip of a balloon-tipped, 7.5 F 
thermodilution catheter. A light emitting fiber directs infrared (IR: 805 nm) light 
and red (R: 660 nm) light into the blood. A second fiber (the near fiber) is 
terminated adjacent to the emitting fiber and receives backscattered light from 
red blood cells. A third fiber (the far fiber) is terminated two fiber diameters (500 
microns) from that souree fiber and also receives backscattered light. The ratio 
of the IR and R signals from the near fiber is designed as X = IR near/R near. X 
was found to be highly dependent on saturation, but also dependent on Het. 
However the ratio R = IR near/IR far directly relates to Het, but is independent 
of saturation because 805 nm is an isobestic wavelenght. Using incorporated 
algorithms based on these observations should give reliable SvO, values 
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independent from Hct changes in the range 20% to 50%. The other studied 
catheter (Opticath"', Oximetrix, Mt View; CA, USA) has two fibers terminated at 
the tip of a balloon-tipped, 7.5 F thermodilution catheter. Light emitting diodes 
generate alternating pulses of three different wavelengths (between 600 and 
1000 nm), 244 times per second via a light emitting fiber. A second fiber 
receives backscattered light from red blood cells and conducts this light to a 
photodetector. The oxygen saturation of hemagiobin (Hb) is derived by a 
computer from the relative intensities corresponding to three different 
wavelength. The study compromised measurements (Opticath"': n = 52; 
Spectracath"': n = 54) in 12 consecutive Jehovah's Witness patients scheduled 
for major surgery. Randomly divided between the patients, either a Spectracath'" 
or Opticath'" SvO, catheter was inserted via the internal jugular vein into the 
pulmonary artery. Befare insertion, according to the manufacturer's 
specifications, the SvO, catheters we re calibrated in vitro and na recalibration 
was performed during the entire study periad. The design of the study was the 
same as in a previously reported study [5J. 
In brief: values of Hct, blood gases, hemodynamics, and oxygenation we re 
obtained befare and after induction of anesthesia, after each step of 
hypervolemic hemodilution, after every 500 mi of blood loss, at the end of 
surgery, 20 min, 2 hand 4 h postoperatively. The in vivo SvO, values of the 
devices we re compared with the in vitro SvO, values obtained with a multiwave 
length Spectrophotometer (OSM3, Radiometer, Copenhagen). 
Statistical analysis was performed by the paired students T-test and the 
Wilcoxon signed rank test. Furthermore the correlation va lues, coefficients of 
determination and regression lines we re determined [6J. These relations were 
also tested by means of a Fisher's Z transformation (correlation coefficient) and 
by means of the test of the regression slope [7J. The accepted probability for a 
statistical difference between means was P < 0.05. 
Results 
The study of each patient varied between 9-12 hours depending on the 
duration of the surgical procedure. Directly after the in vitro calibration of the 
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SvO, gives differences in SvO, values compared to the OSM-3 SvO, ol 1.33 ± 
2.87% lor the Opticath® and -0.83 ± 3.60 % lor the Spectracath® (Tabie 1). At 
the end ol the study period the catheter SvO, values differed lrom the OSM-3 
SvO, by 2.67 ± 4.21 lor the Opticath® and by 1.00 ± 3.39 lor the 
Spectracath®. Throughout the study period at the same levels ol the study, na 
signilicant difference between Opticath® and Spectracath® SvO, values could be 
observed, while lor bath catheters the difference between SvO, catheter value 
and the Spectrophotometer SvO, value at the beg inning ol the study peri ad was 
not significantly different Irom the dillerences in SvO, values at the end ol the 
experimental procedure. Platting Het against the difference between in vivo SvO, 
100 
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Figure 1. Scatterplot of all fiberoptic mixed venous hemoglobin saturation ISvo2) 
data of both catheters- Opticath® top and Spectracath® bottom- against the in 
vitro reference spectrophotometer values IOSM3). The dotted line represents the 
fine of identity Ix = y) and the so!id fine represents the lineair regression !ines 
with their respective coefficient of determinant Ir). 
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Table 1. Selected data on systemic haemodynamics and oxygenation before and after induction of anesthesia; af ter each 
step of hypervolemic hemodilution (Hl, H2, H3); atthe end of surgery (ES); 20 min, 2 and 4 hours postoperatively (PO). 
Ht (Ol Ht (SI CO (Ol CO (SI PWP (Ol PWP (SI PaO, (Ol PaO, (SI Opt·OSM3 Spec"-OSM3 
% % !/min IImin mmHg mmHg mmHg mmHg % % 
pre 38.3 36.0 5.1 5.2 6.8 6.4 89 92 1.33 -0.83 
induction 4.1 3.0 0.8 0.7 3.1 2.3 5 13 2.87 3.60 
post 36.5 35.0 4.3+ 4.2+ 5.8 5.8 179+ 183+ 0.50 -0.67 
induction 4.2 3.4 0.9 1.0 3.3 2.9 30 31 5.11 1.20 
H1 29.3+ ... 29.5 + ... 5.5* 5.8* 10.0 + ... 16.0+* 165 + 182+ 0.33 -0.67 
3.1 3.0 1.3 1.3 3.1 3.0 45 42 3.90 1.21 
H2 25.7+ ... 27.5+ ... 5.7":' 6.2* 15.3 +'" 21.8+ ... 149+ 187+ -0.67 -0.67 
2.5 2.4 1.4 1.5 1.8 3.0 49 28 4.29 0.82 
H3 24+"" 26.0+ ... 6.1 ... 6.2* 19.3+ ... 26.4+ ... 149+ 186+ -0.67 -0.83 
2.2 1.5 1.7 1.4 1.9 2.7 44 28 5.31 1 .16 
ES 22.3+->- 24.3+* 5.4'" 6.3* 18.2 +'" 19.0+* 143+ 139+ -0.17 1.17 
6.7 3.1 1.5 1.7 2.1 7.0 44 35 5.33 2.28 
20 min PO 29.8+ ... 30.0+ * 6.3* 6.5* 13.0+ ... 7.4 98' 111 + 3.67 1.33 
2.6 3.2 2.8 1.1 5.6 2.3 45 44 5.30 3.37 
2 h PO 
30.2+* 30.0 6.7* 5.6* 8.3 4.8 . 122+ 122+ 1.00 0.67 
3.7 3.3 2.3 0.5 3.3 2.2 55 45 5.10 4.31 
4h PO 
30.2+* 29.5+ 7.3* 6.0"" 7.4 3.2 79' 113+ 2.67 1.00 
2.5 3.0 2.8 0.5 3.2 0.4 6 33 4.21 3.39 
(0) concerns the Opticath"', (S) concerns the Spectracath"'. Ht - hematocrit; CO cardiac output; PWP - pulmonary 
wedge pressure; Pa02 = arterial oxygen pressure. The last columns represent the difference in mixed venous saturation 
between catheter minus OSM3. + = P < 5% compared to preanesthetic values; ,. = P < 5% compared to post anesthetic 
values; No difference with P < 5% between Spectracath@ and Opticath@ values at the same level were observed. 
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Fig 2. Scatterplot of the difference between in vivo mixed venous hemoglobin saturation ISvop) and in vitro reference Svo, 
ISvo2 diff) against the change in hematocrit la: Spectracath® ; c: Opticath®) and cardiac output Ib: Spectracath® ; d: 
Opticath ®). Testing both the correlation and regression coefficient proved that both catheters were neither dependent on 
changes in hematocrit nor cardiac output in the measured range. 
comparison of two fjberoptic venous saturation catheters 
and in vitro SvO, of both systems showed that both catheter systems gave SvO, 
values with an accuracy independent from changes in Hct (Figures 2a and cl. 
Changes in CO slightly influenced the accuracy of the Opticath® (r' = 3.2%) 
(Figures 2b and d). Plotting in vivo determinations of SvO, by the fiberoptic 
system against the in vitro reference value of all data points obtained during the 
entire study gives a correlation coefficient r' = 91 % (Y = 0.81 X + 13.6) for 
the Opticath® and r' = 94% (Y = 0.87 X + 10.5) for the Spectracath®. 
Between -5% and + 5% of SvO, catheter minus OSM-3 SvO, values are 42 
(81 %) of the Opticath® and 51 (94%) of the Spectracath® of all measured pairs 
during the whole study period. Other relevant data selected during the study are 
presented in T able 1. 
Discussion 
The value of continuous fiberoptical determinations of SvO, depends on 
how accurately in vivo SvO, approximates the reference spectrophotometric 
measured saturations under different physiologic conditions. Specific obstacles 
as vessel wall artifact and confounding effe cts of varying Hct and secondary 
effects including blood flow, erythrocyte shape might influence the saturation 
measurements (8). The Hct of the blood floating along the tip of the catheter 
might be influenced by flow properties (linear flow vs turbulent flow), and by 
systemic Het value. Because many situations during surgery and intensive care 
lead to sudden changes in Hct, devices must produce reliable continuous 
registration of in vivo SvO,. In vivo SvO, if accurate, might be used as an extra 
parameter during hemorrhage to assess the oxygen transport capacity of the 
blood (2). During stepwise-induced isovolemic hemodilution a gradual decline in 
SvO, was observed while the oxygen extraction (ER) increased. A direct and 
strong correlation was found between SvO, and ER confirming that the SvO, 
during hemodilution reflects the overall balance between VO, and oxygen 
delivery [2,4,9). 
In the present study in humans the reliability of the Spectracath® and 
Opticath® continuo us SvO, devices was tested during sudden changes in Hct, 
cardiac output, and pulmonary wedge pressure (PWP). The results of the study, 
demonstrate that both systems are able to be calibrated in vitro prior to 
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insertion. Furthermore, the reliability of bath devices was not affected by 
changes in Het or PWP. Cardiac output changes had a slight influence on the 
reliability of the Opticath® but not on the accuracy of the Spectracath®. No drift 
was observed in either system during the course of the study. The Spectracath® 
was slightly, but not statistically significant, more accurate than the Opticath® 
system. It is concluded that bath devices refleet measured SvO, over a wide 
range of time, also during abrupt changes in Het. Therefore the continuous 
displayed in vivo SvO, values derived with bath systems can also be used during 
acute hemorrhage as extra parameter to assess the oxygen transport capacity of 
the blood. 
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Chapter 9 
Summary 
In the estimation of oxygen transport the term oxygen availability is used as 
the product of cardiac output and the arterial oxygen content (CaO,). Attempts 
can be made to modify the concept of oxygen availability by subtracting from 
the Ca0 2 the venous content at a critical P0 2 as measured in mixed venous 
blood (PvO,), where oxygen diffusion into tissue becomes compromised and 
oxygen uptake (Va,) may decrease. The real arterial available oxygen content 
(Cavia,) can be calculated by estimating the saturation at the critica I PvO,. For 
our concept 8 35 was chosen as such a dynamic baseline. Similar modification of 
oxygen extraction ratio (ERav) defined as va, divided by the real oxygen 
availability (O,av) should give, more than the classic ER, a realistic indices of 
oxygen availability in relation to oxygen consumption. It can be hypothesized 
that va, starts to decline when ERav is around 1.0. During isovolemic 
hemodilution va, started to drop when ERav reached 1.08 ± 0.09. The S35 
changed from 55.0 ± 2.1 % to 41.5 ± 4.1 %, correlated with changes in PvO,. 
A direct correlation was also found between the increase of the classic ER and 
the change in S". 
We conclude that the S", the Cavia, and the ERav can be of value in 
monitoring the systemic oxygenation and that the concept also includes the 
effect of changes in oxyhemoglobin characteristics on oxygen delivery. 
Key words: arterial available oxygen content; ERav; extraction ratio; 
hemodilution; hypoxia; isovolemic; oxygen consumption; oxyhemoglobin 
dissociation curve; PGo ' 
Introduction 
In the estimation of oxygen transport the term oxygen availability is used as 
the product of cardiac output (CO) and the arterial oxygen content. Attempts 
can be made to modify the concept of oxygen availability by subtracting from 
the arterial oxygen content (CaO,) the venous content at a critical PO" at pH, 
PCO, and hemoglobin concentration as measured in mixed venous blood (critical 
PvO,), where oxygen diffusion into tissue becomes compromised and oxygen 
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uptake (VO,) may decrease. Assuming oxygenation of the tissue is also a 
function of capillary PO" the concept of unavailable arterial oxygen content, 
calculated by estimating the saturation at the critical PvO" emphasizes that 
changes in PvO" when no significant arterial admixture exists, reflect changes in 
mean capillary PO,. 
In former studies we found that during stepwise induced isovolemic 
hemodilution, the VO, started to decline at a PvO, of around 35 torr (4.67 kPa) 
[1]. Therefore, for our concept S35 (saturation of hemoglobin at PO, = 35 torr) 
was chosen as dynamic baseline for oxygen delivery and for calculating the 
unavailable arterial oxygen content. The term oxygen availability (O,av) should 
be reserved for the product of CO and the arterial available oxygen content 
(CavIO,) while the product of CO and total arterial oxygen content (CaO,) should 
be called oxygen flux (0, flux). Similar modification of the oxygen extraction 
ratio (ERav) defined as VO, divided by O,av, should give, more than the classic 
ER (defined as VO, divided by O,flux), a realistic indices of oxygen availability in 
relation to oxygen consumption. 
The concept also includes the effects of changes in oxyhemoglobin 
dissociation curve (ODC) on oxygen delivery. For example, a shift to the right of 
the ODC decreases the S35 and therefore increases CavlO, (Figure 1) with, at 
fixed VO, consequent lowering of ERav, indicating th at more oxygen should be 
available to be delivered before oxygen supply dependenee of oxygen uptake is 
initiated. It can be hypothesized th at for insta nee during isovolemic hemodilution 
VO, starts to decline when ERav is around 1.0 (O,av becomes equal to VO,). 
The aim of the present study was to test th is hypothesis and to determine 
the S36 af ter each step of normoxic acute isovolemic hemodilution. 
Material and methods 
This protocol was approved by the Animal Care and Use Committee of the 
Erasmus University, Rotterdam, The Netherlands. 
Six male Yorkshire pigs (10.2 - 12.0 kg) we re used. After giving 0.3 mg/kg 
midazolam i.m. a catheter was introduced into one of the ear veins and the 
trachea was intubated. Throughout the experimental procedure sedation was 
maintained with a continuous i.v. infusion of 0.2 mg/kg/h midazolam. 
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Figure 1. The effect of changes in P50 and slope of ODC on S35 and the arterial 
available oxygen content (Ca vlO,}. V1 indicates the critical mixed venous blood 
values befare changes in ODC. V2 indicates the critical mixed venous blood 
values af ter changes in ODC. 
After intubation ol the trachea 0.1 mg/kg pancuronium i.v. was given with 
an additional continuous i.v. inlusion ol 0.3 mg/kg/h. The pigs' lungs we re 
ventilated with air and tidal volume was adjusted to keep end-tidal CO, between 
33.8 and 37.5 torr (4.5 and 5.0 kPa). Catheters (Cook Europe, BP8) were placed 
in the left lemoral artery, the right lemoral vein and the right lemoral artery (the 
latter lor arterial blood pressure monitoring). Via the left lemoral vein a 
thermodilution catheter (Swan Ganz" 93A-095-7F, Am. Edwards lab., USA) was 
introduced into a pulmonary artery. In all animals the injectate port was located 
in the right atrium as was proven on postmortem examination. The urine bladder 
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was cannulated and a urine catheter placed. Body temperature (blood 
temperature) was measured with the thermistor electrode of the thermodilution 
catheter and was kept sta bie throughout the procedure by means of a heating 
pad. After all preparations we re completed, the sedated paralyzed animals we re 
ventilated until blood gas tensions, pH and hemodynamic parameters we re 
stabilized (average time: 30 min). Pulse rate, arterial blood pressures, pulmonary 
arterial pressures and the right atrium pressure we re monitored continuously 
(Horizon 2000, Mennen Medical, Israel). After the stabilization period baseline 
measurements we re made, including: pulse rate (HRT), mean arterial blood 
pressure (MAB), systolic pulmonary arterial pressure (sPAP), diastolic pulmonary 
arterial pressure (dPAP), pulmonary wedge pressure (PWP), right atrial pressure 
(RAP) and cardiac output (CO). In addition, arterial and mixed venous blood 
samples were taken for measurements of PO" pH and PCO, (ABL330, 
Radiometer AIS, Denmark) and for measurement of hemoglobin (Hb) and 
oxyhemoglobin content (Spectrophotometer OSM3, Radiometer AIS, Denmark). 
Oxygen flux (a, flux) was calculated as the product of arterial oxygen content 
and cardiac output. Oxygen uptake by the tissue (Va,) was defined as the 
product of CO and the arteriovenous oxygen content difference. The oxygen 
extraction ratio (ER) was calculated as va, divided by a, flux. 
From the values of po" pH, oxyhemoglobin saturation (SAT) of the mixed 
venous blood sample the S", was calculated according to the formula: 
e~PO,) . 100 
S35 = -=-_---"---'-"C". 
1 + e..{Pq) 
where: 
4: Po,) = In 
{N,,)-1.1n 4.67 
So,.o + In 4.67 + k . tanh PO,.o 
1-So,.0 PO,.o k 
and SO,.o 0.867 
k 3.5 
No 2.87 
PO,.o 1.955 (P6o)actual pH 
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(P 50)actual pH 
and 
(P. ) '1O-(0.48·(P~7.4» 50 c 
2 
0.001.80. - 0.1.80. + 2.5).1O-0.48(7.4-P," 
26.85 
The modified oxygen extraction ratio (ERav) was calculated as VO, divided 
by O,av (= CaO, - CvO, divided by CavIO,), whereby the CavlO, is defined as 
the arterial oxygen content minus the oxygen content at a PO, of 35 torr (4.67 
kPa). 
The first step of isovolemic hemodilution with iso-oncotic dextran 40, 50 
giL in 0.9 % salt solution (lsodex®, N.P.B.I, Holland) began after baseline 
measurements were completed. The dextran solution (warmed to 38°C) was 
instilled slowly into the right femoral vein at the same time and at the same rate 
that blood waS removed trom the left femoral artery. Stepwise isovolemic 
hemodilution was induced by steps of 10 mLJkg bodyweight until a total 
exchange of 40 mL/kg bodyweight and afterwards by steps of 5 mLJkg 
bodyweight. New sets of data we re obtained after each step of isovolemic 
hemodilution when blood gas tension, pH and hemodynamic parameters we re 
stabilized again (average time: 5 min). The time between each step of blood 
exchange was 15 min. 
To establish the mean critical ERav ± SD, VO, was plotted against the 
ERav in each anima!. The critical point of ERav after which VO, gradually 
decreased was analytically chosen from the intersection of the two bestfit 
regression lines, determined by a least sum of squares technique as described by 
Schumacker et al [2). 
All values are expressed as means ± SD The accepted probability for a 
statistical significanee bet ween means was P < 0.05. The statistical significanee 
of differences was tested by the Wilcoxon signed-rank test. Regression lines 
we re estimated by methods of least squares. For regression analysis the 
Spearman rank correlation coefficient was used. 
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Results 
The 835 decreased after every reduction in hemoglobin (Tabie 1). The 8 35 at 
100 mL/kg bodyweight blood exchange was nearly 25% lower than the baseline 
value. The change in 835 was not correlated with changes in arterial or mixed 
venous pH and peo,. A direct significant correlation was found with changes in 
Pvc, (Figure 2). 
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Figure 2. Scatterplot of S35 against Pv02 (carrected far pH = 7.4). r,= 0.81. 
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A direct correlation was also found between the increase of the classic ER 
(defined as VO, divided by 0, flux) with the change in S35 (Figure 3). The P50 
and the modified extraction ratio (ERav) are summarized in Table 1. Plotting 
ERav against VO, in each animal, the mean ERav critical at the point of 
intersection of best-fit regression lines was 1.08 ± 0.09 (Figure 4). A plot of the 
mean ERavat each step of hemodilution against the corresponding mean VO, 
gives a critical ERav value of 1.06 (Figure 5) . 
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Table 1 Some parameters of systemic oxygenation af ter every step of blood exchange. 
Blood exchange in 
ml.kg·' body weight 
o (baseline) 
10 
20 
30 
40 
50 
60 
65 
70 
SO 
S5 
90 
95 
100 
Hb 
mmol.L·1 
6.3±0.7 
4.9 ±0.5· 
4.2 ±OA" 
3.8±0.5·'· 
3.3 ±0.3'· 
2.S ±0.2' 
2.5 ±0.3' 
2.3 ±0.2' 
2.1 ± 0.1 .,. 
1.9 ± 0.3'" 
1.8 ± 0.2" 
1.6±0.2* 
lA±0.2' 
lA±0.2' 
8 35 
% 
55.1 ± 2.1 
54.2 ±2A 
53.6±3.1 
52.S±3.2 
51.0±2.9·' 
50.S ± 5.6' 
49A ± 2.S'· 
47A±5.7' 
47.S ± 5.3' 
47.1±4A· 
45.5±4.5·' 
45.7 ± 3.S'· 
43.9 ± 5.S' 
41.5±4.1* 
ER 
0.30 ± O.OS 
0.32±0.07 
0.33±0.07 
0.3S ±0.07 
OA2 ±0.04 
OA6 ± 0.06" 
0.53 ±O.OS'· 
0.56 ±0.07' 
0.59 ±O.OS·' 
0.63 ±0.06' 
0.65 ± O.OS'· 
0.67 ± 0.07" 
0.68 ±O.OS* 
0.72±0.05'· 
ERav 
0.66±0.15 
0.6S±0.13 
0.68±0.16 
0.SO±0.12 
0.S3 ± 0.11 
0.93 ± 0.1 0' 
1.02±0.12·-
1.07±0.10· 
1.09 ± 0.06' 
1.17±0.07' 
1.15 ± 0.06' 
1.20±0.OS' 
1.lS±0.10· 
1.20±0.05' 
Pso 
kPa 
4.39±0.20 
4Al ±0.20 
4A7±0.21 
4.56±0.17 
4.65±0.19 
4.68±0.28'· 
4.72±0.25' 
4.85 ± 0.37" 
4.S0 ± 0.31 ,. 
4.S4±0.20' 
4.92±0.21' 
4.S5 ± 0.19'" 
4.85 ± 0.25" 
4.95 ±0.19* 
Abbreviations: Hb = hemoglobin; 8 35 = saturation of hemoglobin at oxygen tension of 4.67 kPa (35 mmHg); ER 
extraction ratio of total arterial oxygen content; ERav = oxygen extraction ratio of arterial available oxygen content; Pso 
oxygen tension at hemoglobin saturation of 50% (corrected to pH = 7 AO). 
,. P < 0.05 (in comparison to baseline). 
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Discussion 
In the present study S35' the saturation at an oxygen tension of 35 torr 
(4.67 kPa), was used as a dynamic baseline for oxygen delivery calculaHons, 
assuming that oxygen bound to Hb at a tension of less than 35 torr (4.67 kPa) 
should be considered relatively unavailable as a decrease of the end capillary PO, 
below 35 torr (4.67 kPa) may be followed in some organs by tissue hypoxia due 
to limitation of oxygen diffusion into the tissue. Intensive care patients with a 
consistent PvO, of less than 30 torr (4 kPa) did not survive while all survivors 
had a PvO, of more than 35 torr (4.67 kPa). The group of patients with a 
consistent Pv0 2 between 30 and 35 ton included survivors and non-survivors 
[3,4,5]. Schumacker found during hypovolemia in dogs a critical PvO, of 29.0 ± 
2.3 torr (SO) (4.0 ± 0.3 kPa) [6]. 
In dogs during isovolemic hemodilution a critical PvO, between 30 and 40 
torr (4.0 - 5.3 kPa) has been reported [71, while in pigs during isovolemic 
hemodilution a critical PvO, of 32.0 ± 3.1 torr (SO) (4.27 ± 0.41 kPa) was 
determined [1]. 
In the present study a S35 of 55 % was found as baseline value. In terms of 
our definition this means that the arterial available oxygen content (CavlO,) is 
only 45 % of the total arterial oxygen content (CaO,] and that when the required 
VO, should exceed the CavlO" a decrease in VO, would be expected. Ouring 
hemodilution a gradual decrease in S35 at pH and PCO, as measured in the mixed 
venous blood, was observed. This means an increase in the amount of the 
CavlO, as part of the CaO, perhaps diminishing thereby the chance of an oxygen 
supply dependence of oxygen uptake. In the present study the change in the 
actual S35 was accompanied by an acute shift to the right of the OOC as 
expressed by a change in the P50 (corrected to pH = 7.40). No correlation was 
found between the change in S35 and changes in arterial or mixed venous actual 
pH, PCO, or temperature. A close relationship was found between the actual S35 
and the for pH corrected PvO,. Thus alteraHons in OOC characteristic during 
normoxic acute normovolemic hemodilution may partly compensate for the 
reduction in end-capillary PO,. These alterations are in agreement with the 
reported acute changes in P02 of coronary sinus, venous and arterial blood 
during signs of hypoxia of the heart in humans [8,9,10]. The concept of S35 and 
ERav includes the effects of changes in OOC on oxygen delivery. In many 
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studies the rale ol the ODC on tissue oxygenation has been discussed. In all 
these studies the P50 value ol the blood was manipulated. Malmberg et al 
reported that a left shilt ol the ODC in rats limits oxygen delivery during 
hemorrhagic shock [11]. In rats with low P50 blood, increased blood Ilow to brain 
and heart, probably to compensate lor decreased tissue 0, pressure, has been 
observed [12J. Increased blood oxygen allinity decreased canine brain oxygen 
consumption [13], while in dogs reduced blood oxygen allinity after coronary 
artery occlusion signilicantly decreased the extent ol myocardial necrasis lor the 
same degree ol ischemia 1141. 8chumacker et al suggested, that low P50 
conlounds oxygen extraction when delivery is very low, but lound that in dogs 
with reduced P,o, the critical oxygen flux and critical extraction ratio did not 
diller Irom controls [2J. In a review Rand stated that where oxygen reserves are 
minimal, the position ol the ODC may weil be a critical lactor in the survival ol 
the tissue, and thus the entire organism [15]. 
In our study we lound a direct signilicant linear relationship between the 
decrease in 835 and the increase in the classic extraction ratio suggesting that 
the position ol the ODC also inlluences the amount ol oxygen extracted in the 
capillaries Irom hemoglobin. 
In the present study, besides the 835 the value ol the ERav was calculated 
after each step ol isovolemic hemodilution. We reasoned that the relationship 
between CavlO, and VO,' expressed by us as ERav, should give a more realistic 
indices ol oxygen supply in relation to oxygen consumption. It was assumed 
that lor instance during normoxic normovolemic acute hemodilution VO, starts 
to decline when ERav reaches around 1.0. In this study using the 83, as dynamic 
baseline, VO, started to decrease when ERav was 1.08 ± 0.09. Using a plot ol 
the mean ERavat each step ol hemodilution against the corresponding VO, a 
critical ERavol 1.06 was lound. We are unaware ol any previous studies 
comparing such modilied extraction coefficient with the critical point ol VO,. 
We conclude that the 835 , the CavlO, and the ERav can be ol value in 
monitoring the systemic oxygenation and that the concept ol arterial available 
oxygen content also includes the effect ol changes in oxyhemoglobin 
characteristics on oxygen delivery. 
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Chapter 9 
Summary 
A new concept in monitoring systemic oxygenation that includes the effect 
ol changes in oxyhemoglobin dissociation curve (ODC) has been introduced. 
Using the 8" (saturation ol hemoglobin at PO, = 35 mmHg), real arterial oxygen 
content (Cavia,) can be calculated being the maximum amount ol oxygen that 
can be extracted Irom hemoglobin belore oxygen diffusion into tissues becomes 
compromised and oxygen uptake (Va,) may decrease. The relation between va, 
and Cavia, expressed by the extraction ratio ol the arterial available oxygen 
content (ERav) gives a realistic indices ol oxygen supply in relation to oxygen 
consumption. In the present study, during extracorporeal circulation (ECC), a 
severe shift to the left ol the ODC could be observed. The classic parameter lor 
monitoring systemic oxygenation as mixed venous oxygen saturation (8vO,) and 
extraction ratio (ER) did not change. The 8 35 increased because ol the shift to 
the left ol the ODC with consequent decrease in Cavia,. The ERav reached 
critical values during ECC together with hemodilution and hypothermia. A severe 
decrease in mixed venous PO, (pvO,) was also observed. The authors conclude 
th at besides the PvO" the 835 , The Cavia, and especially the ERavare ol value 
in monitoring the systemic oxygenation during hypothermie ECC. 
Key words: blood gases; coronary bypass, ERav, extraction ratio; hypoxia; 
mixed venous P02; mixed venous saturation; oxygen consumption; 
oxyhemoglobin dissociation curve; pump Ilow. 
Introduction 
Release ol oxygen at the tissue level is inlluenced by several lactors as 
blood Ilow, hemoglobin concentration (Hb) and the affinity ol hemoglobin lor 
oxygen as expressed by the position and slope ol the oxyhemoglobin 
dissociation curve (ODC). 
A new concept in monitoring systemic oxygenation that includes the elleet 
ol changes in ODC on oxygen delivery has been proposed 11]. Using the 8" 
(saturation ol hemoglobin at PO, = 35 mmHg), the real arterial available oxygen 
content (Cavia,) can be calculated being the maximum amount ol oxygen that 
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can be extracted Irom hemoglobin belore oxygen diffusion into tissue be co mes 
compromised and oxygen uptake (VO,) may decrease (Figure 1). The basis ol 
the concept is the observation that when end capillary PO, decreases 
somewhere below 35 mmHg (4.67 kPa) in some organs tissue hypoxia may 
begin [2). 
The relation between VO, and CavlO, expressed by the extraction ratio ol 
the available oxygen content (ERav) gives a realistic indices ol oxygen supply in 
relation to oxygen consumption [1]. 
During extracorporeal circulation (ECC) lor cardiac surgery the ODC is 
inlluenced due to alterations in acid-base status, body temperature and 
erythrocyte 2,3-diphosphoglycerate (2,3-DPG) content. These changes result in 
a severe increase in affinity ol hemoglobin lor oxygen [31. 
The purpose ol this preliminary study was to evaluate S35' CavlO, and ERav 
during extracorporeal circulation together with hemodilution and hypothermia. 
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Figure 1. Effect of changes in ODC on S35 and arterial oxygen content (CavIO,I. 
VI indicates critical mixed venous blood values before changes in ODC. V2 
indicates critical mixed venous blood values af ter a shift of the ODC to the rigM 
{from ref. IJ. 
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Materials and methods 
Seven consecutive adult patients scheduled lor coronary bypass surgery 
were included. The evening belore surgery premedication was given with oral 15 
mg Ilurazepam (Dalmadorm®) and 90 min preoperatively with oral 2 mg 
lorazepam (Temesta®). An intravenous cannula was inserted and the radial artery 
was cannulated. Af ter induction of anesthesia, a central venous catheter was 
introduced via the right internal jugular vein. Pressures we re continuously 
displayed and recorded throughout the procedure together with ECG, 
nasopharyngeal and recta I temperature. Anesthesia was induced with lentanyl 
15 f/g.kg", midazolam (Dormicum®) 0.1 mg.kg" and pancuronium bromide 0.1 
mg.kg". After tracheal intubation, the lungs were ventilated with 30% oxygen in 
air, using a servo ventilator 900C (Siemens, Elema, Sweden), with a tidal volume 
ol 10 mL.kg", Irequency ol 12 min" and inspiratorylexpiratory ratio 1:2. 
Anesthesia was maintained with midazolam (Oormicum®) and pancuronium 
bromide. After a stabilization period baseline values we re obtained. Arterial and 
mixed venous blood samples were taken lor measurements ol PO" pH and PCO, 
(ABL330, Radiometer AIS, Denmark) and lor measurements ol Hb and Hb 
oxygen saturation (Spectrophotometer OSM3, Radiometer AIS, Denmark) . The 
actual S36 and P,o (corrected lor pH = 7.4 and body temperature = 37'C) we re 
calculated using lormulas as described previously [11. The classic extract ion ratio 
(ER) was calculated as the arterio-mixed venous oxygen content difference C(a-
vlO, divided by the total arterial oxygen content (CaO,). The ERav was 
calculated as C(a-v)O, divided by Cavia,. Total ECC was then started via atrio-
aortic cannulae using a micropores membrane oxygenator (Shiley M2000, Irvine, 
USA) and a 180' roller pump. The oxygenator and tubes we re primed with 1700 
mL gelatine solution (Haemacel®), 100 mL albumin (20 %), 200 mL mamitol (20 
%) and 50 mL 8.4 % NaHC03. Anticoagulation was with i.v. heparin 3 mg-kg". 
The patients we re cooled using a water-cooled heat exchanger. Pump Ilow was 
recorded and baseline measurements and calculations we re repeated directly 
after ECC was started but belore cooling, 30 min after cooling just belore 
rewarming and directly after rewarming. 
Data are presented as means ± SD. Presented P02 measurements are 
values at the actual body temperature. The accepted probability lor a statistical 
signilicance between means was P<0.05. Differences were tested by the 
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Wilcoxon Signed-rank test. 
Results 
The results are summarized in Table 1. The start of ECC was accompanied 
by a decrease in hematocrit (Hct) from 37 ± 2 % to 24 ± 3 %. The Hct did not 
significantly change throughout the following studied period. During ECC the 
patients we re cooled to a body temperature of 26.4 ± 1. 5"C (nasopharyngeal 
temperature) and before getting oft from ECC, rewarmed to baseline body 
temperatures. The classic parameters for monitoring systemic oxygenation as 
SvO, and ER did not change. Due to hemodilution at the start of ECC CaO, 
decreased from 7.76 mmol.L- 1 to 5.38 mmol. L- I ; no further statistically 
significant changes occurred in CaO, during the following procedures. The 
CavlO, also decreased at the beginning of ECC; not only due to induced 
hemodilution but also due to the increase in S35' Due to cooling a further 
statistically significant increase in S35 could be observed, together with a 
decrease in CavlO,. The S35 did not return to values observed before cooling 
started. At the start of ECC, Pso (corrected to pH = 7.40 and body temperature 
= 37"C) decreased and did not change significantly anymore throughout the 
whole following procedure. 
Discussion 
In the present study the start of normothermic ECC was accompanied by an 
acute significant shift of ODC to the left. This shift did not correlate with 
changes in pH or PCO,. As expected, during hypothermia a further shift to the 
left could be observed, demonstrated by the further increase in S35 after cooling 
was induced. However, the P50 corrected for temperature to 37"C and 
corrected to pH = 7.4 did not change in comparison to the corrected P50 at the 
start of ECC before cooling. The initial fall in the corrected P50 at the start of 
ECC cannot be explained by data from the present study. Others found a 
decrease in 2,3-DPG during cardiopulmonary bypass 13]. This could explain the 
initial shift in ODC which was not correlated with pH, PCO, or body 
temperature. 
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Table 1. Some parameters of systemic oxygenation during extracorporeal circulation (ECC) 
before EeC 
on EeC befere 
coaling 
30 min on Eec 
on EeC just 
befere rewarming 
on EeC after 
rewarming 
pump flow bodytemp 
LJmin.m"2 oe 
S" 
% 
PSOC 
kPa 
Het 
% 
36.8±0.3 63.8±2.0 3.71 ±O.07 37±2 
SV02 
% 
Pv0 2 
kPa 
Ca02 
mmol/L 
CavlO:;! 
mmoijl 
ER ERav 
78.7±10.3 6.42±1.90 7.76±0,66 2.85±0.09 0.22±0.09 0.61 ±0.24 
2.44±0.21 36.1 ±0.1 69.0±4.0" 3.49±0.09'" 24±3'" 79.0±6.0 5.72±0.81 5.38±0.58'" 1.88±0.15"" 0.26±0.050.75±0.15 
1.55±0.20# 26.4 ±1.5"''' 79.0±2,5 ..... 3.52±0.15* 25±2* 80.8±4.8 2.76±0.38'""" 5.51 ±0.63* 1 .30±0.18"''' 0.22±0.03 0.97±0.25 ..... 
1.65±0.10" 26.9±1.'''''' 79,1±2.5'"" 3.49±0.12'" 26±2'" 78.8±3.5 2.37±0.40<o# 5.63±O.7'''1.28±O.24*''O.24±O.031.05±O.20.,.p 
2.54±0.20 36.7±0.3 73.0±1.5 ..... 3.52±0.07" 26±2'" 77.5±0.4 5.13±O.39 5.75±0.SS"'1.S1±0.1S'" O.27±0.OS 0.S7±0.12"''' 
Abbreviations: 535 = saturation of hemoglobin at Oxygen tension of 4.67 kPa (35 mmHg); Psoe = oxygen tension at hemoglobin saturation of 50% (eorreeted to Ph = 7.40 
and body temperature = 37°C); Het = hematoerit; Sv02 = mixed venous saturation of hemoglobin; Pv02 = mixed venous oxygen tension; Ca02 = arterial oxygen content; 
Cavl02 = available oxygen content; ER = extraction ratio; ERav = extraction ratio of the availab!e oxygen . 
... p < 0.05 (eompared to values before ECC); If P < 0.05 (compared to values during ECC before cooling). 
Table 2 .Data of blood gas analysis during extracorporeal circulation IEGG) 
before EeC 
on EeG before 
cooling 
pH(a) 
37 
7.42±O.Q4 
7.50±O.OS'" 
pH (a) pH(v} 
act 37 
7.39±O.a3 
7.41 ±O.O4 
pH(v) paO z Pa0 2 
act 37 act 
kPa kPa 
17.48±9.40 
41.70±8.34'" 
PaCO:! paCO:! PvC0 2 PVCO;- Sa0 2 
37 act 37 act 
kPa kPa kPa kPa % 
5.09±1.0S 5.79±O.32 96±3 
4.09±O.4S'" 5.46±O.65 99±O 
30 min on EeC 7.48±O.04 7.63 ±O.Q4 7.41 ±O.04 7.56±O.04 31.57±S.5S"' 24.22±8.72 4.29±O.40 2.66±O.34 5.24±O.55 3.21 ±0.40 99±O 
on EeC just 
befere rewarming 
7.48±O.03 7.63 ±O.05 7.41 ±O.04 7.56±O.04 30.09±4.63* 24.11 ±4.42 3.98±O.30* 2.45±O.14 4.S0±O.44'" 2.95±O.23 99±O 
on EeG after 
rewarming 
7.54±O.04'" 7.47±O.03* 41.79±2.1S" 3.51 ±O.2S'" 4.43±O.2S'" 99±O 
Abbreviations: pH(a),37 = pH arterial blood corrected to 3rC; pH(a),act = pH arterial blood at the actual body temperature; pH(v),37 = pH mixed venous blood corrected 
to 37"C; pH(v),act = pH mixed venous blood at the actual bOdy temperature; PaC0 2 = arterÎal CO2 tension; PvC02 = mixed venous CO2 tension; Sa02 = arteria! 
hemoglobin saturation. 
* P < 0.05 (compared te values before ECC). 
Chapter 9 
The inerease in oxygen affinity ean be thought to be a limiting factor in 
tissue oxygenation during ECC. The reported deerease in oxygen eonsumption 
during hypothermie ECC might be due not only to redueed metabolic 
requirements, but also to the Iimited amount of oxygen th at ean be extraeted 
from Hb beeause of the severe leftwards shift of the ODC [3]. During 
hypothermie ECC laetate was found to be inereased [3,41 while the 
laetate/pyruvate ratio was found to be eonsistently higher during hypothermia 
than during the rewarming ph ase, suggesting some degree of tissue hypoxia [3]. 
The praetiee of monitoring 8vO" ER or CaO, as parameters for tissue 
oxygenation is therefore questionable during hypothermie ECC. In the present 
study 8vO, and ER did not change during the various stages of the study while 
CaO, did not include the effe cts of shifts in ODe, but only the changes in Het. 
We found PvO, more sensitive for changes in several factors influeneing 
oxygenation. Also others suggest th at PvO, may indeed be the more reliable 
variabie to use [41. However, it is still impossible to eonclude from PvO, 
measurement if the tissue oxygenation is sufficient or not. A new concept in 
monitoring the systemie oxygenation that ineludes the effect of changes in ODe 
on oxygen delivery has been introdueed (11. The concept makes it possible to 
ealeulate the real maximum amount of oxygen th at ean be extraeted from the 
hemoglobin under different eireumstanees. The relation bet ween this so-ealled 
arterial available oxygen content (CavIO,) and the VO, (ERav = VO, divided by 
CavlO,) gives an index of the systemie oxygenation. 
In the present study CavlO, was affeeted by hemodilution as weil as by the 
shift in ODC. The ERav signifieantly inereased with hypothermia indieating that 
the available oxygen reserve decreased. The value of 1.05 ± 0.20 atthe end of 
the hypothermie period indieates th at at this stage of the study hypoxia may 
have exist in some cases, beeause in another study an ERav value of 1.08 ± 
0.09 was found to be eritieal where oxygen uptake starts to deerease due to 
limited oxygen availability (1 I. 
We eonelude that strategies to maintain effeetive oxygen delivery to the 
tissue during hypothermie Eec have to aeeommodate the severe shift to the left 
of the ODC and that 835 , CavlO, and espeeially ERavare of value in monitoring 
systemie oxygenation. It is essential that both pump flow and hemoglobin 
eoneentrations are kept at adequately high levels to prevent an inerease in ERav 
above 1.0 and thus preventtissue hypoxia during hypothermie ECC 
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Chapter 10 
Blood transfusions, although sometimes necessary, have several 
disadvantages including transmission of infectious diseasesl transfusion 
reactions and isosensitization, and immunosuppression. Reducing the amount of 
homologous blood used perioperatively helps to diminish the risk of one of these 
complications occurring. The methods which can be employed to try to avoid 
homologous blood transfusions perioperatively include the use of several 
hemodilution techniques and the application of preoperative autologous blood 
donation. During hemodilution the hemoglobin level of the circulating blood is 
reduced, diminishing the oxygen carrying capacity of the blood. This is 
compensated for by several mechanisms which are discussed in chapter 2, 
including an increase in cardiac output (in anesthetized subjects mainly due to an 
increase in stroke volume). a redistribution of the cardiac output to meet the 
metabolic demands of different organs, possibly a shift of the oxygen 
dissociation curve, and an increase in oxygen extraction ratio. 
Extreme degrees of hemodilution can only be applied in experimental animal 
studies. As described in chapter 3, during extreme normovolemic hemodilution in 
anesthetized pigs we observed an increase in cardiac output mainly due to an 
increase in stroke volume (as described previously). Redistribution of the cardiac 
output occurred, with the heart and brains receiving a relatively large portion. 
The increase in cardiac output was able to largely compensate for the decrease 
in oxygen carrying capacity of the blood and total oxygen consumption was 
maintained. Catecholamines were excluded as a regulatory factor in these 
changes in this experimental model. The heart is further discussed in part two of 
chapter 3. During hemodilution oxygen delivery to the heart actually increased, 
resulting in a decrease in the oxygen extraction ratio despite an increase in 
myocardial oxygen consumption. However, this was accompanied by a 
redistribution of the intramural blood flow away from the subendocardial layer of 
the left ventricle indicating an exhaustion of the compensation mechanism 
(vasodilatation) in this layer. This could cause ischemia of the subendocardial 
layer during extreme hemodilution. 
Changes in mixed venous blood we re also studied during normoxic 
normovolemic hemodilution in pigs and the results are presented in chapter 4. 
The balance between oxygen delivery and oxygen consumption is influenced by 
hemodilution, causing changes in the mixed venous blood. These changes 
include a decrease in mixed venous oxygen saturation and mixed venous oxygen 
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pressure. In this study, oxygen supply dependent oxygen consumption started at 
a mean mixed venous oxygen pressure of 32.2 mmHg and a mean mixed venous 
oxygen saturation of 44%. The oxygen extract ion ratio at this point was 0.57. 
We also studied several aspects of different hemodilution techniques in 
humans. Chapter 5 presents the results of a randomized prospective controlled 
study in which we compared during general anesthesia the effe cts of acute 
preoperative normovolemic hemodilution and the more gradual peroperative 
normovolemic hemodilution with another method of reducing the amount of 
homologous blood used, namely preoperative autologous blood donation. All 
hemodynamic changes that have been described previously we re also observed 
in this study. In addition, we found an increase in pulmonary wedge pressure as 
the hematocrit was reduced. This is probably due to the reduction blood 
viscosity which is induced by hemodilution causing an increase in venous return. 
Given the critical value of a mixed venous oxygen pressure of 32.2 mmHg 
measured during the experimental study described in chapter 4, we tried to 
evaluate whether during this study some patients reached this critical level. We 
found such measurements of Pvo, in 18 out of 30 hemodilution patients at a 
mean hemoglobin level of 4.8 ± 0.2 mmol!1. This indicates th at at a hemoglobin 
level of less than 4.8 mmol!1 in some patients a deficiency in oxygen delivery 
may occur. Also 3 out of 10 control patients at some point during the study had 
Pvo, va lues below 33 mmHg at a ehmoglobin level > 6.0 mmol/l. Further 
analysis showed that these 3 patients had a large change in P,o indicating a 
significant leftward shift of the oxygen hemoglobin dissociation curve, which 
was not found in the 18 hemodilution patients. Therefore, we concluded that the 
low values of Pvo, in the hemodilution patients might be due to a decreased 
oxygen delivery brought about by the decrease in hemoglobin level, while in the 
control patients the decrease in Pvo, might be due to a decreased oxygen 
availability induced by the leftward shift of the oxygen dissociation curve. The 
least number of homologous blood transfusions we re needed peroperatively in 
the PABD group (0.5 ± 0.3 U), and the highest number in the control group (5.9 
± 0.8 U). In the ANH and NHD group these numbers we re 2.0 ± 0.7 U and 4.3 
± 0.5 U, respectively. There was no significant difference in blood loss between 
the four groups. 
Hypervolemic hemodilution is a more practical and less time consuming 
method for achieving acute preoperative hemodilution, but introduces the risk of 
volume overload. The results of a study on the efficacy and safety of 
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hypervolemic hemodilution in anesthetized Jehovah's Witness patients are 
presented in chapter 6. Hemodynamic consequences of this technique are 
largely the same as those of normovolemic hemodilution, with the exception of a 
larger increase in filling pressures (pulmonary wedge pressure and pulmonary 
artery pressure). Inducing hypervolemia by administration of 1500 mi colloid 
combined with 1 500 mi of lactated Ringer' s did not cause any problems in the 
patients studied, especially no signs of cardiac failure. Furthermore, there was 
no significant difference in packed cell volume between patients who had lost 
less than or greater than 20% of their initial blood volume. One of the questions 
th at remains to be answered is whether hypervolemic hemodilution influences 
the total amount of blood loss during surgery. 
Transesophageal echocardiographic evaluation during hypervolemic 
hemodilution showed that the increased cardiac output was solely due to an 
increase in stroke volume. This increase in stroke volume was associated with 
an increase in end-diastolic area of the left ventricle, followed by a decrease in 
end-systolic area. No progressive cardiac dilatation occurred as wedge pressures 
increased. 
Thus, hypervolemic hemodilution was a safe method that allowed major 
surgery in patients refusing the use of blood products. Unfortunately, ho wever, 
one Jehovah's Witness patient with a preoperative anemia died due to a massive 
hemorrhage peroperatively, despite the application of hypervolemic hemodilution. 
This case report is presented in chapter 7. For this patient during the extreme 
hemodilution we we re able to measure several parameters at the critical point of 
hemodilution, as we had previously done in an experimental model. Oxygen 
supply dependent oxygen consumption started at an oxygen delivery of 184 
ml/m'/min at a hemoglobin level of 4.0 g/dl (2.4 mmol/l). Analysis of mixed 
venous blood gases at this critical point showed a mixed venous oxygen 
pressure of 34 mmHg and a mixed venous oxygen saturation of 56%, with an 
oxygen extraction ratio of 0.44. 
Monitoring is an important issue during hemodilution. The aim is to prevent 
any complications caused by a too extreme lowering of the hemoglobin level. 
Mixed venous blood gas values reflect the balance bet ween oxygen consumption 
and oxygen delivery and therefore are important parameters during hemodilution. 
Catheters to measure mixed venous oxygen saturation continuously are 
available, and might be useful as an on-line monitoring tooi during profound 
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hemodilution. However, their accuracy during acute changes in hematocrit or 
cardiac output has been questioned. Chapter 8 presents an evaluation of two 
different types of catheters. One uses three wavelengths (Opticath®), while the 
other uses only two wavelengths but receives backscatlered light via two other 
fibers (Spectracath®). Analysis of the accuracy of these two catheters during 
hypervolemic hemodilution folio wed by surgical blood loss, and thus during 
acute changes in hematocrit and cardiac output, showed that reliability was not 
influenced by changes in hematocrit or pulmonary wedge pressure. Changes in 
cardiac output, however, did have a slight influence on the accuracy of the 
Opticath®, but not on the accuracy of the Spectracath®. No drift was observed in 
either of the two systems. Therefore both catheters can be used to measure 
mixed venous oxygen saturation to assess the oxygen transport capacity of the 
blood. 
In an atlempt to improve the accuracy of predicting when oxygen supply 
becomes critical during hemodilution a new parameter is introduced in chapter 9. 
The amount of oxygen which the tissues can extract is determined by the 
amount of oxygen available for extraction. The normal oxygen extraction ratio 
(ER) is calculated by dividing oxygen consumption by total oxygen delivery. 
However, not all the oxygen bound to hemoglobin and dissolved in the plasma is 
available for delivery to the tissues. Therefore, the modified extraction ratio of 
the available oxygen (ERav) uses the available oxygen content rather than total 
oxygen content for calculation of available oxygen delivery. The ERav is delined 
as oxygen consumption divided by the available oxygen delivery. The S35 is 
delined as the saturation at which the oxygen pressure of the blood is 35 
mmHg. Using this S35 the amount ol oxygen actually available in the blood can 
be calculated and used lor calculation ol the ERav. The ERav is thus inlluenced 
by changes in the position ol the oxygen dissociation curve. A leftward shift wil! 
reduce the availability ol oxygen to be delivered to the tissue and wil! therefore 
reduce the amount ol available oxygen despite a constant total oxygen delivery. 
A leftward shift ol the oxygen dissociation curve will not inlluence the normal 
ER, but will increase the ERav. This theory has been tested during extreme 
hemodilution in pigs, and during the combination ol hemodilution with a 
decrease in body temperature in hu mans. During extreme hemodilution in 
anesthetized pigs a decrease in S35' indicating a rightward shift of the oxygen 
dissociation curve, with an increase in oxygen availability was observed. 
Theoretically the critical point of oxygen delivery should start at an ERavol 
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1.00. Oxygen consumption started to decrease in this study at an ERav of 1.08 
± 0.09, while plotting the mean ERav against the cOffesponding oxygen 
consumption resulted in a critical ERav of 1.06. 
In anesthetized hu mans the study on S35 and ERav was conducted during 
extracorporeal circulation. Lowering of the body temperature caused a leftward 
shift of the oxygen dissociation curve with an increase in the S35' This reduced 
the available oxygen reserve, which was reflected by an increase in ERav to 
1.05 ± 0.20. At this point hypoxia may have existed in some cases. This 
suggests that the use of S35' available oxygen content and especially ERavare of 
value in monitoring the systemic oxygenation. 
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Bloedtransfusies lijken vaak een levensreddende functie te hebben, maar. 
leveren ook heel wat gezondheidsrisico's op. Deze risico's omvatten transfusie 
reacties, een verkeerde bloedtransfusie, overdracht van diverse infecties (o.a. 
HIV, hepatitis, CMV), onderdrukking van het immuunsysteem (met daardoor een 
grotere kans op postoperatieve ontstekingen en mogelijk ook een grotere kans 
op terugkeer van kanker). Verder zijn de kosten verbonden aan deze 
bloedtransfusies niet onaanzienlijk. Redenen genoeg om te proberen deze 
transfusies zoveel mogelijk te vermijden. Hiertoe staan de anesthesioloog een 
aantal methoden ter beschikking, waaronder de toepassing van diverse 
hemodilutie (bloedverdunning) technieken, de intraoperatieve cell saving techniek 
(waarbij het bloedverlies in een speciaal reservoir opgevangen, daarna gewassen 
wordt en vervolgens terug gegeven kan worden aan de patiënt) en het gebruik 
van bloed door de patiënt zelf gedoneerd bij de bloedbank (preoperatieve 
autologe bloed donatie, PABO). 
De besparing op het aantal homologe bloed transfusies door hemodilutie 
technieken wordt bereikt door het feit dat verdund bloed minder erythrocyten 
(rode bloed cellen) bevat, zodat er per liter bloedverlies ook minder erythrocyten 
verloren gaan. In hoofdstuk 2 wordt ingegaan op de diverse compensatie 
mechanismen (zoals die ook werden waargenomen bij de diverse studies in dit 
proefschrift) die in werking treden tijdens de toepassing van hemodilutie. 
Doordat er per liter bloed minder erythrocyten zijn, kan er ook minder zuurstof 
vervoerd worden per liter bloed. Het lichaam compenseert hiervoor door een 
verhoging van het hartminuutvolume (per minuut stromen meer liters bloed door 
het lichaam); een verhoging van de zuurstof extractie ratio (ER, deze wordt 
berekend door de zuurstof consumptie te delen door het zuurstof aanbod; een 
grotere ER betekent dat een groter deel van de hoeveelheid zuurstof in het bloed 
door de weefsels uit het bloed gehaald wordt); een andere verdeling van het hart 
minuten volume (waarbij organen met een relatief hoge zuurstof behoefte, zoals 
hart en hersenen, een relatief groot deel van het hart minuten volume krijgen); 
een verschuiving van de zuurstof dissociatie curve (waardoor het hemoglobine in 
de erythrocyten makkelijker zuurstof afgeeft aan de weefsels). 
Hoofdstuk 3 beschrijft een studie naar de effecten van hemodilutie in 
varkens onder algehele anesthesie. In deze studie wordt aangetoond dat de 
stijging van het hartminuut volume een voldoende compensatie geeft voor de 
afname van het zuurstof dragend vermogen van het bloed tijdens hemodilutie en 
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dat deze stijging voornamelijk veroorzaakt wordt door een toename van het 
slagvolume van het hart en dus niet door een toename van de hartfrequentie. 
Verder werd er een toename gezien van de doorbloeding van alle organen, met 
de grootste toename in hart en hersenen (dus een herverdeling van het hart 
minuut volume). Deze toename was zo groot dat het zuurstof aanbod aan bijna 
alle organen gehandhaafd werd. In het hart werd zelfs een toename van het 
zuurstof aanbod gezien. De lichaams zuurstof consumptie werd hierbij volledig 
gehandhaafd. De zuurstof consumptie door het hart nam iets toe, echter zonder 
een toename van de zuurstof extractie ratio door het hart. Verder werd er 
gekeken of circulerende catecholamines ("stress hormonen") een rol speelden bij 
deze veranderingen: een stijging van deze hormonen werd niet aangetoond. In 
deel twee van hoofdstuk 3 worden de veranderingen in het hart tijdens deze 
varkens experimenten nader belicht. De waargenomen toename van het zuurstof 
aanbod aan het hart is voldoende om de toename van het zuurstof verbruik door 
het hart te compenseren. Echter er wordt een herverdeling gezien van de 
doorbloeding van de linker hartkamer, waarbij de subendocardiale (binnenste) 
laag de relatief kleinste toename liet zien in doorbloeding. Dit wijst erop dat 
binnen het hart compensatie mechanismen in werking treden tijdens hemodilutie 
die bij een te ver doorgevoerde verdunning van het bloed kunnen leiden tot een 
zuurstofgebrek van de subendocardiale laag van de linker hart kamer. Extra 
aandacht hiervoor is nodig in situaties waarbij het zuurstof gebruik door het hart 
verhoogd is of als er beperkingen zijn aan het (maximale) zuurstof aanbod naar 
het hart. 
Hoofdstuk 4 belicht de veranderingen die in de bloedgas waarden optreden 
tijdens hemodilutie in varkens. Een belangrijk probleem tijdens hemodilutie is dat 
het zuurstof aanbod naar het lichaam voldoende moet blijven. Dat wil zeggen er 
moet een balans blijven bestaan tussen zuurstof aanbod en zuurstof verbruik 
door het lichaam. Deze balans wordt gereflecteerd in bepaalde bloedgas waarden 
in het gemengd veneuze bloed (dat is het zuurstofarme bloed verzameld uit het 
hele lichaam, na menging in de rechter harthelftl. met name de gemengd 
veneuze zuurstof saturatie (SvO,) en de gemengd veneuze zuurstof spanning 
(PvO,). Voor deze waarden bestaan kritische grenzen, waarbij er een tekort 
schieten van het zuurstof aanbod aan het lichaam verondersteld wordt als deze 
waarden onder die kritische grens dalen. Op dat moment begint de zuurstof 
consumptie van het lichaam afhankelijk te worden van het zuurstof aanbod en 
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zal dus gaan dalen. Deze knik in de zuurstof consumptie kan gebruikt worden om 
het kritische punt te bepalen. Op deze manier werd bepaald dat in varkens de 
kritische PvO, 32.2 ± 3.1 mmHg en de kritische SvO, 44.2 ± 7.9 % waren. De 
zuurstof extractie ratio (ER) bij dit kritische punt was 0.57 ± 0.08. 
In mensen werd gekeken naar de effecten Van verschillende technieken om 
te besparen op het aantal benodigde homologe (dat wil zeggen niet van de 
patiënt zelf) bloedprodukten rondom een operatie. In hoofdstuk 5 zijn 3 
verschillende methoden (acute normovolemische hemodilutie (ANH), 
pre operatieve donatie van eigen bloed (PABO) en een meer geleidelijke vorm van 
hemodilutie tijdens de operatie (NHD) met elkaar en met een controle groep 
vergeleken. Dit gebeurde bij mannen die onder algehele anesthesie een operatie 
ondergingen die over het algemeen gepaard gaat met veel bloedverlies. Er werd 
gekeken naar de effecten van de verschillende technieken op hemodynamiek 
(onder andere het hartminuutvolume, diverse bloeddrukken, en de zogenaamde 
vullingsdrukken, waaronder de pulmonale wiggedruk), de zuurstofvoorziening 
van .. het lichaam, gebruik van bloedprodukten en bloedverlies. Hierbij werd 
gevonden dat het minste aantal homologe bloedprodukten van de bloedbank 
gebruikt werden in de groep met PABO, gevolgd door de groep met ANH. De 
meeste homologe bloedprodukten werden gebruikt bij de patiënten in de controle 
groep. Tijdens hemodilutie werden dezelfde compensatie mechanismen gezien 
als in andere studies (toename hartminuut volume en toename zuurstof extractie 
ratio). Ondanks het feit dat er sprake was van een streven naar normovolemie 
(d.w.z. een gelijkhouden van het normale circulerende volume) werd er een 
toename van de pulmonale wiggedruk ("vullingsdruk") waargenomen naarmate 
de hematocriet verder daalde. Waarschijnlijk kan dit verklaard worden door een 
afname van de viscositeit (stroperigheid) van het bloed waardoor het bloed 
sneller gaat stromen, met name in die delen van het vaatstelsel met een trage 
stroomsnelheid (d.w.z. het veneuze = zuurstofarme bloed vervoerende deel van 
de circulatie). Hierdoor neemt de hoeveelheid bloed die per minuut terugkeert 
naar het hart toe, waardoor de pulmonale wiggedruk zal stijgen. Verder hebben 
we gekeken of er patiënten waren die ergens tijdens de studie periode een punt 
bereikten waarbij er een aanwijzing is dat het zuurstof aanbod naar de weefsels 
in gevaar komt. Als aanwijzing hiervoor gebruikte we het feit dat de PvO, daalde 
onder de waarde van 33 mmHg (dit is de waarde die gevonden was tijdens het 
al eerder beschreven varkens experiment). Dit gebeurde inderdaad bij achttien 
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van de dertig hemodilutie patiënten, bij een gemiddeld hemoglobine gehalte van 
4.8 ± 0.2 mmol!1. Het is dus mogelijk dat bij een aantal patiënten er een 
tekortschieten van het zuurstof aanbod kan ontstaan bij een Hb < 4.8 mmol!1. 
Bij een controle hierop in de controle groep werden er ook drie van de tien 
patiënten gevonden die onder deze grens zakten met hun PvO,. Hiervoor kon 
echter een verklaring gevonden worden in de vorm van een linksverschuiving 
van de zuurstof dissociatie curve. Dit betekent dat het hemoglobine moeilijker 
zuurstof kan afstaan aan de weefsels, waardoor ondanks een gelijkblijven van 
het totale zuurstof aanbod, de hoeveelheid beschikbare zuurstof afneemt, en er 
via dat mechanisme een relatief tekort aan zuurstof kan ontstaan in de weefsels. 
Deze linksverschuiving kan onder andere veroorzaakt worden door het geven van 
een bloedtransfusie met relatief oud bloedbank bloed, waarvan de zuurstof 
dissociatie curve naar links verschoven is dOOf een afname van het 2,3-DPG 
gehalte. 
In hoofdstuk 6 is een andere vorm van hemodilutie, namelijk de 
hypervolemische hemodilutie toegepast in patiënten die tevens Jehova's 
getuigen zijn. Deze mensen weigeren de toediening van alle vormen van 
bloedprodukten op religieuze gronden. Bij de techniek van hypervolemische 
hemodilutie wordt het circulerend volume uitgebreid door toevoeging van plasma 
vervangende vloeistoffen, en wordt het bloed op deze manier verdund. 
Hypervolemische hemodilutie heeft het voordeel dat het in de praktijk veel 
minder arbeidsintensief is dan ANH. Het nadeel van deze methode is dat er een 
kans bestaat op acute overvulling van de patiënt. We bekeken de efficiëntie en 
veiligheid van deze methode. Er werd geen verschil gezien in het hemoglobine 
gehalte na de operatie tussen een groep met een bloedverlies kleiner dan 20% 
van hun circulerend bloedvolume en een groep met een bloedverlies groter dan 
200/0 van hun circulerend volume. Een toename van het hartminuut volume werd 
gezien, met een toename van de pulmonale wiggedruk (een maat voor de vulling 
van het vaatstelsel), echter zonder tekenen van hartfalen of overvulling (bekeken 
via onder andere transoesofageale echocardiografiel. Deze techniek gaf geen 
complicaties in de bestudeerde patiënten, en maakte in deze groep patiënten ook 
grotere operaties mogelijk zonder de toediening van bloed transfusies. 
Helaas was deze techniek niet in staat alle patiënten veilig door een 
operatie te krijgen. Eén patiënt overleed ten gevolge van een te sterke daling van 
het hemoglobine gehalte. Het beloop bij deze patiënt wordt beschreven in 
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hoofdstuk 7. Het betrof een man met maagkanker en tengevolge daarvan een 
bloedarmoede. Tijdens de operatie was een onverwacht groot bloedverlies ten 
gevolge van een scheur in de milt. Met toestemming van de familie werden de 
verzamelde getallen in een artikel gepubliceerd, omdat uit deze casus iets valt te 
leren over de kritische grenzen van het zuurstof aanbod, zoals ook beschreven in 
hoofdstuk 4. Bij deze patiënt lag de kritische grens van het zuurstof aanbod 
tijdens deze extreme vorm van hemodilutie bij 184 ml/m'/min (4.9 mi/kg/min) bij 
een hemoglobine gehalte van 4.0 g/dl (= 2.4 mmol/ll. Analyse van het gemengd 
veneuze bloed liet zien dat op dit kritische punt de PvO, 34 mmHg, de SvO, 
56%, en de ER 0.44 waren. In hoeverre één patiënt echt iets kan zeggen over 
toepasbaarheid bij alle mensen is niet goed uit te maken, maar de getallen die 
gevonden werden kwamen goed overeen met die tijdens de varkens 
experimenten. 
Zo lijkt het er dus op dat de gemengd veneuze zuurstof saturatie een maat 
is voor de beoordeling van de balans tussen zuurstof aanbod en consumptie 
tijdens hemodilutie. Deze waarde is tegenwoordig continu te meten met behulp 
van bepaalde catheters. Het was echter niet duidelijk of deze catheters ook 
nauwkeurig blijven meten tijdens de snelle en grote veranderingen in 
hemoglobine gehalte en hart minuut volume, zoals die vaak optreden rondom 
operaties. Daarom werden 2 catheters getest op hun nauwkeurigheid in 
patiënten tijdens operaties waarbij gebruik werd gemaakt van hypervolemische 
hemodilutie en dus snelle veranderingen optraden in hemoglobine gehalte en hart 
minuutvolume. De resultaten hiervan zijn weergegeven in hoofdstuk 8. Beide 
catheters bleken goed bruikbaar en betrouwbaar, zodat deze catheters toegepast 
kunnen worden in situaties met groot bloedverlies. De gemeten SvO, waarden 
kunnen dan mede gebruikt worden om het moment dat een transfusie 
noodzakelijk wordt te bepalen. Een nadeel hiervan is dat het getal niet.; zegt over 
individuele organen, maar alleen over het zuurstof aanbod aan het hele lichaam. 
Tenslotte hebben we gepoogd een parameter te ontwikkelen die nog 
nauwkeuriger zou kunnen voorspellen wanneer de kritische grens van 
hemodilutie bereikt wordt. Dit wordt beschreven in hoofdstuk 9. Als 
uitgangspunt werd hierbij genomen dat het zuurstof aanbod naar de weefsels 
bepaald wordt door de hoeveelheid zuurstof die daadwerkelijk beschikbaar is om 
afgegeven te worden vanuit het bloed en dus niet door de totale hoeveelheid 
zuurstof in het bloed. Als de PvO, in het gemengd veneuze bloed onder de al 
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eerder beschreven waarde van 33 mmHg daalt, bestaat de kans dat er in de 
weefsels een zuurstof tekort optreedt. Dat wil zeggen dat van alle zuurstof die 
aanwezig is in het arteriële zuurstof-rijke bloed, alleen de hoeveelheid die als het 
ware boven deze waarde aanwezig is ook daadwerkelijk beschikbaar is om 
effectief afgegeven te worden aan de weefsels. Bij een discussie over zuurstof 
transport wordt er in het algemeen gesproken over de zuurstof extractie ratio 
(ER). Dit is de zuurstof consumptie gedeeld door het totale zuurstof aanbod. Wij 
hebben deze ratio gemodificeerd naar de zu urstof extractie ratio van het 
beschikbare zuurstof (ERav). Dit is de zuurstof consumptie gedeeld niet door het 
totale zuurstof aanbod, maar gedeeld door de hoeveelheid zuurstof die 
theoretisch maximaal beschikbaar is (dus de hoeveelheid die afgegeven kan 
worden tot de zuurstof spanning in het bloed gedaald is onder de 33 mmHg). 
Om deze waarde te kunnen berekenen wordt er gebruik gemaakt van de S", dat 
is de zuurstof saturatie bij een zuurstof spanning van 35 mmHg. Hierdoor wordt 
de ERav, in tegenstelling tot de ER, mede afhankelijk van de ligging van de 
zuurstof dissociatie curve. Dit is geëvalueerd in twee verschillende situaties. De 
eerste in een dier experimenteel model, waarbij extreme hemodilutie toegepast 
werd. Hierbij werd gezien dat als de zuurstof extractie ratio van het beschikbare 
zuurstof inderdaad steeg boven de 106% (de theoretisch maximale extractie 
ratio is 100%) er inderdaad een daling optrad van de zuurstof consumptie. Dit 
wijst erop dat de weefsels niet meer alle benodigde zuurstof uit het bloed 
konden halen. Een tweede studie werd uitgevoerd in mensen die een operatie 
ondergingen waarbij gebruik gemaakt werd van de hart-long machine. Tijdens 
dergelijke procedures wordt naast een verdunning van het bloed (hemodilutie) de 
lichaamstemperatuur verlaagd. Een gunstig effect van deze verlaging van de 
temperatuur is dat de zuurstof consumptie van het lichaam afneemt. Een nadeel 
hiervan is echter dat de zuurstof dissociatie curve naar links verschuift, wat 
inhoudt dat het hemoglobine moeilijker zuurstof kan afstaan aan weefsels. Dit 
houdt dus in dat de hoeveelheid daadwerkelijk beschikbare zuurstof in het bloed 
afneemt bij een gelijkblijven van de totale hoeveelheid zuurstof in het bloed. Met 
behulp van de ERav kon dit verschijnsel inderdaad aangetoond worden. Een 
nadeel van deze meting is wederom dat het alleen een maat is voor het lichaam 
als geheel en geen antwoord geeft op de vraag of de individuele organen en 
weefsels voldoende zuurstof aangeboden krijgen. 
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Ik wil de medewerkers van de diverse laboratoria bedanken voor hun 
bereidwilligheid de extra bepalingen die het doen van onderzoek met zich 
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meebrengen uit te voeren. 
Prof. Dr. Schröder en alle artsen van de afdeling Urologie wil ik bedanken 
voor de mogelijkheid onderzoek te doen tijdens de operaties waarbij zij als 
operateur vaak wel de lasten, maar niet de lusten van mijn onderzoek hebben 
bemerkt. 
Ook alle andere medewerkers van de afdeling Urologie ben ik veel dank 
verschuldigd voor al het geduld waarmee zij mij geholpen hebben voldoende 
patiënten en zoveel mogelijk getallen te verzamelen. Met name de prikzuster van 
10 Noord, Ank Dekker wil ik bedanken voor het zeer trouw nalopen of wel op de 
juiste momenten de juiste buizen bloed werden afgenomen bij "mijn" patiënten. 
Iedereen die ooit op een van de Intesive Care afdelingen geconfronteerd is 
met één van "mijn" patiënten wil ik bedanken voor hun bijdrage. Zonder hun was 
het afronden van mijn laatste onderzoek onmogelijk geweest. 
Ik dank de firma's Fresenius B.V. en Radiometer Nederland B.V. voor hun 
verleende steun. 
Mijn moeder wil ik bedanken voor haar altijd aanwezige hulp, steun en 
liefde. Zonder haar zou het schrijven van dit proefschrift absoluut onmogelijk 
geweest zijn. 
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CURRICULUM VITAE 
De schrijfster van dit proefschrift werd op 19 september 1963 te Rotterdam 
geboren. In 1981 behaalde zij het diploma VWO aan het Emmaus College te 
Rotterdam. In 1981 begon zij aan de studie Biologie aan de Rijksuniversiteit van 
Leiden, alwaar zij in 1982 haar propedeuse Biologie haalde. In 1982 begon zij 
met de studie Geneeskunde aan de Erasmus Universiteit Rotterdam, alwaar zij op 
14 juli 1989 het artsexamen behaalde. Haar werkzaamheden op de afdeling 
anesthesiologie van het Academisch Ziekenhuis Rotterdam Rotterdam/Sophia 
begonnen in augustus 1989. Het eerste jaar was dit als AGNIO op een research 
plaats grotendeels doorgebracht op de afdeling Experimentele Cardiologie van 
prof. Or. P.D. Verdouw, gevolgd door een jaar AGNIO anesthesiologie in het 
Dijkzigt ziekenhuis. Hierna volgde van juli 1991 tot juli 1996 haar opleiding tot 
anesthesiologe onder leiding van prof. Dr. W. Erdmann. Sinds juli 1996 is zij als 
anesthesiologe werkzaam in het Academisch Ziekenhuis Rotterdam Dijkzigt en 
het Sophia Kinder Ziekenhuis. 
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